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Preface
This thesis describes the projects I have worked on during my Ph.D. studies
from April 2007 to June 2010. Part I describes the results of the work carried
out in the Clausen group at DTU, and Part II describes the results of the work
conducted during a 6 months external stay from January to July 2009 in the
Williams group at the University of Queensland (UQ), Brisbane, Australia.
Part I comprises four chapters. In Chapter 1, an introduction to diversity-
oriented synthesis, and a review of diversity-generating strategies toward
libraries of macrocyclic compounds, are given. Chapter 2 includes a descrip-
tion of the strategy for the project and the results which are rounded off
by a conclusion in Chapter 3. Finally, Chapter 4 contains the experimental
procedures used in this project.
Part II consists of Chapter 5, covering an introduction to single walled
carbon nanotubes and techniques for their separation, and a description of
the concept of the project and the results. Furthermore, the chapter contains
a concluding part, summing up the results of the project and giving an
outlook for the future, and finally an experimental section containing the
procedures used in the project.
Appendix A contains a list of abbreviations used in this thesis.
Appendix B includes two published/submitted articles I have worked on
during my Ph.D. studies.
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Abstract
Part I
The formation of a library of diverse macrocyclic compounds with different
functionalities and ring sizes in a few steps from two easily accessible α,ω-diol
building blocks is presented. The building blocks are combined by esterifi-
cations in four different ways leading to the formation of four structurally
isomeric diol precursors. These are then reacted with electrophilic reagents
leading to 17-membered sulfites and 19-membered malonates in reasonable
yields, and 20-22-membered phthalates and an 18-membered oxalate in low
yields. Double-reductive amination of dialdehyde analogs of the diol precur-
sors leads to 15-membered amines in yields ranging from 9 to 60%, reflecting
large differences in reactivity based on steric environment. The convertion
of the two least sterically hindered diols into diiodide analogs is also pre-
sented. However, the desired cyclizations of these precursors have not been
successful.
Part II
The formation and subsequent coupling of a monosilver(I) acetylide of 2,3-
diethynyltriptycene is presented. The silver(I) acetylide is formed in high
yield from both 2,3-diethynyltriptycene and 2,3-di(trimethylsilylethynyl)trip-
tycene by use of the same reagent. Coupling of the silver(I) acetylide with
1-iodoadamantane is demonstrated. Furthermore, attempts at the synthesis
of 1,3-difluoro-5,7-diiodoadamantane from 1,3,5,7-tetraiodoadamantane are
presented. Unfortunately, the reaction is found to be uncontrollable by use
of two different reagents, giving a mixture of fluoro-iodoadamantanes. How-
ever, overall the results provide a good starting point for the synthesis of
new triptycene and adamantane-containing molecules that can interact with
carbon nanotubes.
v
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Danish abstract
Part I
Dannelsen af et mangfoldigt bibliotek af makrocykliske stoffer med forskel-
lige funktionaliteter og ringstørrelser i f˚a trin fra to let tilgængelige α,ω-
diol-byggeblokke bliver præsenteret. Byggeblokkene bliver kombineret ved
esterificeringer p˚a fire forskellige ma˚der, der fører til dannelsen af fire struk-
turelt isomere dioler. Disse bliver derefter reageret med elektrofile reagenser,
hvilket fører til 17-leddede sulfitter og 19-leddede malonater i rimelige ud-
bytter, samt 20-22-leddede phthalater og et 18-leddet oxalat i lave udbytter.
Dobbelt-reduktiv aminering af dialdehyd-analoger af diolerne fører til 15-
leddede aminer i udbytter der ligger mellem 9 og 60%, hvilket afspejler store
forskelle i reaktivitet baseret p˚a sterisk miljø. Konverteringen af de to mindst
sterisk hindrede dioler til diiodid-analoger bliver ogs˚a præsenteret. Imidlertid
er de ønskede cykliseringer af disse substrater ikke lykkedes.
Part II
Dannelse og efterfølgende kobling af et monosølv(I) acetylid af 2,3-diethynyl-
triptycen bliver præsenteret. Sølv(I) acetylidet dannes i et højt udbytte fra
b˚ade 2,3-diethynyltriptycen og 2,3-di(trimethylsilylethynyl)triptycen ved an-
vendelse af samme reagens. Kobling af sølv(I) acetylidet med 1-iodadamantan
bliver demonstreret. Desuden bliver flere forsøg p˚a syntesen af 1,3-difluor-5,7-
diiodadamantan fra 1,3,5,7-tetraiodadamantan præsenteret. Desværre har
reaktionen vist sig at være vanskelig at kontrollere ved brug af to forskellige
reagenser, der begge fører til dannelsen af en blanding af fluor-iodadamanta-
ner. Imidlertid udgør resultaterne samlet set et godt udgangspunkt for syn-
tese af nye triptycen- og adamantanbaserede molekyler, der kan interagere
med kulstof-nanorør.
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Chapter 1
Macrocyclic drug discovery -
from natural products to
diversity-oriented synthesis
Macrocyclic compounds are attractive compounds for drug discovery due to
the fact that naturally occuring macrocycles often display diverse and inter-
esting biological activities. These include for example antibiotic, antifungal,
anticancer and immunosuppressive activities as seen for erythromycin (1),1
amphotericin B (2),2 epithilone B (3)3 and rapamycin (4),4 respectively (see
Figure 1.1).
The reason for the biological activity can be found in several structural
advantages characteristic for macrocyclic compounds. They are conforma-
tionally preorganized, enabling them to bind selectively to targets with min-
imal entropic loss. However, they have a certain flexibility, which, in combi-
nation with their functionally independent subregions, enables them to bind
non-covalently to each other (e.g. 25) or to mediate the assembly of other
macromolecules by non-covalent interactions (e.g. 46). Furthermore, they
have the ability of burying away polar functionalities, leading to improved
membrane permeability as compared to their linear analogs. Proteolytic and
metabolic stability is also improved as a consequence of the reduced accessible
conformational space.7 An example of a synthetic macrocycle with improved
target selectivity as compared to its linear analog is the cyclic compound
5, which is a 17-fold more potent inhibitor of the matrix metalloproteinase
MMP-8 than the linear analog 6 (Figure 1.2).8
3
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Figure 1.1: Structures of naturally occuring macrocyclic drugs: erythromycin (1), am-
photericin B (2), epithilone B (3) and rapamycin (4).
Figure 1.2: Compounds 5 and 6 are inhibitors of MMP-8, which is a member of the
family of MMPs needed for maintenance of the extracellular matrix. The macrocyclic
compound 5 is a 17-fold more potent inhibitor than the linear analog 6.
1.1 Lessons from nature
Current macrocyclic drugs are almost exclusively derived from natural sources
and are either identical to or closely related to naturally occuring macrocy-
cles.9 Despite the valuable characteristics described above for macrocyclic
compounds and the proven success of more than a hundred marketed macro-
cyclic drugs, so far, this compound class has been poorly explored within
drug discovery.7 The main reason for this is the often complex structures of
naturally occuring macrocycles and the synthetic effort thus required.
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However, it is possible to prepare significantly less complex synthetic
macrocycles, and valuable inspiration for this can be found in nature. Hence,
it has been found that some substructures are frequently present in naturally
occuring macrocycles. These are, for example, polyketides, heterocycles,
peptide, biphenyl and (bi)aryl ether domains.10
An approach, combining natural product drug discovery with combinato-
rial chemistry has been suggested.11, 12 This strategy relies on the design of
synthetic compounds from easily accessible building blocks containing natu-
rally occurring substructural motifs, and hence it gives rapid access to syn-
thetic libraries of compounds resembling natural products.
1.2 Diversity-oriented synthesis
In recent years, a field named diversity-oriented synthesis (DOS) has been
employed within chemical biology.13, 14 Whereas target-oriented synthesis
(TOS) aims to access a single target structure with known or predicted prop-
erties, and combinatorial chemistry aims to access a collection of analogs of
such a structure, the aim in DOS is to populate chemical space∗ broadly with
complex and diverse structures having unknown properties (Figure 1.3).14
Figure 1.3: Illustration of the difference between TOS (a), combinatorial synthesis (b),
and DOS (c) in terms of the occupation of chemical space.
1.2.1 Planning of DOS
TOS comprises linear and convergent synthetic pathways, which are planned
in the reverse-synthetic direction by using retrosynthetic analysis, going from
complex→simple. In contrast, DOS is planned by using forward-synthetic
∗Chemical space is multidimensional. Each dimension is defined by a descriptor, which
can be of biological or chemical nature.14
6
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analysis,15 going from simple and similar→complex and diverse, leading to
branched and divergent synthetic pathways.14
Complexity and diversity-generating reaction pathways, including pair-
wise relationships, where the product of one complexity and diversity-genera-
ting reaction is the substrate for another, are valuable in the planning of DOS
and can lead to highly complex and diverse products in just a few synthetic
steps starting from simple and similar building blocks.14
Complexity-generating reactions
Based on the structures and functions of natural products, it is suggested
that structural complexity may have a positive influence on macromolecule-
perturbing function and specificity of action. Hence, the aim of DOS is to
access small molecules with complex molecular skeletons,∗ and moreover, to
access more globular or spherical molecular skeletons as compared to the
relatively flat molecular skeletons often used in combinatorial chemistry. To
maximize efficiency, synthetic pathways in DOS should be no more than three
to five steps.14
Diversity-generating reactions
The desired diversity obtained from diversity-generating reactions can be
divided into three distinct diversity elements: appendage diversity, stereo-
chemical diversity and skeletal diversity.14
Appendage diversity: Obtained through the use of coupling reactions
to attach different appendages to a common molecular skeleton, leading to
the generation of all possible combinations of the skeleton and the used ap-
pendages. This process is identical to the central process in combinatorial
chemistry.14
Stereochemical diversity: Achieved through the use of enantio- or di-
astereoselective reactions, ideally producing a combinatorial matrix of stereo-
isomeric products in a process analogous to the above.14
Skeletal diversity: Obtained through two different strategies; a reagent-
based approach and a substrate-based approach (Figure 1.4). In the first
approach, a common substrate is transformed into a collection of products
having different molecular skeletons through the use of different reagents
(Figure 1.4a).13, 16, 17 The second approach involves the transformation of a
collection of substrates having different appendages that pre-encode skeletal
∗The overall three-dimensional shape of a complex molecular skeleton is defined by a
large number and/or variety of rigidifying elements: covalent bonds, non-covalent bonds,
and non-bonding interactions.14
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information (called σ elements) into a collection of products having different
molecular skeletons by the use of common reagents (Figure 1.4b).18
Figure 1.4: Illustration of the two general approaches for the generation of skeletal
diversity: (a) the reagent-based approach and (b) the substrate-based approach.
Simultaneous generation of complexity and diversity
To achieve high levels of both complexity and diversity, an approach in-
corporating complexity-generating reactions into stereochemical and skeletal
diversity-generating reactions has been suggested to be effective.19 Moreover,
there has recently been a growing interest in the development of a systematic
and general strategy for achieving this goal.20
1.3 Diversity-generating strategies toward li-
braries of new macrocycles
The formation of macrocyclic compounds rather than cyclic or linear oligo-
mers is challenging. Specifically, the conformation of the precursor has a large
influence on macrocyclizations,21 and it is often necessary to tailor reaction
conditions to individual substrates.22, 23 Hence, the synthesis of macrocycles
within DOS is difficult as it requires a cyclization method that is practical
and general enough to work reliably with a wide variety of substrates and
functional groups. Moreover, the minimization of steps and hereby the de-
mand to avoid protection groups is difficult. However, strategies toward this
goal have been developed.24
1.3.1 Multicomponent macrocyclizations
The use of multicomponent reactions (MCRs) involving bifunctional build-
ing blocks is an efficient approach for DOS. In particular, the Ugi reac-
8
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tion has been proposed to give the structural variation required for such
an approach.25 A strategy for the one-pot assembly of diverse and complex
macrocycles, mainly employing the Ugi four-component reaction (Ugi-4CR),
has been proposed by Wessjohann.26 This strategy has been termed ’multi-
ple multicomponent macrocyclization including bifunctional building blocks’
(MiB).26
The Ugi-4CR is a reaction between an isonitrile, an aldehyde, an amine,
and a carboxylic acid to form a dipeptide (Figure 1.5a). It is possible to
achieve highly diverse products by varying the substituents of each of the
four components. When this reaction strategy is expanded to involve two or
more MCRs for the formation of macrocycles, the resulting products may be
described as uni- or bidirectional (Figure 1.5b+c). The unidirectional prod-
uct is the result of an MiB involving unsymmetrically∗ bifunctional building
blocks and basically a higher homolog of the single Ugi macrocyclization (Fig-
ure 1.5b), whereas the bidirectional product is the result of an MiB involving
symmetrically bifunctional building blocks (Figure 1.5c).26
Recently, Wessjohann and co-workers demonstrated that the above strat-
egy is suitable for the rapid generation of diverse bidirectional macrocy-
cles with exocyclic substituents resembling natural products, e.g. 7 (Fig-
ure 1.6).28 In order to obtain appendage diversity by introducing natural-
product-like side chains in the one-pot process, carboxylic acid building
blocks with appended amino acids or carbohydrates were used. These were
combined with formaldehyde as the aldehyde building block, and different
diamines and diisocyanides as the bifunctional building blocks, containing
biaryl ether, heterocycle, heterofunctionalized chain or benzene moieties.
The diisocyanides were synthesized in two steps from the corresponding com-
mercially available diamines.28
Very recently, a new protocol for synthesizing cyclic peptides of type 8
(Figure 1.7) based on the Ugi-4CR was introduced by the group of Yudin.29
Amphoteric amino aldehydes with the nucleophilic center at the α-position
were shown to aid in high-yielding and stereoselective formation of cyclic pep-
tides. Initially, an imine was formed from the amino aldehyde and a linear
peptide. Subsequent cyclization of the resulting zwitterion with tert-butyl
isonitrile followed by transannular attack of the amine onto the mixed anhy-
dride yielded the cyclic peptides 8. Further diversification by ring opening
of the aziridine ring is possible.29
∗The term ’unsymmetrically bifunctional’ refers to a building block with two different
MCR reactive functional groups on either side of the molecule, whereas the term ’symmet-
rically bifunctional’ refers to a building block with two identical MCR reactive functional
groups on both sides of the molecule. This terminology is independent of the symmetry
or asymmetry of the core of the building block.26
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Figure 1.5: Illustration of: (a) the Ugi-4CR forming a dipeptide, (b) the use of unsym-
metrically bifunctional building blocks in Ugi-4CR MiB to obtain a unidirectional product,
and (c) the use of symmetrically bifunctional building blocks in Ugi-4CR MiB to obtain
a bidirectional product. FG1−4 refer to the Ugi-4CR reactive functional groups (-NC,
-CHO, -NH2, -COOH) in any combination.
27
Figure 1.6: The formation of bidirectional macrocycle 7 with carbohydrate (amino-
glucose) moieties.
1.3.2 Ringclosures of combinations of building blocks
A majority of approaches to DOS of macrocycles has been based on the for-
mation of cyclization precursors in a few steps from easily accessible building
blocks followed by cyclization by use of an established method, examples of
10
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Figure 1.7: Stereoselective formation of 8.
which are described below.
Macrolactonization and macrolactamization
Since naturally occurring macrocycles are often found to be lactones or lac-
tams,10 many examples of the application of lactonization and lactamization
ring closing methods have been reported. As a recent example of a diversity-
generating strategy based on macrolactonizations, the formation of a library
of diverse macrodiolides (e.g. 9 and 10 in Figure 1.8) has been demonstrated
by Panek and Porco.30 The strategy takes advantage of directly accessible
cyclization precursors (hydroxy esters) obtained through stereoselective ad-
dition of crotyl silanes to different electrophiles.31 The hydroxy esters are
then cyclodimerized (as illustrated in Figure 1.8a) by use of tin-catalyzed
transesterifications performed under microwave heating. Initial biological
evaluation of the library led to the identification of compound 10 (Figure
1.8b) as a κ opioid receptor antagonist that may have potential utility for
the treatment of various neuropsychiatric conditions (e.g. depression).30
Figure 1.8: (a) The synthesis of 9 through cyclodimerization of two different hydroxy
esters, and (b) the structure of another member 10 of a library of macrodiolides.
Analogously to the above described method, macrocyclic bislactams have
recently been synthesized by zirconium-catalyzed cyclodimerization of alloc-
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protected amino esters with the aim to facilitate transannular cyclizations
leading to polycyclic frameworks.32
Another example of a method employing macrolactonization is the syn-
thesis of complex polyketide-like macrocycles (e.g. 11 in Figure 1.9) reported
by the group of Leighton.33 These are formed through short syntheses of
simple polyol fragments followed by cyclization according to the Yamaguchi
macrolactonization protocol.34 Only the 14-membered macrocycles were pro-
duced in the macrolactonization reaction.33
Figure 1.9: Yamaguchi macrolactonization of a simple polyol fragment to yield the
complex polyketide-like macrocycle 11.
Ring-closing metathesis
Ring-closing metathesis (RCM) has become one of the most popular macro-
cyclization methods in natural product synthesis due the high functional
group compatibility, the possibility for further transformations, and the de-
velopment of stable catalysts.23 As a consequence hereof, the RCM reaction
has also found its way to DOS. Recently, a diversity-oriented approach em-
ploying a cross-enyne metathesis and RCM cascade (Figure 1.10) has been
presented by the group of Kotha.35 Cascade precursors were built from three
building blocks: glycine/α-aminoisobutyric acid, propargyl alcohol/bromide,
and an unsaturated alcohol/bromide. Various macrocycles (e.g. 12) were
generated through combination of the precursors with 1,5-hexadiene in the
tandem metathesis sequence. Linear side-products (e.g. 13) not undergoing
RCM were also formed.35
Click reactions
Sharpless et al. introduced the term ’click chemistry’ referring to simple,
selective, high-yielding reactions of easily accessible compounds.36 Within
this category, especially the Cu-catalyzed alkyne-azide cycloaddition37 has
been widely utilized in recent years.38 Obviously, this kind of reactions are
12
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Figure 1.10: Cross-enyne metathesis and RCM cascade to form macrocycle 12 and
side-product 13.
suitable for DOS, and, recently, a skeletal diversity-generating method em-
ploying alkyne-azide cycloadditions for macrocyclic ring formation has been
suggested by Marcaurelle and co-workers.39 Different simple azido alkyne
substrates were formed, which were used for both the Cu-catalyzed alkyne-
azide cycloaddition forming a 1,4-triazole (e.g. 14 in Figure 1.11) and the
recently introduced Ru-catalyzed alkyne-azide cycloaddition40 forming a 1,5-
triazole (e.g. 15). The latter is the first example of an intramolecular Ru-
catalyzed alkyne-azide cycloaddition.39
Figure 1.11: Catalyst controlled selective synthesis of macrocycles 14 and 15 from azido
alkyne substrate.
1.4 Modern techniques for macrocycle syn-
thesis
The large number of products synthesized in DOS and the required flash chro-
matography purifications render traditional solution phase synthesis imprac-
tical. Reactions that are selective, high-yielding, and rapidly creates more
diversity are required to make solution-phase synthesis convenient. Further-
more, syntheses in which purification does not have to be done after every
step are desired.24 Modern techniques have been developed to overcome these
problems and allow rapid access to huge libraries. These include solid-phase
synthesis, fluorous synthesis, and preparation on a DNA template.
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1.4.1 Solid-phase synthesis
There are many advantages to solid-phase synthesis when it comes to library
creation. Most importantly, the use of synthesis automization is possible.
Furthermore, the purification procedure is much more simple as compared
to solution-phase synthesis, and conversions are often higher as it is often
possible to use excess reagent. In case of macrocyclization, it is possible to
use rigid or low loading resins, resembling very dilute solutions by having the
functional groups far away from each other.24
Examples of libraries from solid-phase synthesis
An investigation of the ability of a variety of substrates to cyclize on solid-
phase was presented by Schreiber and co-workers.41 A pilot library of diverse
13- and 14-membered macrocycles (e.g. 16 in Figure 1.12) was synthesized
from stereochemically and regiochemically diverse hydroxy acids. Figure 1.12
is a schematic view of how one of the hydroxy acids (protected with allyl and
PMB), which were obtained from common starting materials in solution-
phase, was attached to the resin, deprotected and esterified with another
hydroxy acid (allyl protected). Removal of the protection groups followed
by Yamaguchi lactonization (or attempt at it) and cleavage from the solid
support furnished the macrocyclic products in 0-75% yield, reflecting a great
influence of the steric environment on the cyclizations.41
Figure 1.12: Synthesis of macrocycle 16 from hydroxy acid components.
More recently, a new methodology for the synthesis of cyclic peptides of
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type 17 (Figure 1.13) was reported by Gilon and co-workers.42 The cycliza-
tions were accomplished by a bis(trichloromethyl) carbonate (BTC) mediated
urea bridge formation between two amino moieties positioned on N -alkyl side
chains of glycine derivatives. Different ring sizes were obtained through the
use of different lengths of side chains. This approach offers an opportunity to
increase the diversity by altering the amino acid sequence and the position
of the side chains.42
Figure 1.13: Solid-phase synthesis of cyclic peptides 17 with varying ring sizes (n = 2,
3, 4, 6) from peptides bearing amino alkyl side chains.
Split-pool synthesis
Split-pool synthesis is a powerful tool within solid-phase synthesis provid-
ing quick access to huge libraries of compounds. An example of a split-pool
synthesis of a library of more than 2.000 14-membered para-cyclophanes of
type 18 (Figure 1.14), has been presented by Schreiber and co-workers.43 As
an alternative to the traditional strategies employing acyclic precursors for
cyclization, the macrocycle forming step in this strategy is a skeletal trans-
formation of a steroidal structure. A steroidal epoxide was synthesized in
five steps and loaded onto macrobeads. These were then split and reacted
with different reagents in two different pathways, one promoting epoxide
opening by use of thiols and secondary amines, and one promoting epox-
ide opening by use of primary amines followed by alkylation of the amines.
The compounds were then pooled and a Diels-Alder reaction with different
ynones was performed giving a diene product, which was transformed into a
macrocyclophane through a retro-Diels-Alder reaction.43
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Figure 1.14: An overview of the split-pool synthesis of more than 2.000 14-membered
para-cyclophanes 18.
Cyclative release
Macrocycle synthesis on solid-phase has opened up opportunity for achieving
simple purification in the ring-closing step by connecting this step to the
resin-release step. This method ensures that only cyclic products are cleaved
from the resin, whereas linear byproducts will remain attached.
As a recent example of the application of cyclative release, the synthesis
of a combinatorial library of macrocyclic peptidomimetics of types 19 and
20 (Figure 1.15) has been reported by Marsault and co-workers.44 Initially,
a library of approximately 10.000 compounds was screened to find a lead
compound, which is an antagonist to the human motilin receptor. A library
of analogs for SAR analysis was then prepared by use of two complementary
solid-phase parallel approaches employing RCM or macrolactamization as
the cyclative release methods. By varying the three amino acids and the
tether, a library of 53 macrocyclic compounds was synthesized and tested for
binding affinity for the human motilin receptor.44 An extension of the library
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by use of new unnatural amino acids containing basic side chains has led to
increased binding affinities.45
Figure 1.15: Cyclative release of peptidomimetics 19 and 20 by RCM and macrolac-
tamization, respectively. Amino acids are shown as L-configured for clarity.
1.4.2 Fluorous synthesis
Fluorous synthesis utilizes functionalized perfluoroalkyl groups attached to
substrates or reagents. Conceptually, fluorous tags are very similar to solid-
phase tags. However, their solubility in organic solvents provides some dis-
tinct advantages over solid-phase tags such as the possibility to monitor re-
actions by use of traditional analytical techniques.46 Excess reagent can be
removed easily by fluorous-solid phase extraction.47
A diversity-oriented approach involving cyclative release of products (e.g.
macrocycle 21 in Figure 1.16) from a fluorous-tagged linker has been reported
by the group of Nelson.48, 49 This approach has led to a library of compounds
with more than 80 distinct scaffolds including macrocycles formed by RCM
reactions as well as other compounds obtained by metathesis cascade reac-
tions.48
Figure 1.16: Synthesis of macrocycle 21 employing a fluorous-tagged linker (RF).
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1.4.3 Preparation on DNA template
Liu and co-workers have developed an approach for DNA-templated syn-
thesis and selection of macrocyclic fumaramides of type 25 (Figure 1.17)
employing three biotinylated DNA-linked building blocks.50 Starting from a
lysine-linked DNA oligonucleotide with three coding regions, the first reagent
is hybridized to the first region, giving 22. Attachment of the building block
to the lysine, capping with a streptavidin-linked bead followed by subjec-
tion to basic conditions removed the DNA linker, and the process was re-
peated with another DNA-linked reagent giving 23. Attachment of a third
DNA-linked building block containing a Wittig ylide linker, capping with a
streptavidin-linked bead followed by NaIO4 mediated unmasking of an alde-
hyde linked to the lysine side chain gave the cyclization precursor 24. Wittig
cyclization with concomitant cleavage of the linker furnished the DNA-linked
macrocyclic fumaramide 25. Using this strategy, a library of 65 members was
generated and subjected to in vitro selections for binding to carbonic anhy-
drase. The DNA templates of the binding macrocycles were subsequently
amplified and decoded to confirm the identity of a control macrocycle having
known target affinity.50
Figure 1.17: DNA duplex-driven synthesis of 25. R = NHCH3 or tryptamine; Ar =
–(p-C6H4)–.
More recently, it was demonstrated that this strategy, after some opti-
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mizations, could be extended to the synthesis of a massive library of more
than 13.000 macrocycles.51
1.5 Concluding remarks
There is a growing interest in the application of synthetic macrocycles to
chemical biology, potentially leading to drug discovery. The aim to occupy
a vast part of chemical space has prompted the development of a range of
methods for macrocycle synthesis. However, it is still unknown whether the
(previously) unoccupied parts of chemical space provide increased chances of
finding new compounds with biological activity. The answer to that question
lies in future formation and screening of a large number of libraries.
Chapter 2
New macrocyclic compounds
from diversity-oriented
synthesis
A novel strategy for formation of a library of diverse macrocyclic compounds
is presented. Diversity is created both through formation of different diol
cyclization precursors in a few steps from easily accessible building blocks
and through subsequent cyclizations by use of different methods.
2.1 Recent method development
Recently, a method for formation of macrocyclic compounds from diol pre-
cursurs was developed in the group of Clausen.52 As seen in Figure 2.1, a
diol 26 was cyclized by use of different reagents, thus creating a carbonate
27, a sulfite 28, a phosphotriester 29, a sulfide 30, and an amine 31. In the
latter two cases, the diol 26 was converted to a diiodide and a dialdehyde,
respectively, prior to cyclization.52
2.2 The strategy
Encouraged by the above methods for formation of macrocyclic rings from
diol precursors,52 the generation of a library of diverse macrocycles based on
this strategy is pursued. According to the planning strategies described in
Chapter 1 (Section 1.1 and Subsection 1.2.1), the aim is to produce macro-
cycles in a few diversity-generating steps starting from two simple building
blocks as outlined in Figure 2.2. The idea is to form four structurally isomeric
diol precursors through combinations of the building blocks by esterifications.
19
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Figure 2.1: Recent method development.
These are then ready to be cyclized, as above, either in one step by reaction
with bis-electrophilic reagents, or in two steps by forming the dialdehyde or
diiodide derivatives and then reacting them with a nucleophilic reagent.
This strategy leads to skeletal diversity in the combination step as well
as in the cyclization step. Specifically, in the combination step different se-
quences of the structural elements of the building blocks are obtained, and
in the cyclization step different functionalities are introduced, leading to dif-
ferent ring sizes and conformations. Considering that the building blocks are
appended to each other in different ways, the last step falls into the cate-
gory of a substrate-based approach to skeletal diversity-generating reactions
(Subsection 1.2.1).
2.2.1 Choice of building blocks
The parent structures, 32 and 33, of the chosen building blocks for this
project are shown in Figure 2.3. These can be readily obtained from commer-
cially available starting materials and contain fragments inspired by nature,
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Figure 2.2: Schematic representation of the strategy.
as 32 contains a heterocycle (triazole) and 33 contains a hydroxy alkene
(a fragment inspired by polyketides). The α,ω-diol nature of the building
blocks is essential for this strategy, as it relies on the versatility of the hy-
droxy group, offering opportunity for conversions and functionalizations in a
number of ways.
Figure 2.3: Parent structures of the chosen building blocks.
For building block 32, the hydroxy groups will remain unconverted (but
may however be protected) under the diol synthesis (illustrated as the lower
building block in Figure 2.2), whereas for building block 33, one of the hy-
droxy groups will be converted to the corresponding carboxylic acid (illus-
trated as the upper building block in Figure 2.2). It should be noted that
this relationship might be reversed leading to a total of eight different diols.
Building block 33 contains an additional hydroxy group, which leaves
opportunity for introduction of different appendages at a later stage of the
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synthesis. 33 will be synthesized as a racemic mixture, and hence the macro-
cyclic compounds will too be racemic mixtures. This will increase the odds of
finding a macrocyclic compound that displays biological activity. However, it
will be possible, and also desirable in case of biological activity, to synthesize
the two enantiomers selectively, since a fragment of building block 33 con-
taining the chiral center can be synthesized by asymmetric allylic alkylation
of 2-methyl-2-vinyloxirane (Figure 2.4).53
Figure 2.4: Asymmetric allylic alkylation yielding a fragment of building block 33.
2.3 Results and discussion
The synthesis of the building blocks is described below, followed by diol
precursor synthesis and subsequent cyclizations (and attempts hereof). Pre-
liminary investigations have previously been carried out by the group of
Clausen.54
2.3.1 Synthesis of the building blocks
The synthesis of the triazole-containing building block is shown in Figure
2.5. Substitution of 4-chlorobutyl benzoate with sodium azide, followed by
a copper(I) catalyzed alkyne-azide cycloaddition reaction37 of the resulting
azide 34 with TBDMS protected propargyl alcohol afforded the protected
triazole building block 35. Reductive cleavage of the benzoyl group gave one
of the desired alcohol derivatives 36 (ready for esterification) in a high yield.
An initial attempt at the synthesis of the other desired alcohol derivative
involved the use of a triphenylsilyl (TPS) ether as protection group giving
37. The TPS ether is normally more stable to cleavage by TBAF than the
TBDMS ether.55 Surprisingly, the expected selective removal of the TBDMS
group failed by use of TBAF at -78 ◦C as the TPS ether was found to be
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Figure 2.5: Synthesis of the triazole building block.
more prone to cleavage than the TBDMS ether for this substrate, thus giv-
ing 36. The same result was obtained by use of PPTS at 0 ◦C, although
not surprising, as the TBDMS ether is more stable to acid than the TPS
ether.55 However, the product 39 was achieved in a good yield by TBDPS
protection of 36 and subsequent selective removal of the TBDMS group by
acidic solvolysis.56
The synthesis of the other building block is shown in Figure 2.6. Grig-
nard reaction57 of TBDMS protected hydroxy acetone with vinyl magnesium
chloride followed by a cross-metathesis reaction58 with methyl acrylate gave
the (E )-enol building block 41 in a good yield. The Hoveyda-Grubbs’ second
generation catalyst 4859 (Figure 2.7) was more efficient in this transforma-
tion than the Grubbs’ second generation catalyst 49.60 Interestingly, despite
the reaction being somewhat slower with 0.5% catalyst loading as compared
to 5%, the overall conversion was found to be higher with the lower loading.
Methyl acrylate was added in large excess (20 equivalents) to disfavor ho-
modimerization of 40 since both reactants are slowly homodimerizing alkenes
(Type II alkenes for catalyst 49).61 The excellent E -selectivity of the reaction
arises from the quaternary allylic nature of 40.61
PMB protection of 41 with p-methoxybenzyl trichloroacetimidate (PMB-
TCA)62 under mild conditions63 gave 42, which could be hydrolyzed under
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Figure 2.6: Synthesis of the (E )-enol building block.
Figure 2.7: Hoveyda-Grubbs’ second generation catalyst 48 and Grubbs’ second gener-
ation catalyst 49. Mes = 2,4,6-trimethylphenyl; Cy = cyclohexyl.
basic conditions to yield one of the desired carboxylic acid derivatives 43 in a
high yield. PMBTCA was prepared in a quantitative yield from anisalcohol
and trichloroacetonitrile according to a literature procedure.64 The alcohol 44
was obtained from 42 by reductive cleavage of the methyl ester. Deprotection
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with TBAF went smoothly, giving the diol 45 in an excellent yield. Most
satisfyingly, the allylic hydroxy group could be selectively TBDPS protected
at -78 oC in dichloromethane. Swern65 and sodium chlorite66 oxidations gave
the other desired carboxylic acid 47 in a high yield. Preliminary attempts to
selectively cleave the TBDMS group from the TPS protected analog of 44
proved unsuccessful for the same reason as specified above for the triazole
building block.
2.3.2 Synthesis of the diols
The alcohols 36 and 39 were combined with the carboxylic acids 43 and
47 by carbodiimide promoted esterifications67 (Figure 2.8) yielding the four
esters 50, 52, 54, and 56, which were deprotected smoothly with TBAF to
give the desired diol precursors.
2.3.3 Synthesis of macrocyclic sulfites
The diols 51, 53, 55 and 57 were treated with thionyl chloride, triethylamine
and DMAP according to the recently developed method.52 This involves
slow addition of a solution of thionyl chloride in dichloromethane to a dilute
solution of the diol (12 mM), triethylamine and DMAP in dichloromethane.
The 17-membered macrocyclic sulfites 58, 60, 62 and 64 (Figure 2.9) were
obtained in yields ranging from 43% to 79% reflecting a difference in the steric
environment of the cyclization precursors. This is further emphasized by the
fact that the diastereomeric ratio of 58, formed from the most sterically
hindered diol precursor, differs from the diastereomeric ratios of the other
sulfites in being 2:1 as compared to 1:1 (or 3:2). Not surprisingly, cyclizations
of the two least sterically hindered diol precursors 55 and 57 result in higher
yields than cyclizations of the more hindered substrates 51 and 53.
Subsequent cleavage of the PMB ethers with DDQ to obtain the sulfites
59a, 61, 63 and 65 resulted in yields ranging from 30% to 67%. The low
yield for the deprotection of 58 is caused by lability of the product to column
chromatography. This was proven by the isolation of a 5-membered cyclic
sulfite byproduct 59b formed upon nucleophilic attack by the tertiary hy-
droxy group on the macrocyclic sulfite. The identification of the product 59a
and the byproduct 59b as single diastereomers confirms that only one of the
diastereomers of the deprotected sulfite is susceptible to the intramolecular
transesterification of the sulfite.
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Figure 2.8: Synthesis of the diol precursors. Reagents and conditions: (a) EDC·HCl,
DMAP, CH2Cl2; (b) TBAF, THF.
2.3.4 Synthesis of macrocyclic malonates
The above cyclization method was extended to the formation of malonates.
Diol precursors 51 and 53 were treated with malonyl chloride under the above
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Figure 2.9: Synthesis of macrocyclic sulfites. Reagents and conditions: (a) SOCl2, Et3N,
DMAP, CH2Cl2; (b) DDQ, CH2Cl2/H2O 18:1.
conditions, giving the 19-membered malonates 66 and 68 (Figure 2.10) in
37 and 34% yield, respectively. Thus, the yields for formation of malonates
are slightly lower than for the formation of sulfites, possibly related to the
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difference in ring sizes formed and/or the relative reactivity of the reagents.
Figure 2.10: Synthesis of macrocyclic malonates. Reagents and conditions: (a) malonyl
chloride, Et3N, DMAP, CH2Cl2; (b) DDQ, CH2Cl2/H2O 18:1.
The malonates were deprotected analogously to the sulfites, giving 67 and
69. The products were obtained in higher yields than their sulfite analogs,
presumably because the malonates are more stable than the sulfites.
2.3.5 Synthesis of macrocyclic phthalates
The method was furhter extended to the synthesis of phthalates. A phthalate
70 (20-membered), an isophthalate 71 (21-membered) and a terephthalate
72 (22-membered) (Figure 2.11) were synthesized from diol 51. The yields
were lower than for the formation of malonates. Since the phthalates have
larger ring sizes than the malonates, this supports that the yield of this
macrocyclization method is related to the ring size formed.
Due to the low yields of the phthalates and the amount of the diol pre-
cursor thus required for upscaling, it was chosen not to deprotect these com-
pounds. However, they are still interesting for investigation of biological
properties.
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Figure 2.11: Synthesis of macrocyclic phthalates from diol 51.
2.3.6 Synthesis of macrocyclic oxalate
An 18-membered oxalate 73 (Figure 2.12) was synthesized from diol 53 ac-
cording to the above method, albeit in a low yield. As the conversion seen
on TLC indicated a yield that is significantly higher than the isolated 9%,
the product is presumably unstable to column chromatography.
Figure 2.12: Synthesis of macrocyclic oxalate from diol 53.
For the reasons specified above for the phthalates, combined with the
instability to column chromatography, the oxalate was not deprotected.
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2.3.7 Attempts at the synthesis of macrocyclic diether
It was attempted to synthesize a 19-membered macrocyclic diether 74 from
diol 51 and dibromopropane (Figure 2.13). However, neither the use of
potassium carbonate (Figure 2.13a) nor sodium hydride (Figure 2.13b) was
successful. In the former case, no reaction was seen - not even after stirring
at 60 ◦C for 2 days. In the latter case, ester cleavage was seen.
Figure 2.13: Attempts at the synthesis of diether 74 from diol 51.
2.3.8 Synthesis of macrocyclic amines
The previously reported method, converting a diol to a dialdehyde followed
by a double-reductive amination,52 was applied to diol 51 (Figure 2.14). Be-
fore that publication, the use of double-reductive amination of dialdehydes
with a monoamine to prepare macrocyclic compounds had never been re-
ported.68 The dialdehyde cyclization precursor 75 was prepared by oxidation
of 51 in an excellent yield. For this reaction, IBX69 was found to be superior
to the Dess-Martin periodinane70 as oxidizing agent. IBX was prepared by
oxidation of 2-iodobenzoic acid according to a literature procedure.71
3,4-dimethoxybenzylamine (DMBNH2) was chosen as the amine, since it
has been reported that removal of the DMB group from a tertiary amine
can be accomplished under mild conditions by the use of DDQ.72 Unfortu-
nately, double-reductive amination of 75 resulted in only 9% yield of the
15-membered product 76 (entry 1, Table 2.1). The formation of several
byproducts, probably of an oligomeric nature, was indicated by TLC.
Several experiments were conducted in order to optimize the yield (entries
2-9, Table 2.1). Substituting Na(OAc)3BH
73 with the more reactive reducing
agents NaBH4
74 (entry 2) or NaCNBH3
75 (entry 3) did not lead to any
formation of the amine 76; only the formation of byproducts was indicated
by TLC as described above. The use of a longer imine formation time before
addition of the reducing agent (entry 4) was also unsuccessful.
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Figure 2.14: Conversion of diol 51 to dialdehyde 75 followed by double-reductive ami-
nation giving amine 76.
Substituting DMBNH2 with ammonium acetate (entry 5, Table 2.1) seem-
ed attractive, as it is a smaller reagent that decreases the steric crowding at
the reaction site along with eliminating the need for a subsequent deprotec-
tion. Unfortunately, this did not result in formation of the desired product,
but reduction of the dialdehyde to the monoaldehyde 77 and the diol 51
(Figure 2.15).
Figure 2.15: Reaction of dialdehyde 75 with ammonium acetate yielding monoaldehyde
77 and diol 51.
The identification of product 77 reveals that the α,α,α-trisubstituted
carbonyl group is reduced faster than the other carbonyl group. An attempt
to catalyze imine formation by addition of 1% of acetic acid to the solvent
(entry 6, Table 2.1) also resulted in aldehyde reduction instead of product
formation.
The use of magnesium ions as a template76 for imine formation (entry
7, Table 2.1) did not improve the yield of 76. Altering the concentration of
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Entry Amine Reducing agent Other conditions Yield of
amine
1 DMBNH2 Na(OAc)3BH - 9%
2 DMBNH2 NaBH4 - 0%
3 DMBNH2 NaCNBH3 - 0%
4 DMBNH2 Na(OAc)3BH 17h imine formation 0%
5 Ammonium
acetate
Na(OAc)3BH - 0%
∗
6 DMBNH2 Na(OAc)3BH AcOH/CH2Cl2 1:99 0%
∗
7 DMBNH2 Na(OAc)3BH DMF/CH2Cl2 1:22,
MgCl2
<10%
8 DMBNH2 Na(OAc)3BH 0.002 M <10%
9 DMBNH2 Na(OAc)3BH 0.045 M <10%
10 Benzylamine Na(OAc)3BH - 0%
11 n-Propyl-
amine
Na(OAc)3BH - 0%
12 1,3-Diamino-
propane
Na(OAc)3BH CaCl2 0%
13 1,3-Diamino-
propane
Na(OAc)3BH - 0%
∗
Table 2.1: Different reaction conditions tried for the synthesis of a macrocyclic amine
from dialdehyde 75. The reaction was performed in a 12 mM solution of 75 in CH2Cl2
and 15-25 minutes were allowed for imine formation before addition of the reducing agent
unless otherwise stated. ∗ Isolation of the reduced product(s) 77 (and 51).
the dialdehyde 75 either to a more dilute (entry 8) or a more concentrated
solution (entry 9) resulted in a decreased yield of the product.
The possibility of using other primary amines was also investigated. How-
ever, attempts at the double-reductive amination of 75 with the previously
used benzylamine52 (entry 10, Table 2.1) and the smaller n-propylamine
(entry 11) were unsuccessful. Furthermore, attempts at using a diamine,
1,3-diaminopropane with or without calcium ions as a template (entry 12-
13), were not successful. The reduced starting material 77 was isolated in
the latter case.
The reason for the low yield of formation of 76 and the failure of the
attempts at optimization described above was likely to be found in the steric
environment of the aldehyde groups of 75, especially in one of them being an
α,α,α-trisubstituted carbonyl group. Thus, it was decided to investigate the
cyclizations of the two less sterically hindered dialdehydes 78 and 80 (Figure
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2.16), obtained in excellent yields from 55 and 57. Most satisfyingly, the
products 79 and 81 of these cyclizations were obtained in highly improved
yields, 46% and 60%, respectively. Thus, these results confirm that 75 is too
sterically hindered to undergo double-reductive amination in a satisfactory
yield.
Figure 2.16: Conversion of diols 55 and 57 to dialdehydes 78 and 80 followed by double-
reductive amination giving amines 79 and 81.
The deprotection of the amines turned out to be a very slow reaction,
especially for the removal of the DMB group. Hence, the PMB group of the
amines 79 and 81 could be selectively cleaved by use of 3 equivalents of DDQ
over 21 hours, yielding the amines 82 and 83 (Figure 2.17).
Several attempts at the full deprotection of the amines 81 and 79 to
84 and 85 (Figure 2.18) were carried out with DDQ and CAN (see Table
2.2). Since the CH2Cl2/H2O 18:1 solvent system has been reported to be
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Figure 2.17: Selective removal of the PMB group from amines 79 and 81 yielding amines
82 and 83.
the optimal solvent system for DDQ deprotection,77 the first unsuccessful
attempt was carried out analogously to the deprotection of the sulfites and
malonates, albeit with more equivalents of DDQ (entry 1). Other attempts
were carried out by use of a more concentrated CH2Cl2/H2O 5:1 solvent
system (entries 2-3) according to a literature procedure for removal of a
DMB group from a tertiary amine.78 However, also in this case, only the
monoprotected amines were isolated.
Figure 2.18: Full deprotection of amine 81 yielding amine 84 in a mixture with amine
83 and attempt at the full deprotection of amine 79 giving the monoprotected amine 82.
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Entry Amine Oxidizing
agent
Equiv Solvent Other
condi-
tions
Yield of
product
1 81 DDQ 5 CH2Cl2/H2O
18:1
10 mM 0%
2 81 DDQ 5 CH2Cl2/H2O
5:1
33 mM 0%
3 79 DDQ 5 CH2Cl2/H2O
5:1
33 mM 0%
4 81 CAN 5 CH3CN/H2O
5:1
10 mM 0%∗
5 81 DDQ 3.3 CH2Cl2/Phos-
phate buffer
(pH 7) 5:1
33 mM 0%
6 79 DDQ 9.9 CH2Cl2/Phos-
phate buffer
(pH 7) 5:1
33 mM 0%
7 79 DDQ 5 CH2Cl2/H2O
5:1
33 mM,
40 ◦C
0%
8 79 DDQ 9.9 CH2Cl2/Phos-
phate buffer
(pH 7) 5:1
33 mM,
40 ◦C
0%
9 81 DDQ 20 CH2Cl2/MeOH
9:1
17 mM,
7 days
15%
10 79 DDQ 20 CH2Cl2/MeOH
9:1
17 mM,
7 days
trace
Table 2.2: Different reaction conditions tried for the formation of the deprotected amines
84 and 85 from 81 and 79, respectively. The reaction time was less than 24 hours unless
otherwise stated. ∗ The monodeprotected amine 83 was not formed in this case.
An attempt to use CAN for the deprotection of 81 (entry 4, Table 2.2)
resulted in consumption of the starting material but no formation of either
the monodeprotected amine 83 or the desired product 84.
Attempts at substituting the water phase of the CH2Cl2/H2O 5:1 solvent
system with a phosphate buffer (entries 5-6, Table 2.2) were carried out
in order to keep the solvent neutral under the reaction, thus keeping the
DMB group as electron rich as possible. However, no improvement was seen.
Performing the experiment at an elevated temperature (entries 7-8) either
with a water or buffer phase was also unsuccessful.
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Substituting the usual biphasic CH2Cl2/H2O solvent system with a mis-
cible solvent system (CH2Cl2/MeOH 9:1) (entry 9, Table 2.2) led to some
conversion, although the use of as much as 20 equivalents of DDQ over 7
days gave a modest NMR yield of 15%. Attempts at the isolation of 84
(verified by LCMS) from a mixture of the amines 83 and 84 by flash column
chromatography were not successful, presumably due to the two compounds
having the same Rf value. Unfortunately, the full deprotection of 79 to 85
(entry 10) only gave trace of product by use of these conditions.
It is evident from literature that this reaction is highly substrate depen-
dent, since it has been reported that deprotection of DMB protected amines
can be inefficient for some substrates,79 whereas for others even the removal
of the less electron-rich PMB group from a tertiary amine is possible.80
2.3.9 Attempts at the synthesis of macrocyclic sulfides
Next, it was intended to synthesize 15-membered macrocyclic sulfides from
diiodides as previously reported52 by use of bis(tributyltin) sulfide in the
presence of CsF and 18-crown-6.81, 82 Bis(tributyltin) sulfide was prepared
from tributyltin chloride and sodium sulfide according to a literature proce-
dure.81
Initially, an attempt to convert diol 51 into a diiodide was carried out.
However, reacting 51 with iodine, triphenylphosphine and imidazole only
gave a monoiodide 86 (Figure 2.19). This is presumably due to the difficult
substitution of the activated neopentylic hydroxy group. The monoiodide
86 was obtained in a 32% NMR yield in a mixture with triphenylphosphine
oxide, due to a difficult separation of these two compounds.
Figure 2.19: Conversion of diol 51 into monoiodide 86.
As expected, subjection of the two less hindered diols 55 and 57 to the
above reaction conditions led to formation of the diiodides 87 and 88 (Fig-
ure 2.20). However, the intended synthesis of the sulfides 89 and 90 from
diiodides 87 and 88 (Figure 2.21) was not successful. The reason for the un-
successful result is likely to be found in the diiodides not being stable enough
for the reaction, since decomposition of the starting material was indicated
by TLC and has been seen by NMR analysis of stored material.
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Figure 2.20: Conversion of diols 55 and 57 into diiodides 87 and 88.
Figure 2.21: Attempt at the synthesis of sulfides 89 and 90 from diiodides 87 and 88.
The more reactive 1,3-benzenedithiol was then employed in an attempt
at forming the 19-membered disulfide 91 (Figure 2.22a) from diiodide 88.
A solution of 88 in dichloromethane was added dropwise to a solution of
1,3-benzenedithiol and potassium carbonate in dichloromethane, followed by
triethylamine. The starting material was consumed but no cyclic product
was isolated.
A previously reported macrocyclization method involving slow addition
(12 hours) of separate solutions of a dithiol and a dibromide in DMF to a
dilute suspension of cesium carbonate in DMF83 was also applied to these
substrates (Figure 2.22b). Unfortunately, the result was the same as above.
The formation of a disulfide by the above method83 has been reported to
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Figure 2.22: Attempts at the synthesis of disulfide 91 from diiodide 88.
be low-yielding in case of the synthesis of a dithia-18-crown-6 derivative.84
Thus, in the case of diiodide 88, the missing formation of a cyclic product
could be due to the reaction being difficult for this substrate and/or due to
the diiodide not being stable enough for the reaction.
Chapter 3
Conclusion
The project has resulted in the formation of a library of diverse macrocyclic
compounds with different ring sizes and functionalities. The macrocycles
were synthesized in a few steps from easily accessible building blocks in ac-
cordance with the planning strategies for DOS.
A novel strategy within DOS of macrocycles is introduced, utilizing the
versatility of the primary alcohol. Specifically, two α,ω-diols were combined
in four different ways by esterifications leading to the formation of four struc-
turally isomeric diol precursors, which could be cyclized in a number of ways
along with introducing different functionalities.
The diols were cyclized directly to form sulfites (17-membered) and mal-
onates (19-membered) followed by removal of a PMB group from a tertiary
hydroxy group, giving reasonable yields for both steps. However, the yield
for one of the sulfite deprotections was low due to one of the diastereomers
being transesterified into a 5-membered sulfite. Syntheses of a phthalate (20-
membered), an isophthalate (21-membered), a terephthalate (22-membered),
and an oxalate (18-membered) were also accomplished, however in low yields.
Unfortunately, attempts at the synthesis of a diether (19-membered) were un-
successful, due to the reagents either not having the required reactivity or
causing ester cleavage.
Dialdehydes and diiodides were formed from some of the diols with the
aim to form macrocycles by reaction with nucleophilic reagents. Not surpris-
ingly, an attempt at the synthesis of a diiodide from one of the diols bearing
a neopentylic hydroxy group only led to the formation of a monoiodide.
Double-reductive amination of the dialdehydes with DMBNH2 led to the
formation of amines (15-membered). The yield of cyclization was low for a
dialdehyde that contained an α,α,α-trisubstituted carbonyl group, whereas
the yields were much higher for two less sterically hindered dialdehydes. Sub-
sequent removal of the PMB and DMB groups from the latter two amines
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turned out to be difficult, as only the PMB group was removed under con-
ditions employing more equivalents of DDQ and longer reaction times than
usual. The use of a very large excess of DDQ over 7 days led to 15% con-
version to the fully deprotected product. However, attempts at separating
the product from the monodeprotected amine were not successful as the two
amines presumably have the same Rf value.
Unfortunately, attempts at forming sulfides (15-membered) and disulfides
(19-membered) from the diiodides were not successful, presumably due to
instability of the diiodides.
The library of diverse macrocyclic compounds formed in this project is
currently being screened for biological activity. Furthermore, investigations
of the structural properties are currently being undertaken. Hopefully, the
synthetic strategy described herein will encourage others to create libraries
of new diverse macrocyclic compounds.
Chapter 4
Experimental section
Starting materials, reagents, and solvents were purchased from Sigma-Aldrich
Chemical Co. and used without further purification. Reactions involving air
or moisture sensitive reagents were carried out under N2. CH2Cl2, DMF,
CH3CN and DMSO were dried over 4 A˚ molecular sieves. THF, Et2O and
toluene were distilled from Na under N2. Et3N was distilled from CaH2 un-
der N2. TLC was performed on Merck aluminum sheets precoated with silica
gel 60 F254. Compounds were visualized by charring after dipping in a solu-
tion of p-anisaldehyde (10 mL of H2SO4 and 10 mL of p-anisaldehyde in 200
mL of 95% EtOH), or cerium sulfate (6.25 g of (NH4)6Mo7O24 and 1.5 g of
Ce(SO4)2 in 250 mL of 10% aqueous H2SO4). Flash column chromatography
was performed using Merck silica gel 60 (particle size 0.040-0.063 mm). NMR
spectra were recorded using a Varian Mercury 300 MHz spectrometer or a
Varian Unity Inova 500 MHz spectrometer. Chemical shifts were measured
in ppm and coupling constants in Hz, and the field is indicated in each case.
The solvent peaks from CDCl3 (7.26 ppm in
1H NMR and 77.16 ppm in 13C
NMR) or CD3OD (3.31 ppm in
1H NMR) were used as standards. In case
of diastereomeric mixtures, the following abbreviations are used; maj: major
diastereomer, min: minor diastereomer, both: both diastereomers, one: one
diastereomer. Elemental analyses were obtained from H. Kolbe, Mikroana-
lytisches Laboratorium, Mu¨lheim/Ruhr, Germany. IR analysis was carried
out on a Perkin-Elmer 1600 series FTIR spectrometer or on a Bruker Al-
pha FTIR spectrometer. Melting points were measured with a Buch Holm
melting point apparatus and are uncorrected. High-resolution LC-DAD-MS
was performed on an Agilent 1100 system equipped with a photodiode array
detector (DAD) and coupled to an LCT orthogonal time-of-flight mass spec-
trometer (Waters-Micromass) with a Z -spray electrospray ionization (ESI)
source and a LockSpray probe (M + H 556.2771) and controlled by Mass-
Lynx 4.0 software.
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4-(4-((tert-Butyldimethylsilyloxy)methyl)-1H -1,2,3-triazol-1-yl)bu-
tyl benzoate 35
4-Chlorobutyl benzoate (10.02 g, 47.09 mmol) and Bu4NI (1.74 g, 4.71 mmol)
were dissolved in anhydrous DMF (94 mL). NaN3 (3.83 g, 58.86 mmol) was
added cautiously. The solution was slowly heated to 60 ◦C and stirred for 23
hours. The mixture was transferred to a separatory funnel and diluted with
Et2O (600 mL). After washing with water (3×320 mL), the resulting organic
phase was concentrated in vacuo to afford 34 as a yellow oil, which was used
without further purification. The crude was dissolved in THF (422 mL) and
DIPEA (12.09 mL, 70.64 mmol) was added followed by CuI (8.97 g, 47.09
mmol) and tert-butyldimethylsilyl propargyl ether (9.55 mL, 47.09 mmol).
After stirring at 20 ◦C for 18 hours, the yellow mixture was filtered through
a pad of Celite, and the filtrate was concentrated in vacuo giving a green
oil. The residue was dissolved in EtOAc (500 mL) and washed with water
(2×330 mL) and brine (330 mL). The organic phase was dried (MgSO4), fil-
tered and concentrated in vacuo to afford an oil which was purified by flash
column chromatography (MeOH/CH2Cl2 3:97) to give the triazole 35 (18.34
g, quantitative yield) as a yellow oil. Rf 0.60 (EtOAc/heptane 1:1); IR (neat,
AgCl) ν 3428 (w), 3138 (m), 3069 (m), 2956 (s), 1719 (s), 1602 (m), 1585
(m), 1451 (s), 1389 (m), 1361 (m), 1271 (s), 1219 (m), 1176 (m), 1096 (s)
cm−1; 1H NMR (300 MHz, CDCl3) δ 8.04-8.01 (2H, m), 7.60-7.52 (2H, m),
7.47-7.42 (2H, m), 4.88 (2H, s), 4.46 (2H, t, J 7.1 Hz), 4.36 (2H, t, J 6.3 Hz),
2.15-2.05 (2H, m), 1.87-1.77 (2H, m), 0.91 (9H, s), 0.10 (6H, s); 13C NMR
(75 MHz, CDCl3) δ 166.6, 149.0, 133.2, 130.1, 129.6 (2C), 128.5 (2C), 121.5,
64.0, 58.1, 49.9, 27.3, 26.0 (3C), 25.9, 18.4, -5.2 (2C).
4-(4-((tert-Butyldimethylsilyloxy)methyl)-1H -1,2,3-triazol-1-yl)bu-
tan-1-ol 36
A solution of the triazole 35 (1.98 g, 5.08 mmol) in anhydrous CH2Cl2 (49
mL) was cooled to -78 ◦C. DIBAL-H (1.0 M in hexane, 11.2 mL, 11.2 mmol)
was added, and the mixture was stirred at -78 ◦C for 3 hours. The reac-
tion was quenched with MeOH (2.0 mL) and allowed to reach 20 ◦C. A sat.
aq. solution of Rochelle’s salt (60 mL), water (40 mL) and Et2O (250 mL)
were added, and the viscous mixture was stirred vigorously for 15 minutes.
The mixture was transferred to a separatory funnel and the organic layer
was isolated. The aqueous layer was extracted with EtOAc (3×80 mL) and
the pooled organic phases were dried (MgSO4), filtered and concentrated in
vacuo to give a yellow oil. The product was purified by flash column chro-
matography (EtOAc/heptane 1:1 → EtOAc) to afford the alcohol 36 (1.31
g, 90%) as a colorless oil. Rf 0.10 (EtOAc/heptane 1:1); IR (neat, AgCl) ν
43
3372 (m), 2929 (s), 1734 (w), 1636 (w), 1559 (w), 1473 (m), 1257 (m), 1006
(s), 840 (s) cm−1; 1H NMR (300 MHz, CDCl3) δ 7.50 (1H, s), 4.85 (2H, s),
4.41 (2H, t, J 7.1 Hz), 3.69 (2H, t, J 6.2 Hz), 2.07-1.98 (2H, m), 1.81 (1H,
br s, OH), 1.63-1.54 (2H, m), 0.91 (9H, s), 0.10 (6H, s); 13C NMR (75 MHz,
CDCl3) δ 148.8, 121.6, 61.9, 58.0, 50.2, 29.4, 27.1, 26.0 (3C), 18.5, -5.2 (2C);
Anal. calcd. for C13H27N3O2Si: C, 54.70; H, 9.53; N, 14.72. Found: C,
54.63; H, 9.50; N, 14.81.
4-((tert-Butyldimethylsilyloxy)methyl)-1-(4-(triphenylsilyloxy)bu-
tyl)-1H -1,2,3-triazole 37
The alcohol 36 (1.66 g, 5.82 mmol) was dissolved in anhydrous DMF (10
mL). Imidazole (0.79 g, 11.64 mmol) and TPSCl (2.57 g, 8.73 mmol) were
added. After stirring at 20 ◦C for 18 hours, the mixture was diluted with
EtOAc (20 mL) and then washed with water (10 mL) and brine (10 mL).
The organic phase was dried (MgSO4), filtered and concentrated in vacuo.
The residue was purified by flash column chromatography (MeOH/CH2Cl2
1:199) to afford 37 (1.54 g, 49%) as a yellow oil. 1H NMR (300 MHz, CDCl3)
δ 7.62-7.59 (6H, m), 7.48-7.36 (10H, m), 4.84 (2H, s), 4.31 (2H, t, J 7.2 Hz),
3.83 (2H, t, J 6.0 Hz), 2.05-1.95 (2H, m), 1.64-1.55 (2H, m), 0.91 (9H, s), 0.10
(6H, s); 13C NMR (75 MHz, CDCl3) δ 148.7, 135.4 (6C), 134.1 (3C), 130.3
(3C), 128.1 (6C), 121.5, 63.0, 58.1, 50.1, 29.3, 27.1, 26.0 (3C), 18.5, -5.1 (2C).
4-((tert-Butyldimethylsilyloxy)methyl)-1-(4-(tert-butyldiphenylsi-
lyloxy)butyl)-1H -1,2,3-triazole 38
The alcohol 36 (5.95 g, 20.85 mmol) was dissolved in anhydrous DMF (41.7
mL). Imidazole (2.84 g, 41.70 mmol) and TBDPSCl (8.13 mL, 31.28 mmol)
were added. After stirring for 1 hour at 20 ◦C, the mixture was diluted with
EtOAc (140 mL) and then washed with water (70 mL) and brine (70 mL).
The organic phase was dried (MgSO4), filtered and concentrated in vacuo.
The residue was purified by flash column chromatography (EtOAc/heptane
1:1) to give 38 (10.92 g, quantitative yield) as a colorless oil. Rf 0.85
(EtOAc/hep-tane 3:1); IR (neat) ν 3135 (w), 3071 (w), 3050 (w), 2998 (w),
2953 (m), 2930 (s), 2886 (m), 2857 (s), 1589 (w), 1471 (m), 1463 (m), 1428
(m), 1389 (m), 1361 (w), 1334 (w), 1308 (w), 1255 (m), 1218 (w), 1188 (w),
1134 (m), 1105 (s), 1088 (s), 1045 (m), 1022 (m), 1007 (m), 972 (w), 938
(w), 910 (w), 836 (m), 777 (m), 736 (m), 687 (s) cm−1; 1H NMR (300 MHz,
CDCl3) δ 7.66-7.63 (4H, m), 7.43-7.35 (7H, m), 4.85 (2H, s), 4.34 (2H, t, J
7.2 Hz), 3.68 (2H, t, J 6.0 Hz), 2.06-1.96 (2H, m), 1.61-1.52 (2H, m), 1.04
(9H, s), 0.91 (9H, s), 0.10 (6H, s); 13C NMR (75 MHz, CDCl3) δ 147.0, 135.7
(4C), 133.8 (2C), 129.8 (2C), 127.8 (4C), 121.4, 63.1, 58.1, 50.2, 29.4, 27.2,
27.0 (3C), 26.0 (3C), 19.3, 18.5, -5.1 (2C).
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(1-(4-(tert-Butyldiphenylsilyloxy)butyl)-1H -1,2,3-triazol-4-yl)met-
hanol 39
The disilylprotected compound 38 (10.92 g, 20.85 mmol) was dissolved in
MeOH (350 mL). PPTS (262 mg, 1.04 mmol) was added, and the solution
was heated to 55 ◦C. After stirring for 23 hours, the solvent was removed
in vacuo. The residue was redissolved in EtOAc (420 mL) and washed with
brine (420 mL) and water (420 mL). The organic phase was dried (MgSO4),
filtered and concentrated in vacuo. The residue was purified by flash column
chromatography (EtOAc/heptane 3:7→ EtOAc) to give the alcohol 39 (6.54
g, 77%) as white crystals. Rf 0.39 (EtOAc/heptane 3:1); m.p. 111-112
◦C;
IR (neat) ν 3232 (s), 3126 (m), 2927 (s), 2854 (m), 1472 (w), 1427 (m), 1359
(w), 1225 (w), 1145 (w), 1109 (s), 1081 (s), 1020 (m), 980 (m), 817 (w),
708 (s) cm−1; 1H NMR (300 MHz, CDCl3) δ 7.65-7.62 (4H, m), 7.47 (1H,
s), 7.43-7.35 (6H, m), 4.79 (2H, d, J 6.1 Hz), 4.35 (2H, t, J 7.2 Hz), 3.68
(2H, t, J 6.0 Hz), 2.23 (1H, t, J 6.1 Hz, OH), 2.07-1.97 (2H, m), 1.63-1.52
(2H, m), 1.04 (9H, s); 13C NMR (75 MHz, CDCl3) δ 147.8, 135.6 (4C), 133.7
(2C), 129.8 (2C), 127.8 (4C), 121.7, 63.0, 56.3, 50.3, 29.4, 27.0, 27.0 (3C),
19.3; anal. calcd. for C23H31N3O2Si: C, 67.44; H, 7.63; N, 10.26. Found: C,
67.52; H, 7.59; N, 10.22.
(+/-)-1-(tert-Butyldimethylsilyloxy)-2-methylbut-3-en-2-ol 40
1-(tert-Butyldimethylsilyloxy)propan-2-one (12 mL, 62.18 mmol) was dis-
solved in anhydrous THF (114 mL). The mixture was stirred at 0 ◦C, and
vinyl magnesium chloride (1.6 M in THF, 47 mL, 74.62 mmol) was added
dropwise over 20 minutes. The cooling bath was removed and after two
hours, the reaction mixture was diluted with Et2O (480 mL) and washed
with sat. aq. NH4Cl (290 mL) and water (290 mL). The combined aqueous
phases were extracted with Et2O (200 mL). The combined organic phases
were dried (MgSO4), filtered and concentrated in vacuo to give 40 as a col-
orless oil (10.43 g, 78%), which was used without further purification. Rf
0.63 (EtOAc/heptane 1:1); IR (neat, AgCl) ν 3447 (br), 3088 (w), 2931 (s),
1718 (w), 1653 (w), 1472 (m), 1362 (m), 1257 (m), 1100 (s), 1006 (m), 922
(m), 838 (s), 778 (m) cm−1; 1H NMR (300 MHz, CDCl3) δ 5.87 (1H, dd, J
17.4 Hz, 10.8 Hz), 5.29 (1H, dd, J 17.4 Hz, 1.4 Hz), 5.11 (1H, dd, J 10.8
Hz, 1.4 Hz), 3.47 (1H, d, J 9.5 Hz), 3.42 (1H, d, J 9.5 Hz), 1.23 (3H, s),
0.90 (9H, s), 0.06 (3H, s), 0.06 (3H, s); 13C NMR (75 MHz, CDCl3) δ 142.4,
113.6, 73.1, 70.4, 26.0 (3C), 23.9, 18.5, -5.2, -5.3.
(+/-)-(E)-Methyl 5-(tert-butyldimethylsilyloxy)-4-hydroxy-4-met-
hylpent-2-enoate 41
45
Alcohol 40 (8.40 g, 38.82 mmol) was dissolved in anhydrous CH2Cl2 (400
mL) and methyl acrylate (69.45 mL, 776.4 mmol) was added. Hoveyda-
Grubbs’ 2nd generation catalyst (0.122 g, 0.195 mmol) was added, and the
mixture was heated to reflux. After stirring for 48 hours, the mixture was
concentrated in vacuo to give a green semisolid, which was recrystallized
from EtOAc/heptane, and a crystalline byproduct was filtered off. The fil-
trate was concentrated in vacuo to give a green oil. The crude product was
purified by flash column chromatography (EtOAc/heptane 1:7) to afford the
methyl ester 41 (9.31 g, 88%) as a pale yellow oil. Rf 0.30 (EtOAc/heptane
1:4); IR (neat, AgCl) ν 3482 (br), 2954 (s), 2858 (s), 1728 (s), 1662 (m),
1472 (m), 1437 (m), 1363 (m), 1259 (s), 1100 (s), 981 (m), 838 (s), 778
(m) cm−1; 1H NMR (300 MHz, CDCl3) δ 6.91 (1H, d, J 15.7 Hz), 6.10
(1H, d, J 15.7 Hz), 3.74 (3H, s), 3.53 (1H, d, J 9.6 Hz), 3.48 (1H, d, J 9.6
Hz), 1.26 (3H, s), 0.88 (9H, s), 0.06 (3H, s), 0.04 (3H, s); 13C NMR (75 MHz,
CDCl3) δ 167.2, 152.1, 119.9, 73.1, 69.8, 51.7, 25.9 (3C), 23.6, 18.4, -5.3, -5.4.
(+/-)-(E)-Methyl 5-(tert-butyldimethylsilyloxy)-4-(4-methoxyben-
zyloxy)-4-methylpent-2-enoate 42
The methyl ester 41 (4.16 g, 15.16 mmol) and PMBTCA64 (8.14 g, 30.32
mmol) were dissolved in anhydrous toluene (125 mL), and La(OTf)3 (622
mg, 1.06 mmol) was added. After stirring at 20 ◦C for 16 hours, the mixture
was filtered through a pad of Celite. The filtrate was concentrated in vacuo
to give a yellowish oil which was purified by flash column chromatography
(EtOAc/toluene/heptane 1:50:50) to give the PMB-protected methyl ester
42 (5.07 g, 85%) as a colorless oil. Rf 0.73 (toluene/heptane 1:4); IR (neat,
AgCl) ν 2952 (s), 2856 (s), 2061 (w), 1883 (w), 1726 (s), 1658 (m), 1613 (m),
1587 (m), 1515 (s), 1465 (m), 1382 (m), 1250 (s), 1113 (s), 939 (m), 840 (s)
cm−1; 1H NMR (300 MHz, CDCl3) δ 7.26 (2H, d, J 8.6 Hz), 6.99 (1H, d, J
16.0 Hz), 6.88 (2H, d, J 8.6 Hz), 6.06 (1H, d, J 16.0 Hz), 4.44 (1H, d, J 10.7
Hz), 4.38 (1H, d, J 10.7 Hz), 3.81 (3H, s), 3.77 (3H, s), 3.63 (2H, s), 1.41
(3H, s), 0.89 (9H, s), 0.05 (3H, s), 0.04 (3H, s); 13C NMR (75 MHz, CDCl3)
δ 167.0, 159.1, 151.2, 131.1, 129.1 (2C), 121.6, 113.9 (2C), 78.3, 69.0, 65.3,
55.4, 51.8, 25.9 (3C), 20.3, 18.3, -5.3 (2C).
(+/-)-(E)-5-(tert-Butyldimethylsilyloxy)-4-(4-methoxybenzyloxy)-
4-methylpent-2-enoic acid 43
The methyl ester 42 (3.47 g, 8.79 mmol) was dissolved in THF (132 mL)
and cooled to 0 ◦C. A solution of LiOH (631 mg, 26.37 mmol) in H2O (44
mL) was added, and the resulting mixture was stirred at 20 ◦C. After 46
hours, the reaction was quenched with sat. aq. NaH2PO4 (100 mL), and
EtOAc (100 mL) was added. The organic phase was isolated, and the aque-
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ous phase was extracted with EtOAc (3×100 mL). The pooled organic phases
were washed with water (200 mL) and brine (200 mL). Subsequently, they
were dried (MgSO4), filtered and concentrated in vacuo. The residue was
purified by flash column chromatography (EtOAc/heptane/AcOH 9:90:1)
to afford the carboxylic acid 43 (2.97 g, 89%) as a white solid. Rf 0.60
(EtOAc/heptane/AcOH 70:30:1); m.p. 68-71 ◦C; IR (neat) ν 2927 (br), 1880
(w), 1698 (s), 1652 (m), 1614 (m), 1587 (m), 1515 (s), 1463 (m), 1373 (m),
1254 (s), 939 (m), 845 (s) cm−1; 1H NMR (300 MHz, CDCl3) δ 7.26 (2H, d, J
8.6 Hz), 7.09 (1H, d, J 16.0 Hz), 6.87 (2H, d, J 8.6 Hz), 6.06 (1H, d, J 16.0
Hz), 4.44 (1H, d, J 10.7 Hz), 4.38 (1H, d, J 10.7 Hz), 3.80 (3H, s), 3.63 (2H,
s), 1.42 (3H, s), 0.88 (9H, s), 0.04 (3H, s), 0.03 (3H, s); 13C NMR (75 MHz,
CDCl3) δ 171.9, 159.1, 153.8, 131.0, 129.1 (2C), 121.4, 113.9 (2C), 78.3, 68.9,
65.4, 55.4, 25.9 (3C), 20.3, 18.3, -5.3 (2C); anal. calcd. for C20H32O5Si: C,
63.12; H, 8.48. Found: C, 63.20; H, 8.36.
(+/-)-(E)-5-(tert-Butyldimethylsilyloxy)-4-(4-methoxybenzyloxy)-
4-methylpent-2-en-1-ol 44
The methyl ester 42 (703 mg, 1.78 mmol) was dissolved in anhydrous CH2Cl2
(16 mL) and cooled to -78 ◦C. DIBAL-H (1.0 M in hexanes, 3.92 mL, 3.92
mmol) was added, and the mixture was stirred at -78 ◦C for 3 hours. The
reaction was quenched with MeOH (1.0 mL) and the cold bath was removed.
At 20 ◦C, a sat. aq. solution of Rochelle’s salt (20 mL), water (10 mL) and
Et2O (100 mL) were added, and the viscous mixture was stirred vigorously
for 15 minutes. The organic phase was isolated, and the aqueous phase was
extracted with EtOAc (3×50 mL). The pooled organic phases were dried
(MgSO4), filtered and concentrated in vacuo to give a yellow oil. The oil was
purified by flash column chromatography (EtOAc/heptane 1:2) to afford the
alcohol 44 (0.583 g, 89%) as a colorless oil. Rf 0.87 (MeOH/EtOAc 1:99);
IR (neat, AgCl) ν 3418 (br), 2930 (s), 1740 (m), 1613 (m), 1587 (m), 1514
(s), 1464 (m), 1379 (m), 1250 (s), 1172 (m), 1110 (s) cm−1: 1H NMR (300
MHz, CDCl3) δ 7.25 (2H, d, J 8.5 Hz), 6.86 (2H, d, J 8.5 Hz), 5.88 (1H, dt,
J 16.2 Hz, 5.3 Hz), 5.74 (1H, d, J 16.2 Hz), 4.39 (2H, s), 4.19 (2H, dd, J 5.3
Hz, 1.0 Hz), 3.79 (3H, s), 3.59 (1H, d, J 9.9 Hz), 3.55 (1H, d, J 9.9 Hz), 1.36
(3H, s), 0.89 (9H, s), 0.04 (3H, s), 0.03 (3H, s); 13C NMR (75 MHz, CDCl3)
δ 158.9, 134.5, 131.8, 130.7, 129.0 (2C), 113.8 (2C), 78.0, 69.6, 64.7, 63.6,
55.4, 26.0 (3C), 20.3, 18.4, -5.2, -5.2; anal. calcd. for C20H34O4Si: C, 65.53;
H, 9.35. Found: C, 65.45; H, 9.31.
(+/-)-(E)-4-(4-Methoxybenzyloxy)-4-methylpent-2-en-1,5-diol 45
The alcohol 44 (8.80 g, 24.01 mmol) was dissolved in anhydrous THF (59
mL) and TBAF (1.0 M in THF, 36.01 mL, 36.01 mmol) was added drop-
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wise. After stirring for 19 hours, the mixture was diluted with EtOAc (150
mL) and washed with sat. aq. NH4Cl (120 mL) and water (2×120 mL). The
combined aqueous phases were extracted with EtOAc (2×120 mL). The com-
bined organic phases were dried (MgSO4), filtered and concentrated in vacuo.
The residue was purified by flash column chromatography (EtOAc/heptane
1:1 → MeOH/EtOAc 1:99) giving the diol 45 (6.06 g, quantitative yield) as
a colorless oil, which crystallizes upon storage at 5 ◦C to give a white solid.
Rf 0.54 (MeOH/EtOAc 1:99); m.p. 44-45
◦C; IR (neat, AgCl) ν 3379 (br),
2935 (s), 1613 (m), 1586 (m), 1514 (s), 1465 (m), 1381 (m), 1302 (m), 1248
(s), 1173 (m), 1112 (m), 1036 (s), 981 (m), 913 (w), 891 (w), 822 (m), 733
(m) cm−1: 1H NMR (300 MHz, CDCl3) δ 7.25 (2H, d, J 8.6 Hz), 6.87 (2H,
d, J 8.6 Hz), 5.91 (1H, dt, J 16.1 Hz, 5.2 Hz), 5.78 (1H, d, J 16.1 Hz), 4.33
(2H, s), 4.19 (2H, d, J 5.2 Hz), 3.80 (3H, s), 3.50 (2H, s), 2.08 (2H, br s),
1.38 (3H, s); 13C NMR (75 MHz, CDCl3) δ 159.1, 132.9, 131.8, 131.1, 129.2
(2C), 113.9 (2C), 77.9, 69.7, 64.6, 63.0, 55.4, 19.3.
(+/-)-(E)-5-(tert-Butyldiphenylsilyloxy)-2-(4-methoxybenzyloxy)-
2-methylpent-3-en-1-ol 46
The diol 45 (1.41 g, 5.60 mmol) was dissolved in anhydrous CH2Cl2 (65 mL)
and imidazole (539 mg, 8.41 mmol) was added. The mixture was cooled
to -78 ◦C, and a solution of TBDPSCl (1.46 mL, 5.60 mmol) in anhydrous
CH2Cl2 (10 mL) was added over 5 minutes. After 3 hours, the mixture
was diluted with CH2Cl2 (60 mL) and washed with brine (40 mL) and wa-
ter (40 mL). The combined organic phases were dried (MgSO4), filtered and
concentrated in vacuo. The crude product was purified by flash column chro-
matography (EtOAc/heptane 1:2) affording the TBDPS-protected alcohol 46
(2.75 g, quantitative yield) as a colorless oil. Rf 0.30 (EtOAc/heptane 1:2);
IR (neat, AgCl) ν 3457 (br), 2932 (s), 1613 (m), 1588 (m), 1514 (s), 1473
(m), 1428 (m), 1380 (m), 1302 (m), 1249 (s), 1173 (m), 1112 (s), 978 (m),
823 (m), 741 (m), 702 (m) cm−1: 1H NMR (300 MHz, CDCl3) δ 7.70-7.66
(4H, m), 7.45-7.33 (6H, m), 7.23 (2H, d, J 8.5 Hz), 6.86 (2H, d, J 8.5 Hz),
5.81-5.80 (2H, m), 4.29-4.28 (4H, m), 3.80 (3H, s), 3.52 (1H, d, J 10.9 Hz),
3.41 (1H, d, J 10.9 Hz), 1.98 (1H, br s), 1.36 (3H, s), 1.07 (9H, s); 13C NMR
(75 MHz, CDCl3) δ 159.1, 135.6 (4C), 133.7, 133.7, 131.9, 131.5, 131.2, 129.8
(2C), 129.3 (2C), 127.8 (4C), 113.9 (2C), 77.9, 69.8, 64.7, 64.1, 55.4, 27.0
(3C), 19.4, 19.3; anal. calcd. for C30H38O4Si: C, 73.43; H, 7.81. Found: C,
73.27; H, 7.75.
(+/-)-(E)-5-(tert-Butyldiphenylsilyloxy)-2-(4-methoxybenzyloxy)-
2-methylpent-3-enoic acid 47
Anhydrous CH2Cl2 (220 mL) and DMSO (5.79 mL, 81.66 mmol) were mixed
48 CHAPTER 4. EXPERIMENTAL SECTION
and cooled to -78 ◦C. Oxalyl chloride (3.45 mL, 40.83 mmol) was added drop-
wise, followed by dropwise addition of a solution of the alcohol 46 (10.02 g,
20.42 mmol) in anhydrous CH2Cl2 (110 mL). After 30 minutes, anhydrous
Et3N (28.50 mL, 204.15 mmol) was added. After further 15 minutes, the mix-
ture was allowed to reach 20 ◦C and then diluted with CH2Cl2 (600 mL) and
washed with sat. aq. NH4Cl (400 mL) and water (400 mL) The organic phase
was dried (MgSO4), filtered and concentrated in vacuo to give the crude alde-
hyde, which was used without further purification. The crude aldehyde was
dissolved in THF (120 mL). t-BuOH (240 mL) and 2-methyl-2-butene (86
mL, 811.23 mmol) were added followed by a solution of NaClO2 (23.26 g,
257.14 mmol) and NaH2PO4 (30.85 g, 257.14 mmol) in water (160 mL). Af-
ter 11
2
hours, the mixture was diluted with sat. aq. NaH2PO4 (500 mL) and
stirred for 15 minutes. Subsequently, the mixture was extracted with EtOAc
(3×500 mL) and the combined organic phases were dried (MgSO4), filtered
and concentrated in vacuo. The residue was purified by flash column chro-
matography (EtOAc/heptane/AcOH 66:33:1) to afford the carboxylic acid
47 (9.89 g, 96%) as a colorless oil. Rf 0.25 (MeOH/toluene 5:95); IR (neat)
ν 3071 (m), 3049 (m), 2997 (m), 2956 (m), 2931 (m), 2893 (m), 2857 (m),
1712 (m), 1613 (m), 1588 (w), 1513 (m), 1462 (m), 1428 (m), 1380 (m), 1302
(m), 1247 (s), 1202 (m), 1174 (m), 1107 (s), 1028 (m), 998 (m), 971 (m), 939
(m), 909 (m), 821 (m), 735 (m), 700 (s) cm−1: 1H NMR (300 MHz, CDCl3)
δ 7.68-7.65 (4H, m), 7.42-7.34 (6H, m), 7.25 (2H, d, J 8.7 Hz), 6.89 (2H, d,
J 8.7 Hz), 6.01 (1H, dt, J 15.7 Hz, 3.4 Hz), 5.92 (1H, m), 4.43 (1H, d, J
10.5 Hz), 4.38 (1H, d, J 10.5 Hz), 4.29 (2H, dd, J 3.4 Hz, 1.1 Hz), 3.82 (3H,
s), 1.65 (3H, s), 1.07 (9H, s); 13C NMR (75 MHz, CDCl3) δ 175.4, 159.5,
135.6 (4C), 133.5, 133.2 (2C), 129.9 (2C), 129.8, 129.6 (2C), 128.1, 127.9
(4C), 114.0 (2C), 80.2, 66.5, 63.6, 55.4, 26.9 (3C), 22.1, 19.4; anal. calcd. for
C30H36O5Si: C, 71.39; H, 7.19. Found: C, 70.67; H, 7.17.
Representative procedure for the preparation of esters 50, 52, 54,
and 56
(+/-)-(E)-4-(4-((tert-Butyldimethylsilyloxy)methyl)-1H -1,2,3-tri-
azol-1-yl)butyl 5-(tert-butyldimethylsilyloxy)-4-(4-methoxybenzyl-
oxy)-4-methylpent-2-enoate 50
The carboxylic acid 43 (0.624 g, 1.640 mmol) and the alcohol 36 (0.515 g,
1.804 mmol) were dissolved in anhydrous CH2Cl2 (25 mL) and DMAP (0.040
g, 0.328 mmol) and EDC·HCl (0.472 g, 2.460 mmol) were added. The reac-
tion was stirred for 18 hours at 20 ◦C and then concentrated in vacuo. The
residue was purified by flash column chromatography (EtOAc/heptane 1:2)
to afford the ester 50 (0.930 g, 87%) as a colorless oil. Rf 0.31 (MeOH/toluene
5:95); IR (neat, AgCl) ν 2927 (s), 1734 (s), 1653 (m), 1613 (m), 1516 (m),
49
1472 (m), 1374 (m), 1249 (s), 1104 (s), 939 (w), 839 (m), 779 (m) cm−1; 1H
NMR (300 MHz, CDCl3) δ 7.46 (1H, s), 7.25 (2H, d, J 8.4 Hz), 6.97 (1H,
d, J 16.0 Hz), 6.86 (2H, d, J 8.4 Hz), 6.02 (1H, d, J 16.0 Hz), 4.84 (2H,
s), 4.42 (1H, d, J 11.1 Hz), 4.38 (2H, t, J 7.4 Hz), 4.37 (1H, d, J 11.1 Hz),
4.18 (2H, t, J 6.3 Hz), 3.79 (3H, s), 3.61 (2H, s), 2.05-1.95 (2H, m), 1.76-1.65
(2H, m), 1.40 (3H, s), 0.91 (9H, s), 0.87 (9H, s), 0.09 (6H, s), 0.02 (3H, s),
0.01 (3H, s); 13C NMR (75 MHz, CDCl3) δ 166.4, 159.1, 151.5, 148.9, 131.1,
129.0 (2C), 121.6, 121.5, 113.9 (2C), 78.3, 68.9, 65.3, 63.5, 58.1, 55.4, 49.9,
27.2, 26.0 (3C), 25.9 (3C), 25.9, 20.2, 18.5, 18.3, -5.1 (2C), -5.3 (2C).
(+/-)-(E)-(1-(4-(tert-Butyldiphenylsilyloxy)butyl)-1H -1,2,3-triaz-
ol-4-yl)methyl 5-(tert-butyldimethylsilyloxy)-4-(4-methoxybenzyl-
oxy)-4-methylpent-2-enoate 52
Colorless oil, 87% yield. Rf 0.40 (MeOH/toluene 5:95); IR (neat) ν 3139 (w),
3071 (w), 3048 (w), 2998 (w), 2954 (s), 2930 (s), 2894 (m), 2857 (s), 1720 (s),
1656 (w), 1613 (w), 1588 (w), 1514 (m), 1463 (m), 1442 (m), 1428 (m), 1387
(m), 1361 (w), 1301 (m), 1249 (s), 1169 (m), 1105 (s), 1033 (m), 1007 (m),
938 (w), 910 (w), 836 (s), 823 (m), 777 (m), 731 (m), 701 (s) cm−1; 1H NMR
(300 MHz, CDCl3) δ 7.65-7.62 (4H, m), 7.56 (1H, s), 7.45-7.36 (6H, m), 7.23
(2H, d, J 8.5 Hz), 7.00 (1H, d, J 16.1 Hz), 6.85 (2H, d, J 8.5 Hz), 6.05 (1H,
d, J 16.1 Hz), 5.30 (2H, s), 4.46-4.32 (4H, m), 3.79 (3H, s), 3.68 (2H, t, J
6.0 Hz), 3.60 (2H, s), 2.07-1.97 (2H, m), 1.61-1.52 (2H, m), 1.38 (3H, s), 1.04
(9H, s), 0.86 (9H, s), 0.01 (3H, s), 0.00 (3H, s); 13C NMR (75 MHz, CDCl3)
δ 171.6, 164.4, 157.3, 148.2, 141.0 (4C), 139.0 (2C), 136.4, 135.2 (2C), 134.4
(2C), 133.2 (4C), 129.1, 126.7, 119.2 (2C), 83.6, 74.3, 70.6, 68.4, 63.2, 60.7,
55.7, 34.7, 32.4, 32.3 (3C), 31.3 (3C), 25.6, 24.7, 23.7, 0.0, 0.0.
(+/-)-(E)-(1-(4-(tert-Butyldiphenylsilyloxy)butyl)-1H -1,2,3-triaz-
ol-4-yl)methyl 5-(tert-butyldiphenylsilyloxy)-2-(4-methoxybenzyl-
oxy)-2-methylpent-3-enoate 54
Colorless oil, 58% yield. Rf 0.40 (MeOH/toluene 5:95); IR (neat) ν 3136 (w),
3071 (w), 3048 (w), 3013 (w), 2998 (w), 2955 (m), 2931 (m), 2892 (m), 2857
(m), 1736 (m), 1613 (w), 1588 (w), 1514 (m), 1471 (m), 1462 (m), 1427 (m),
1387 (m), 1362 (w), 1302 (w), 1248 (m), 1174 (m), 1105 (s), 1047 (m), 1032
(m), 998 (m), 968 (m), 939 (w), 910 (w), 822 (m), 735 (m), 700 (s) cm−1; 1H
NMR (300 MHz, CDCl3) δ 7.67-7.62 (8H, m), 7.48 (1H, s), 7.44-7.32 (12H,
m), 7.26 (2H, d, J 8.7 Hz), 6.84 (2H, d, J 8.7 Hz), 6.03 (1H, dt, J 15.7 Hz,
1.6 Hz), 5.91 (1H, dt, J 15.7 Hz, 4.0 Hz), 5.31 (2H, s), 4.42 (1H, d, J 10.6
Hz), 4.36 (1H, d, J 10.6 Hz), 4.28 (2H, t, J 7.3 Hz), 4.24 (2H, dd, J 4.0 Hz,
1.6 Hz), 3.78 (3H, s), 3.66 (2H, t, J 6.0 Hz), 2.01-1.91 (2H, m), 1.56 (3H,
s), 1.55-1.48 (2H, m), 1.05 (9H, s), 1.04 (9H, s); 13C NMR (75 MHz, CDCl3)
δ 173.2, 159.2, 142.7, 135.6 (4C), 135.6 (4C), 133.7 (2C), 133.6 (2C), 131.6,
130.7, 129.8 (4C), 129.4, 129.4 (2C), 127.8 (4C), 127.8 (4C), 123.7, 113.8
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(2C), 80.1, 66.9, 63.8, 63.0, 58.6, 55.4, 50.3, 29.4, 27.0, 27.0 (3C), 26.9 (3C),
24.2, 19.4, 19.3.
(+/-)-(E))-4-(4-((tert-Butyldimethylsilyloxy)methyl)-1H -1,2,3-tri-
azol-1-yl)butyl 5-(tert-butyldiphenylsilyloxy)-2-(4-methoxybenzyl-
oxy)-2-methylpent-3-enoate 56
Colorless oil, 71% yield. Rf 0.31 (MeOH/toluene 5:95); IR (neat) ν 3136
(w), 3071 (w), 3048 (w), 2997 (w), 2954 (m), 2931 (s), 2893 (m), 2856 (m),
1734 (m), 1613 (m), 1588 (w), 1514 (m), 1462 (m), 1428 (m), 1381 (m), 1362
(m), 1301 (m), 1247 (s), 1174 (m), 1105 (s), 1043 (m), 970 (m), 939 (w), 836
(m), 777 (m), 740 (m), 701 (m) cm−1; 1H NMR (300 MHz, CDCl3) δ 7.68-
7.64 (4H, m), 7.42-7.33 (7H, m), 7.28 (2H, d, J 8.6 Hz), 6.85 (2H, d, J 8.6
Hz), 6.04 (1H, dt, J 15.7 Hz, 1.5 Hz), 5.92 (1H, dt, J 15.7 Hz, 3.8 Hz), 4.83
(2H, s), 4.44 (1H, d, J 10.8 Hz), 4.38 (1H, d, J 10.8 Hz), 4.31 (2H, t, J 7.0
Hz), 4.26 (2H, dd, J 3.9 Hz, 1.5 Hz), 4.18 (2H, t, J 6.4 Hz), 3.79 (3H, s),
2.01-1.90 (2H, m), 1.73-1.60 (2H, m), 1.58 (3H, s), 1.06 (9H, s), 0.91 (9H, s),
0.09 (6H, s); 13C NMR (75 MHz, CDCl3) δ 173.2, 159.2, 148.8, 135.6 (4C),
133.6 (2C), 131.5, 130.8, 129.9 (2C), 129.6, 129.2 (2C), 127.8 (4C), 121.5,
113.8 (2C), 80.2, 66.8, 64.3, 63.8, 58.1, 55.4, 49.7, 27.1, 26.9 (3C), 26.0 (3C),
25.7, 24.0, 19.4, 18.5, -5.1 (2C).
Representative procedure for the preparation of diols 51, 53, 55,
and 57
(+/-)-(E)-4-(4-(Hydroxymethyl)-1H -1,2,3-triazol-1-yl)butyl 5-hy-
droxy-4-(4-methoxybenzyloxy)-4-methylpent-2-enoate 51
The ester 50 (2.034 g, 3.14 mmol) was dissolved in anhydrous THF (27.7
mL) and TBAF (1.0 M in THF, 9.42 mL, 9.42 mmol) was added dropwise.
The mixture was stirred for 41
2
hours and then diluted with EtOAc (140 mL),
washed with sat. aq. NH4Cl (80 mL) and water (2×80 mL). The combined
aqueous phases were extracted with EtOAc (2×80 mL) and the combined
organic phases were dried (MgSO4), filtered and concentrated in vacuo. The
residue was purified by flash column chromatography (MeOH/EtOAc 1:99
→ 5:95) to afford the diol 51 (1.133 g, 86%) as a colorless oil. Rf 0.10
(MeOH/EtOAc 1:99); IR (neat) ν 3374 (br), 3142 (m), 2938 (m), 2873 (m),
2839 (m), 1712 (s), 1654 (m), 1612 (m), 1513 (m), 1462 (m), 1443 (m), 1383
(m), 1301 (m), 1247 (s), 1171 (m), 1110 (m), 1031 (s), 895 (w), 821 (m), 778
(w), 754 (w), 726 (w) cm−1; 1H NMR (300 MHz, CDCl3) δ 7.54 (1H, s), 7.25
(2H, d, J 8.8 Hz), 6.97 (1H, d, J 16.1 Hz), 6.88 (2H, d, J 8.8 Hz), 6.04 (1H,
d, J 16.1 Hz), 4.77 (2H, s), 4.40 (2H, t, J 7.1 Hz), 4.39 (1H, d, J 10.6 Hz),
4.32 (1H, d, J 10.6 Hz), 4.17 (2H, t, J 6.3 Hz), 3.80 (3H, s), 3.60 (1H, d,
J 11.5 Hz), 3.55 (1H, d, J 11.5 Hz), 2.07-1.97 (2H, m), 1.75-1.66 (2H, m),
1.42 (3H, s); 13C NMR (75 MHz, CDCl3) δ 166.1, 159.3, 150.0, 147.9, 130.4,
51
129.3 (2C), 122.5, 121.8, 114.0 (2C), 78.1, 68.9, 65.3, 63.7, 56.7, 55.4, 49.9,
27.1, 25.7, 19.3; anal. calcd. for C21H29N3O6: C, 60.13; H, 6.97; N, 10.02.
Found: C, 60.02; H, 7.06; N, 9.88.
(+/-)-(E)-(1-(4-Hydroxybutyl)-1H -1,2,3-triazol-4-yl)methyl 5-hy-
droxy-4-(4-methoxybenzyloxy)-4-methylpent-2-enoate 53
White solid, 78% yield. Rf 0.15 (MeOH/EtOAc 1:99); m.p. 70-71
◦C; IR
(neat) ν 3332 (br), 3120 (m), 3072 (w), 3034 (w), 2935 (m), 2870 (m), 2838
(m), 1716 (s), 1655 (m), 1612 (m), 1586 (w), 1513 (m), 1462 (m), 1442 (m),
1381 (m), 1316 (m), 1301 (m), 1249 (m), 1218 (m), 1171 (s), 1108 (m), 1046
(s), 1007 (m), 973 (m), 942 (w), 900 (w), 871 (m), 827 (m), 815 (m), 781
(m) cm−1; 1H NMR (300 MHz, CDCl3) δ 7.65 (1H, s), 7.24 (2H, d, J 8.7
Hz), 7.00 (1H, d, J 16.1 Hz), 6.87 (2H, d, J 8.7 Hz), 6.07 (1H, d, J 16.1
Hz), 5.30 (2H, s), 4.41 (2H, t, J 7.1 Hz), 4.37 (1H, d, J 10.4 Hz), 4.31 (1H,
d, J 10.4 Hz), 3.80 (3H, s), 3.67 (2H, t, J 6.2 Hz), 3.57 (1H, d, J 11.5 Hz),
3.52 (1H, d, J 11.5 Hz), 2.07-1.97 (2H, m), 1.62-1.53 (2H, m), 1.41 (3H, s);
13C NMR (75 MHz, CDCl3) δ 166.0, 159.3, 150.4, 142.7, 130.4, 129.2 (2C),
124.1, 122.2, 114.0 (2C), 78.1, 68.8, 65.2, 61.9, 57.8, 55.4, 50.3, 29.3, 27.0,
19.3; anal. calcd. for C21H29N3O6: C, 60.13; H, 6.97; N, 10.02. Found: C,
60.04; H, 7.08; N, 9.94.
(+/-)-(E)-(1-(4-Hydroxybutyl)-1H -1,2,3-triazol-4-yl)methyl 5-hy-
droxy-2-(4-methoxybenzyloxy)-2-methylpent-3-enoate 55
Colorless oil, 76% yield. Rf 0.15 (MeOH/EtOAc 1:99); IR (neat) ν 3362
(br), 3143 (m), 3042 (w), 2937 (m), 2870 (m), 2839 (m), 1732 (s), 1612 (m),
1586 (w), 1513 (s), 1456 (m), 1443 (m), 1381 (m), 1302 (m), 1245 (s), 1175
(m), 1107 (s), 1084 (m), 1051 (m), 1027 (s), 968 (m), 821 (m), 784 (w), 755
(w) cm−1; 1H NMR (300 MHz, CDCl3) δ 7.60 (1H, s), 7.27 (2H, d, J 8.8
Hz), 6.85 (2H, d, J 8.8 Hz), 5.96 (1H, dt, J 15.8 Hz, 4.4 Hz), 5.87 (1H, d,
J 15.8 Hz), 5.35 (1H, d, J 12.7 Hz), 5.29 (1H, d, J 12.7 Hz), 4.44 (1H, d,
J 10.4 Hz), 4.39 (2H, t, J 7.0 Hz), 4.37 (1H, d, J 10.4 Hz), 4.15 (2H, dd, J
4.4 Hz, 0.9 Hz), 3.79 (3H, s), 3.63 (2H, t, J 6.2 Hz), 2.08-1.93 (2H, m), 1.60
(3H, s), 1.57-1.48 (2H, m); 13C NMR (75 MHz, CDCl3) δ 173.0, 159.2, 142.5,
131.9, 130.6, 130.5, 129.4 (2C), 123.9, 113.8 (2C), 80.0, 66.8, 62.5, 61.7, 58.4,
55.4, 50.3, 29.3, 26.9, 23.1; anal. calcd. for C21H29N3O6: C, 60.13; H, 6.97;
N, 10.02. Found: C, 60.45; H, 7.06; N, 10.08.
(+/-)-(E)-4-(4-(Hydroxymethyl)-1H -1,2,3-triazol-1-yl)butyl 5-hy-
droxy-2-(4-methoxybenzyloxy)-2-methylpent-3-enoate 57
Colorless oil, 93% yield. Rf 0.10 (MeOH/EtOAc 1:99); IR(neat) ν 3360 (br),
3144 (m), 2961 (m), 2936 (m), 2872 (m), 2839 (m), 1730 (s), 1668 (w), 1613
(m), 1586 (w), 1553 (w), 1513 (s), 1457 (m), 1382 (m), 1301 (m), 1246 (s),
1175 (m), 1112 (m), 1084 (m), 1031 (s), 979 (m), 880 (w), 821 (m), 778 (m),
756 (m) cm−1; 1H NMR (300 MHz, CDCl3) δ 7.52 (1H, s), 7.28 (2H, d, J 8.7
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Hz), 6.85 (2H, d, J 8.7 Hz), 6.00 (1H, dt, J 15.8 Hz, 4.5 Hz), 5.90 (1H, d, J
15.8 Hz), 4.73 (2H, s), 4.45 (1H, d, J 10.6 Hz), 4.38 (1H, d, J 10.6 Hz), 4.34
(2H, t, J 7.0 Hz), 4.20-4.16 (4H, m), 3.78 (3H, s), 3.30 (2H, br s), 1.98 (2H,
tt, J 7.3 Hz, 7.3 Hz), 1.71-1.62 (2H, m), 1.59 (3H, s); 13C NMR (75 MHz,
CDCl3) δ 173.0, 159.1, 147.9, 131.9, 130.5, 130.5, 129.2 (2C), 122.2, 113.8
(2C), 80.0, 66.6, 64.3, 62.3, 56.1, 55.4, 49.8, 27.0, 25.5, 22.9; anal. calcd. for
C21H29N3O6: C, 60.13; H, 6.97; N, 10.02. Found: C, 59.71; H, 7.19; N, 9.94.
Representative procedure for the preparation of macrocyclic sul-
fites 58, 60, 62, and 64
Sulfite 58
The diol 51 (107 mg, 0.26 mmol) was dissolved in anhydrous CH2Cl2 (21
mL). Anhydrous Et3N (0.11 mL, 0.77 mmol) and DMAP (6 mg, 0.05 mmol)
were added. A solution of SOCl2 in anhydrous CH2Cl2 (0.36 M, 1 mL, 0.36
mmol) was added over 10 minutes at 20 ◦C, under vigorous stirring. Af-
ter stirring for 1 hour, the reaction mixture was concentrated in vacuo. The
residue was redissolved in EtOAc, filtered through Celite and concentrated in
vacuo. Purification by flash column chromatography (MeOH/CH2Cl2 1:99)
gave the sulfite 58 (60 mg, 51%) as white crystals. Rf 0.60 (MeOH/EtOAc
1:99); m.p. 91-93 ◦C; dr: 2:1, de: 33% (NMR); IR (neat) ν 3133 (w), 2963
(m), 2933 (m), 2879 (m), 2841 (m), 1716 (s), 1657 (m), 1613 (m), 1587 (w),
1515 (m), 1457 (m), 1390 (m), 1361 (w), 1317 (m), 1304 (m), 1286 (m), 1247
(m), 1194 (m), 1168 (s), 1111 (m), 1028 (s), 1001 (m), 939 (m), 899 (m), 828
(m), 777 (m), 729 (m), 706 (m), 690 (m), 669 (m) cm−1; 1H NMR (500 MHz,
CDCl3) δ 7.57 (maj, s), 7.56 (min, s), 7.24 (min, d, J 8.6 Hz), 7.21 (maj, d, J
8.6 Hz), 6.87 (min, d, J 8.7 Hz), 6.86 (maj, d, J 8.7 Hz), 6.82 (both, d, J 16.1
Hz), 6.05 (min, d, J 16.1 Hz), 6.03 (maj, d, J 16.1 Hz), 5.55 (maj, d, J 13.3
Hz), 5.49 (min, d, J 13.0 Hz), 4.96 (min, d, J 13.0 Hz), 4.95 (maj, d, J 13.3
Hz), 4.48-4.33 (m), 4.30-4.24 (m), 4.19-4.11 (m), 4.14 (min, d, J 10.1 Hz),
4.13 (maj, J 11.0 Hz), 3.92 (maj, d, J 11.0 Hz), 3.87 (min, d, J 10.1 Hz),
3.79 (both, s), 2.09-2.02 (m), 1.76-1.66 (m), 1.45 (min, s), 1.43 (maj, s); 13C
NMR (75 MHz, CDCl3) δ 165.6 (min), 165.5 (maj), 159.3 (min), 159.2 (maj),
149.2 (min), 148.6 (maj), 143.8 (maj), 143.4 (min), 130.2 (maj), 130.2 (min),
129.1 (2C, min), 128.9 (2C, maj), 123.0 (min), 122.9 (maj), 122.8 (maj), 122.5
(min), 114.0 (2C, min), 113.9 (2C, maj), 76.3 (maj), 76.2 (min), 69.3 (maj),
67.7 (min), 65.3 (maj), 65.2 (min), 63.5 (both), 56.6 (min), 56.0 (maj), 55.4
(both), 49.5 (both), 26.8 (both), 25.0 (min), 24.9 (maj), 20.2 (min), 19.6
(maj); HRMS (ESI): m/z calcd. for C21H27N3O7S [M+H]
+ 466.1643, found
466.1637.
Sulfite 60
White crystals, 43% yield; Rf 0.60 (MeOH/EtOAc 1:99); m.p. 130-131
◦C;
53
dr: 3:2, de: 20% (NMR); IR(neat) ν 3133 (w), 3075 (w), 3034 (w), 2963 (m),
2875 (m), 2841 (w), 1714 (s), 1643 (w), 1612 (m), 1585 (w), 1514 (m), 1462
(m), 1446 (m), 1384 (m), 1304 (m), 1250 (s), 1225 (m), 1203 (m), 1174 (m),
1141 (m), 1115 (m), 1056 (m), 1031 (m), 1001 (m), 977 (m), 897 (m), 884
(m), 854 (m), 824, 806, 773, 733, 711 cm−1; 1H NMR (300 MHz, CDCl3) δ
7.63 (both, s), 7.22 (both, d, J 8.6 Hz), 6.87 (both, d, J 8.6 Hz), 6.85 (both,
d, J 16.1 Hz), 6.04 (min, d, J 16.1 Hz), 6.03 (maj, d, J 16.1 Hz), 5.39-5.38
(m), 4.53-4.37 (m), 4.40 (both, d, J 10.6 Hz), 4.34 (both, d, J 10.6 Hz), 3.94
(min, d, J 10.3 Hz), 3.91 (maj, d, J 9.6 Hz), 3.79 (both, s), 3.78 (min, d, J
10.3 Hz), 3.74 (maj, d, J 9.6 Hz), 3.65-3.48 (m), 1.97-1.86 (m), 1.54-1.46 (m),
1.44 (both, s); 13C NMR (75 MHz, CDCl3) δ 166.0 (maj), 165.9 (min), 159.3
(maj), 159.3 (min), 150.3 (maj), 150.0 (min), 144.2 (both), 130.2 (min),
130.2 (maj), 129.1 (2C, maj), 129.0 (2C, min), 123.9 (maj), 123.8 (min),
122.8 (maj), 122.7 (min), 114.0 (2C, maj), 114.0 (2C, min), 76.4 (min), 76.3
(maj), 68.3 (min), 67.4 (maj), 65.3 (maj), 65.2 (min), 62.7 (maj), 62.1 (min),
57.7 (both), 55.4 (both), 50.1 (both), 27.1 (min), 27.0 (maj), 26.3 (min), 26.3
(maj), 19.6 (maj), 19.4 (min).
Sulfite 62
White crystals, 79% yield; Rf 0.60 (MeOH/EtOAc 1:99); m.p. 130-131
◦C;
dr: 1:1 (NMR); IR (neat) ν 3127 (w), 3071 (w), 3044 (w), 3001 (w), 2954
(m), 2930 (m), 2877 (w), 2858 (w), 2836 (w), 1730 (s), 1680 (w), 1613 (m),
1586 (w), 1512 (m), 1454 (m), 1390 (m), 1331 (w), 1303 (m), 1274 (w), 1246
(m), 1233 (m), 1199 (m), 1172 (m), 1133 (m), 1106 (m), 1053 (m), 1036 (m),
1011 (m), 994 (m), 971 (m), 951 (m), 919 (m), 898 (m), 820 (m), 780 (m),
754 (m), 732 (m) cm−1; 1H NMR (300 MHz, CDCl3) δ 7.61 (both, s), 7.33
(both, d, J 8.7 Hz), 6.88 (both, d, J 8.7 Hz), 5.76-5.73 (m), 5.49 (one, d,
J 12.5 Hz), 5.46 (one, d, J 12.5 Hz), 5.32 (one, d, J 12.5 Hz), 5.30 (one,
d, J 12.5 Hz), 4.54-4.31 (m), 4.28-4.26 (m), 4.12-4.02 (m), 3.80 (both, s),
3.77-3.67 (m), 2.04-1.92 (m), 1.63 (one, s), 1.63 (one, s), 1.59-1.47 (m); 13C
NMR (75 MHz, CDCl3) δ 172.4 (both), 159.3 (both), 143.0 (both), 134.9
(one), 134.4 (one), 130.3 (one), 130.3 (one), 129.4 (2C, both), 125.8 (one),
125.6 (one), 124.3 (one), 124.2 (one), 113.9 (2C, both), 80.0 (one), 79.9 (one),
67.0 (both), 62.3 (one), 62.1 (one), 62.0 (one), 61.7 (one), 58.2 (both), 55.4
(both), 50.0 (both), 27.0 (one), 27.0 (one), 26.4 (one), 26.4 (one), 22.2 (one),
22.1 (one); anal. calcd. for C21H27N3O7S: C, 54.18; H, 5.85; N, 9.03. Found:
C, 54.28; H, 5.77; N, 8.95.
Sulfite 64
White crystals, 74% yield; Rf 0.60 (MeOH/EtOAc 1:99); m.p. 92
◦C; dr:
1:1 (NMR); IR(neat) ν 3145 (w), 3046 (w), 2994 (m), 2960 (m), 2941 (m),
2922 (m), 2877 (m), 2837 (m), 1735 (s), 1614 (m), 1587 (w), 1512 (m), 1458
(m), 1440 (m), 1387 (m), 1303 (m), 1243 (m), 1201 (m), 1189 (m), 1172 (m),
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1145 (m), 1107 (s), 1038 (m), 1006 (m), 981 (m), 941 (m), 924 (m), 904 (s),
839 (m), 813 (m), 804 (m), 786 (m), 757 (m), 739 (m), 717 (m) cm−1; 1H
NMR (300 MHz, CDCl3) δ 7.65 (one, s), 7.64 (one, s), 7.28 (one, d, J 8.6
Hz), 7.27 (one, d, J 8.6 Hz), 6.86 (both, d, J 8.6 Hz), 5.86-5.84 (m), 5.60
(one, d, J 13.4 Hz), 5.55 (one, d, J 13.4 Hz), 4.96 (one, d, J 13.4 Hz), 4.93
(one, d, J 13.4 Hz), 4.51-4.22 (m), 3.79 (both, s), 1.99-1.84 (m), 1.76-1.64
(m), 1.59 (one, s), 1.58 (one, s); 13C NMR (75 MHz, CDCl3) δ 172.3 (both),
159.3 (both), 143.4 (one), 143.3 (one), 134.7 (one), 134.7 (one), 130.2 (one),
130.2 (one), 129.3 (2C, both), 125.4 (one), 125.3 (one), 124.1 (one), 124.1
(one), 113.9 (2C, both), 79.9 (one), 79.9 (one), 66.8 (both), 64.1 (one), 64.1
(one), 62.7 (one), 62.6 (one), 55.4 (both), 55.3 (one), 55.1 (one), 49.5 (both),
27.5 (one), 27.5 (one), 25.5 (both), 22.3 (both).
Representative procedure for the preparation of deprotected sul-
fites 59a, 59b, 61, 63, and 65
Sulfites 59a and 59b
The sulfite 58 (259 mg, 0.56 mmol) was dissolved in CH2Cl2 (52.8 mL)
and water (2.9 mL). DDQ (152 mg, 0.67 mmol) was added, and the mix-
ture was stirred at 20 ◦C for 6 hours. Then the mixture was diluted with
EtOAc (260 mL) and washed with 40% aqueous NaHSO3 (260 mL) and wa-
ter (2×260 mL). The aqueous phase was extracted with EtOAc (260 mL) and
the combined organic phases were dried (MgSO4), filtered and concentrated
in vacuo. The residue was purified twice by flash column chromatography
(EtOAc/toluene 1:1) to give the deprotected sulfite 59a (58 mg, 30%, one
diastereomer) as white crystals and the sulfite 59b (one diastereomer). 59a:
Rf 0.42 (MeOH/EtOAc 1:99); m.p. 121-123
◦C; IR(neat) ν 3362 (m), 3134
(m), 2961 (m), 2929 (m), 2876 (m), 1716 (s), 1658 (m), 1467 (m), 1455 (m),
1408 (w), 1392 (w), 1378 (w), 1362 (w), 1304 (m), 1284 (m), 1248 (m), 1194
(m), 1177 (m), 1133 (m), 1105 (m), 1059 (m), 1049 (m), 1033 (m), 1004 (m),
989 (m), 947 (m), 886 (m), 815 (m), 766 (m), 731 (m) cm−1; 1H NMR (300
MHz, CDCl3) δ 7.64 (1H, s), 6.78 (1H, d, J 15.8 Hz), 6.05 (1H, d, J 15.8
Hz), 5.66 (1H, d, J 13.2 Hz), 4.87 (1H, d, J 13.2 Hz), 4.50 (1H, ddd, J 13.9
Hz, 7.0 Hz, 5.1 Hz), 4.38 (1H, ddd, J 13.9 Hz, 7.0 Hz, 5.1 Hz), 4.22 (2H, t,
J 5.5 Hz), 4.03 (1H, d, J 10.3 Hz), 3.86 (1H, d, J 10.3 Hz), 2.99 (1H, br
s), 2.17-2.01 (2H, m), 1.77-1.65 (2H, m), 1.33 (3H, s); 13C NMR (75 MHz,
CDCl3) δ 165.7, 150.8, 143.1, 123.8, 120.9, 71.9, 71.3, 63.3, 55.3, 49.7, 26.6,
25.2, 23.7; HRMS (ESI): m/z calcd. for C13H19N3O6S [M+H]
+ 346.1067,
found 346.1048; anal. calcd. for C13H19N3O6S: C, 45.21; H, 5.55; N, 12.17.
Found: C, 45.30; H, 5.51; N, 12.08. 59b: Rf 0.12 (MeOH/EtOAc 1:99);
1H NMR (300 MHz, CDCl3) δ 7.56 (1H, s), 6.81 (1H, d, J 15.5 Hz), 6.04
(1H, d, J 15.5 Hz), 4.81 (2H, s), 4.56 (1H, d, J 8.9 Hz), 4.42 (1H, d, J 8.9
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Hz), 4.43-4.39 (2H, m), 4.18 (2H, t, J 6.3 Hz), 2.05-1.97 (2H, m), 1.78 (3H,
s), 1.74-1.67 (2H, m); HRMS (ESI): m/z calcd. for C13H19N3O6S [M+H]
+
346.1067, found 346.1094.
Sulfite 61
White crystals, 47% yield; Rf 0.42 (MeOH/EtOAc 1:99); m.p. 115-118
◦C;
dr: 3:2, de: 20% (NMR); IR(neat) ν 3152 (w), 3065 (w), 2965 (m), 2944 (m),
2917 (w), 2872 (w), 2842 (w), 1747 (m), 1725 (m), 1711 (s), 1657 (m), 1611
(w), 1514 (m), 1466 (w), 1449 (m), 1413 (w), 1382 (m), 1324 (m), 1300 (m),
1283 (m), 1264 (m), 1249 (m), 1220 (m), 1179 (m), 1149 (m), 1134 (m), 1027
(m), 1003 (m), 975 (m), 928 (m), 892 (m), 846 (w), 821 (m), 802 (w), 787
(m), 757 (m), 741 (m), 700 (m) cm−1; 1H NMR (300 MHz, CDCl3) δ 7.64
(maj, s), 7.63 (min, s), 6.84 (maj, d, J 15.6 Hz), 6.82 (min, d, J 15.6 Hz),
6.07 (both, d, J 15.6 Hz), 5.46 (maj, d, J 12.2 Hz), 5.41 (min, d, J 12.3 Hz),
5.32 (min, d, J 12.3 Hz), 5.27 (maj, d, J 12.2 Hz), 4.52-4.37 (m), 3.91 (min,
d, J 10.1 Hz), 3.87 (maj, d, J 10.0 Hz), 3.77 (maj, d, J 10.0 Hz), 3.72 (min,
d, J 10.1 Hz), 3.68 (min, dt, J 7.2 Hz, 7.2 Hz), 3.64 (maj, dt, J 7.1 Hz, 7.1
Hz), 3.51 (maj, dt, J 7.6 Hz, 7.6 Hz), 3.47 (min, dt, J 7.6 Hz, 7.6 Hz), 2.69
(both, br s), 2.02-1.78 (m), 1.52-1.41 (m), 1.33 (min, s), 1.32 (maj, s); 13C
NMR (75 MHz, CDCl3) δ 166.2 (maj), 166.2 (min), 151.8 (maj), 151.8 (min),
144.3 (maj), 144.2 (min), 123.9 (min), 123.8 (maj), 120.8 (both), 72.2 (min),
72.1 (maj), 70.7 (maj), 69.0 (min), 62.6 (min), 62.0 (maj), 57.5 (min), 57.5
(maj), 50.1 (maj), 50.1 (min), 27.1 (both), 26.2 (both), 23.6 (both); HRMS
(ESI): m/z calcd. for C13H19N3O6S [M+H]
+ 346.1067, found 346.1068; anal.
calcd. for C13H19N3O6S: C, 45.21; H, 5.55; N, 12.17. Found: C, 45.06; H,
5.48; N, 12.07.
Sulfite 63
White crystals, 65% yield; Rf 0.36 (MeOH/EtOAc 1:99); m.p. 129-130
◦C;
dr: 1:1 (NMR); IR (neat) ν 3503 (br), 3142 (w), 2970 (m), 2941 (m), 2889
(w), 2871 (w), 1713 (s), 1470 (w), 1447 (m), 1364 (m), 1342 (w), 1264 (m),
1228 (m), 1197 (s) 1150 (m), 1135 (m), 1069 (m), 1053 (m), 983 (m), 970
(m), 946 (m), 920 (m), 871 (m), 839 (w), 821 (w), 805 (w), 777 (m), 731
(m), 678 (m) cm−1; 1H NMR (500 MHz, CDCl3) δ 7.55 (both, s), 5.88-5.82
(one, m), 5.81 (one, d, J 15.4 Hz), 5.75 (one, d, J 15.4 Hz), 5.70 (both, d, J
12.5 Hz), 5.16 (one, d, J 12.5 Hz), 5.15 (one, d, J 12.5 Hz), 4.58-4.42 (m),
4.39-4.23 (m), 4.07-4.01 (m), 3.74-3.65 (m), 3.28 (both, br s), 2.07-1.97 (m),
1.96-1.85 (m), 1.66-1.54 (m), 1.53 (both, s); 13C NMR (75 MHz, CDCl3) δ
174.9 (one), 174.8 (one), 142.7 (one), 142.7 (one), 136.3 (one), 135.2 (one),
124.1 (both), 124.1 (one), 123.9 (one), 74.3 (both), 62.2 (one), 62.0 (one),
61.9 (one), 61.8 (one), 58.9 (one), 58.8 (one), 50.0 (one), 50.0 (one), 26.9
(one), 26.9 (one), 26.4 (one), 26.3 (one), 25.2 (both); HRMS (ESI): m/z
calcd. for C13H19N3O6S [M+H]
+ 346.1067, found 346.1073; anal. calcd. for
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C13H19N3O6S: C, 45.21; H, 5.55; N, 12.17. Found: C, 44.59; H, 5.78; N,
12.07.
Sulfite 65
White crystals, 67% yield; Rf 0.36 (MeOH/EtOAc 1:99); m.p. 93-95
◦C; dr:
1:1 (NMR); IR (neat) ν 3500 (m), 3151 (w), 2966 (m), 2872 (w), 1719 (s),
1676 (w), 1454 (m), 1443 (m), 1373 (m) 1278 (m), 1198 (m), 1171 (s), 1134
(m), 1075 (w), 1049 (m), 1027 (m), 978 (m), 940 (m), 925 (m), 889 (m), 854
(m), 835 (m), 788 (m), 767 (m), 736 (m), 710 (m), 670 (m) cm−1; 1H NMR
(300 MHz, CDCl3) δ 7.63 (one, s), 7.61 (one, s), 5.94-5.74 (m), 5.63 (one,
dd, J 13.6 Hz, 0.4 Hz), 5.54 (one, dd, J 13.6 Hz, 0.4 Hz), 4.97 (one, dd, J
13.6 Hz, 0.4 Hz), 4.91 (one, dd, J 13.6 Hz, 0.4 Hz), 4.61-4.18 (m), 4.05-3.98
(m), 3.36 (both, br s), 1.99-1.62 (m), 1.46 (one, s), 1.45 (one, s); 13C NMR
(75 MHz, CDCl3) δ 175.1 (one), 175.0 (one), 143.7 (one), 143.7 (one), 135.4
(one), 135.3 (one), 124.1 (one), 124.0 (one), 123.8 (one), 123.6 (one), 74.1
(one), 74.1 (one), 64.6 (one), 64.6 (one), 63.0 (one), 62.2 (one), 55.7 (one),
54.6 (one), 49.5 (one), 49.5 (one), 27.4 (one), 27.3 (one), 26.0 (one), 25.9
(one), 25.8 (one), 25.8 (one); HRMS (ESI): m/z calcd. for C13H19N3O6S
[M+H]+ 346.1067, found 346.1063; anal. calcd. for C13H19N3O6S: C, 45.21;
H, 5.55; N, 12.17. Found: C, 45.56; H, 5.76; N, 11.85.
Representative procedure for the preparation of macrocyclic mal-
onates 66 and 68
Malonate 66
The diol 51 (55 mg, 0.13 mmol) was dissolved in anhydrous CH2Cl2 (9.74
mL) and anhydrous Et3N (0.05 mL, 0.36 mmol) and DMAP (3 mg, 0.03
mmol) were added. A solution of malonyl chloride in anhydrous CH2Cl2 (0.18
M, 1 mL, 0.18 mmol) was added over 10 minutes at 20 ◦C, under vigorous
stirring. After stirring for 11
2
hours, the reaction mixture was concentrated
in vacuo. The residue was redissolved in EtOAc, filtered through Celite
and concentrated in vacuo. Purification by flash column chromatography
(MeOH/CH2Cl2 1:99) gave the malonate 66 (23 mg, 37%) as a colorless oil.
Rf 0.54 (MeOH/EtOAc 1:99); IR (neat) ν 3146 (w), 2956 (m), 2872 (w),
2838 (w), 1751 (s), 1733 (s), 1715 (s), 1656 (w), 1613 (m), 1586 (w), 1514
(m), 1463 (m), 1443 (m), 1409 (w), 1385 (m), 1364 (m), 1300 (m), 1247 (s),
1172 (m), 1146 (m), 1130 (m), 1030 (m), 993 (m), 911 (m), 822 (m), 727
(m) cm−1; 1H NMR (300 MHz, CDCl3) δ 7.68 (1H, s), 7.24 (2H, d, J 8.7
Hz), 6.91 (1H, d, J 16.0 Hz), 6.87 (2H, d, J 8.7 Hz), 6.04 (1H, d, J 16.0 Hz),
5.36 (1H, d, J 12.7 Hz), 5.21 (1H, d, J 12.7 Hz), 4.46 (2H, t, J 6.4 Hz), 4.42
(1H, d, J 10.5 Hz), 4.36 (1H, d, J 10.5 Hz), 4.29 (1H, d, J 11.1 Hz), 4.22
(1H, d, J 11.1 Hz), 4.28-4.13 (2H, m), 3.80 (3H, s), 3.48 (1H, d, J 16.3 Hz),
3.42 (1H, d, J 16.3 Hz), 2.05-1.89 (2H, m), 1.67-1.59 (2H, m), 1.45 (3H, s);
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13C NMR (75 MHz, CDCl3) δ 166.7, 165.9, 165.9, 159.3, 149.3, 143.0, 130.3,
129.0 (2C), 124.0, 122.4, 114.0 (2C), 76.1, 69.5, 65.2, 63.0, 59.1, 55.4, 49.5,
41.2, 27.0, 25.5, 20.6.
Malonate 68
White crystals, 34% yield; m.p. 113-115 ◦C; Rf 0.54 (MeOH/EtOAc 1:99);
IR(neat) ν 3153 (w), 3064 (w), 3039 (w), 2998 (w), 2944 (m), 2916 (w), 2872
(m), 2842 (w), 1747 (s), 1726 (s), 1712 (s), 1657 (m), 1611 (m), 1587 (w),
1514 (m), 1465 (w), 1449 (m), 1413 (w), 1383 (m), 1324 (m), 1300 (m), 1283
(m), 1265 (m), 1249 (m), 1220 (m), 1179 (s), 1149 (m), 1135 (m), 1122 (m),
1059 (m), 1027 (s) 976 (m), 928 (m), 847 (m), 821 (m), 803 (m), 788 (m),
757 (m), 742 (w) cm−1; 1H NMR (500 MHz, CDCl3) δ 7.70 (1H, s), 7.24 (2H,
d, J 8.5 Hz), 6.94 (1H, d, J 16.0 Hz), 6.87 (2H, d, J 8.5 Hz), 6.08 (1H, d,
J 16.0 Hz), 5.38 (1H, d, J 12.8 Hz), 5.35 (1H, d, J 12.8 Hz), 4.48-4.43 (2H,
m), 4.42 (1H, d, J 10.7 Hz), 4.37 (1H, d, J 10.7 Hz), 4.27 (1H, d, J 11.2
Hz), 4.15 (1H, d, J 11.2 Hz), 4.00-3.90 (2H, m), 3.80 (3H, s), 3.34 (1H, d,
J 15.9 Hz), 3.30 (1H, d, J 15.9 Hz), 1.96-1.91 (2H, m), 1.54-1.47 (2H, m),
1.44 (3H, s); 13C NMR (75 MHz, CDCl3) δ 166.2, 166.1, 165.7, 159.3, 149.4,
148.6, 130.3, 129.0 (2C), 124.2, 122.5, 113.9 (2C), 76.3, 69.5, 65.2, 64.2, 58.1,
55.4, 49.6, 41.3, 26.1, 25.3, 20.2.
Representative procedure for the preparation of deprotected macro-
cyclic malonates 67 and 69
Malonate 67
The malonate 66 (100 mg, 0.21 mmol) was dissolved in CH2Cl2 (19.5 mL)
and water (1.1 mL). DDQ (56 mg, 0.25 mmol) was added, and the mix-
ture was stirred at 20 ◦C for 51
2
hours. Then the mixture was diluted with
EtOAc (100 mL) and washed with 40% aqueous NaHSO3 (120 mL) and wa-
ter (2×80 mL). The aqueous phase was extracted with EtOAc (120 mL) and
the combined organic phases were dried (MgSO4), filtered and concentrated
in vacuo. The residue was purified twice by flash column chromatography
(EtOAc/toluene 1:1) to give the deprotected malonate 67 (59 mg, 78%) as
a colorless oil. Rf 0.38 (MeOH/EtOAc 1:99); IR (neat) ν 3468 (br), 3148
(w), 2958 (m), 1713 (s), 1658 (m), 1444 (m), 1373 (m), 1328 (m), 1264 (s),
1182 (m), 1136 (s), 1046 (m), 1024 (m), 979 (m) cm−1; 1H NMR (500 MHz,
CDCl3) δ 7.70 (1H, s), 6.92 (1H, d, J 15.7 Hz), 6.04 (1H, d, J 15.7 Hz),
5.44 (1H, d, J 12.6 Hz), 5.17 (1H, d, J 12.6 Hz), 4.48 (1H, d, J 10.9 Hz),
4.46 (2H, t, J 6.4 Hz), 4.42 (1H, m), 4.03 (1H, d, J 10.9 Hz), 4.02 (1H, m),
3.48 (1H, d, J 17.5 Hz), 3.45 (1H, d, J 17.5 Hz), 2.13 (1H, m), 2.04 (1H,
m), 1.73 (1H, m), 1.57 (1H, m), 1.36 (3H, s); 13C NMR (75 MHz, CDCl3)
δ 168.1, 166.1, 165.7, 151.5, 142.5, 124.6, 120.2, 72.2, 71.1, 63.2, 59.1, 49.5,
41.1, 26.9, 25.1, 23.6; HRMS (ESI): m/z calcd. for C16H21N3O7 [M+H]
+
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368.1452, found 368.1449; anal. calcd. for C16H21N3O7: C, 52.31; H, 5.76;
N, 11.44. Found: C, 52.23; H, 5.71; N, 11.40.
Malonate (69)
White crystals, 69% yield; m.p. 105-106 ◦C; Rf 0.38 (MeOH/EtOAc 1:99);
IR (neat) ν 3308 (br), 3156 (w), 2986 (w), 2968 (m), 2941 (w), 2873 (w), 1727
(s), 1711 (s), 1650 (w), 1462 (w), 1447 (w), 1422 (w), 1376 (w), 1351 (m),
1324 (m), 1295 (m), 1259 (m), 1239 (m), 1224 (m), 1169 (m), 1075 (m), 1065
(m), 1030 (m), 1007 (m), 981 (m), 841 (m), 782 (m) cm−1; 1H NMR (500
MHz, CDCl3) δ 7.69 (1H, s), 6.96 (1H, d, J 15.7 Hz), 6.10 (1H, d, J 15.7 Hz),
5.39 (1H, d, J 12.6 Hz), 5.33 (1H, d, J 12.6 Hz), 4.49-4.40 (2H, m), 4.24 (1H,
d, J 11.2 Hz), 4.17 (1H, d, J 11.2 Hz), 3.92 (2H, t, J 7.3 Hz), 3.35 (1H, d, J
16.4 Hz), 3.32 (1H, d, J 16.4 Hz), 1.96-1.90 (2H, m), 1.52-1.45 (2H, m), 1.35
(3H, s); 13C NMR (75 MHz, CDCl3) δ 166.5, 166.1, 165.9, 151.4, 143.8, 124.2,
120.4, 72.3, 71.4, 64.3, 57.8, 49.7, 41.2, 25.9, 25.4, 24.1; HRMS (ESI): m/z
calcd. for C16H21N3O7 [M+H]
+ 368.1452, found 368,1450; anal. calcd. for
C16H21N3O7: C, 52.31; H, 5.76; N, 11.44. Found: C, 52.18; H, 5.74; N, 11.29.
Representative procedure for the preparation of macrocyclic
phthalates 70, 71, and 72
Macrocyclic phthalates 70, 71, and 72 were prepared from diol 51 anal-
ogously to the representative procedure for the preparation of macrocyclic
malonates 66 and 68, by substitution of malonyl chloride with phthaloyl
chloride, isophthaloyl chloride, and terephthaloyl chloride, respectively.
Phthalate 70: Colorless oil, 19% yield; 1H NMR (300 MHz, CDCl3) δ 7.88
(1H, m), 7.75 (1H, s), 7.55-7.51 (3H, m), 7.28 (2H, d, J 8.8 Hz), 6.97 (1H,
d, J 16.0 Hz), 6.89 (2H, d, J 8.8 Hz), 6.07 (1H, d, J 16.0 Hz), 5.49 (1H, d,
J 12.7 Hz), 5.43 (1H, d, J 12.7 Hz), 4.58 (1H, d, J 11.4 Hz), 4.48-4.43 (4H,
m), 4.43 (1H, d, J 11.4 Hz), 4.20-4.15 (2H, m), 3.81 (3H, s), 2.02-1.92 (2H,
m), 1.65-1.57 (2H, m), 1.51 (3H, s); 13C NMR (75 MHz, CDCl3) δ 167.9,
166.4, 166.2, 159.3, 149.7, 143.1, 133.4, 132.0, 130.9, 130.6, 130.1, 129.8,
129.0 (2C), 128.2, 124.2, 122.1, 114.0 (2C), 76.1, 69.6, 65.3, 63.0, 58.9, 55.5,
49.4, 26.9, 25.2, 21.4; HRMS (ESI): m/z calcd. for C29H31N3O8 [M+H]
+
550.2184, found 550.2191.
Isophthalate 71: Amorphous solid, 21% yield; 1H NMR (300 MHz, CDCl3)
δ 8.50 (1H, t, J 1.7 Hz), 8.25 (2H, dd, J 7.8 Hz, 1.7 Hz), 7.79 (1H, s), 7.56
(1H, t, J 7.8 Hz), 7.26 (2H, d, J 8.4 Hz), 7.02 (1H, d, J 15.9 Hz), 6.86 (2H,
d, J 8.4 Hz), 6.13 (1H, d, J 15.9 Hz), 5.55 (1H, d, J 12.9 Hz), 5.49 (1H, d,
J 12.9 Hz), 4.51 (1H, d, J 11.3 Hz), 4.50 (1H, d, J 10.8 Hz), 4.51-4.46 (2H,
m), 4.43 (1H, d, J 10.8 Hz), 4.30 (1H, d, J 11.3 Hz), 4.17-4.09 (2H, m), 3.78
(3H, s), 1.99-1.90 (2H, m), 1.59-1.54 (2H, m), 1.52 (3H, s); 13C NMR (75
MHz, CDCl3) δ 166.1, 165.7, 165.2, 159.2, 149.7, 142.9, 134.7, 134.3, 130.6,
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130.5, 130.4, 130.1, 129.0, 128.9 (2C), 124.6, 122.4, 114.0 (2C), 76.4, 69.0,
65.1, 63.4, 59.0, 55.4, 49.7, 26.8, 25.5, 20.6; HRMS (ESI): m/z calcd. for
C29H31N3O8 [M+H]
+ 550.2184, found 550.2173.
Terephthalate 72: White solid, 9% yield; m.p. 162-163 ◦C; 1H NMR (300
MHz, CDCl3) δ 8.01 (2H, d, J 8.4 Hz), 7.96 (2H, d, J 8.4 Hz), 7.56 (1H,
s), 7.23 (2H, d, J 8.4 Hz), 6.87 (2H, d, J 8.4 Hz), 6.85 (1H, d, J 15.8 Hz),
5.97 (1H, d, J 15.8 Hz), 5.63 (1H, d, J 12.5 Hz), 5.57 (1H, d, J 12.5 Hz),
4.64 (1H, d, J 11.4 Hz), 4.57-4.37 (2H, m), 4.48 (1H, d, J 10.8 Hz), 4.38
(1H, d, J 10.8 Hz), 4.23 (1H, d, J 11.4 Hz), 4.01-3.83 (2H, m), 3.80 (3H, s),
1.88-1.78 (2H, m), 1.50 (3H, s), 1.43-1.27 (2H, m); HRMS (ESI): m/z calcd.
for C29H31N3O8 [M+H]
+ 550.2184, found 550.2187.
Representative procedure for the preparation of macrocyclic ox-
alate 73
Macrocyclic oxalate 73 was prepared from diol 53 analogously to the repre-
sentative procedure for the preparation of macrocyclic malonates 66 and 68,
by substitution of malonyl chloride with oxalyl chloride.
Oxalate 73: 9% yield; 1H NMR (300 MHz, CDCl3) δ 7.63 (1H, s), 7.23 (2H,
d, J 8.7 Hz), 6.91 (1H, d, J 15.9 Hz), 6.87 (2H, d, J 8.7 Hz), 6.07 (1H, d,
J 15.9 Hz), 5.41 (1H, d, J 12.6 Hz), 5.36 (1H, d, J 12.6 Hz), 4.52 (1H, d, J
11.1 Hz), 4.51-4.47 (2H, m), 4.44 (1H, d, J 10.8 Hz), 4.36 (1H, d, J 10.8 Hz),
4.24-4.17 (2H, m), 4.18 (1H, d, J 11.1 Hz), 3.80 (3H, s), 2.01-1.92 (2H, m),
1.47 (3H, s), 1.46-1.40 (2H, m); HRMS (ESI): m/z calcd. for C23H27N3O8
[M+H]+ 474.1871, found 474.1877.
Representative procedure for the preparation of dialdehydes 75,
78, and 80
(+/-)-(E))-4-(4-Formyl-1H -1,2,3-triazol-1-yl)butyl 2-(4-methoxy-
benzyloxy)-2-methyl-5-oxopent-3-enoate 80
The diol 57 (51 mg, 0.12 mmol) was dissolved in CH3CN (2.1 mL). IBX
71
(202 mg, 0.72 mmol) was added, and the suspension was heated to 55 ◦C. Af-
ter stirring at 55 ◦C for 31
2
hours, the suspension was concentrated in vacuo.
The residue was redissolved in Et2O, filtered and concentrated in vacuo giv-
ing the dialdehyde 80 (50 mg, quantitative yield) as a colorless oil. Rf 0.46
(MeOH/CH2Cl2 5:95); IR (neat) ν 3133 (w), 2960 (m), 2937 (m), 2872 (m),
2837 (m), 1733 (s), 1688 (s), 1612 (m), 1531 (m), 1513 (s), 1463 (m), 1443
(m), 1384 (m), 1301 (m), 1245 (s), 1174 (m), 1110 (s), 1092 (s), 1028 (s), 979
(m), 822 (m), 782 (m) cm−1; 1H NMR (300 MHz, CDCl3) δ 10.13 (1H, s),
9.62 (1H, d, J 7.7 Hz), 8.02 (1H, s), 7.27 (2H, d, J 8.5 Hz), 6.99 (1H, d, J
15.9 Hz), 6.87 (2H, d, J 8.5 Hz), 6.43 (1H, dd, J 15.9 Hz, 7.7 Hz), 4.44 (2H,
s), 4.43 (2H, t, J 7.1 Hz), 4.23 (2H, t, J 6.3 Hz), 3.80 (3H, s), 2.07-1.97 (2H,
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m), 1.77-1.70 (2H, m), 1.67 (3H, s); 13C NMR (75 MHz, CDCl3) δ 193.2,
185.1, 171.3, 159.4, 155.1, 147.9, 132.3, 129.6, 129.1 (2C), 125.3, 113.9 (2C),
80.3, 67.4, 64.9, 55.4, 50.2, 26.9, 25.5, 23.6.
(+/-)-(E))-(1-(4-Oxobutyl)-1H -1,2,3-triazol-4-yl)methyl 2-(4-met-
hoxybenzyloxy)-2-methyl-5-oxopent-3-enoate 78
Colorless oil, 98% yield; Rf 0.35 (MeOH/CH2Cl2 5:95); IR (neat) ν 3143
(w), 2957 (m), 2938 (m), 2837 (m), 2733 (w), 1723 (s), 1688 (s), 1613 (m),
1514 (s), 1461 (m), 1443 (m), 1386 (m), 1302 (m), 1247 (s), 1175 (m), 1106
(s), 1048 (m), 1028 (m), 979 (m), 913 (m), 821 (m), 729 (m) cm−1; 1H NMR
(300 MHz, CDCl3) δ 9.72 (1H, s), 9.58 (1H, d, J 7.8 Hz), 7.58 (1H, s), 7.25
(2H, d, J 8.6 Hz), 6.99 (1H, d, J 15.9 Hz), 6.86 (2H, d, J 8.6 Hz), 6.38 (1H,
dd, J 15.9 Hz, 7.8 Hz), 5.37 (1H, d, J 13.2 Hz), 5.32 (1H, d, J 13.2 Hz),
4.44-4.37 (4H, m), 3.80 (3H, s), 2.52 (2H, t, J 6.8 Hz), 2.24-2.15 (2H, m),
1.66 (3H, s); 13C NMR (75 MHz, CDCl3) δ 200.3, 193.2, 171.3, 159.4, 155.1,
142.3, 132.2, 129.6, 129.4 (2C), 124.1, 113.9 (2C), 80.2, 67.5, 58.9, 55.4, 49.4,
40.2, 23.8, 22.7.
(+/-)-(E)-4-(4-Formyl-1H -1,2,3-triazol-1-yl)butyl 4-(4-methoxy-
benzyloxy)-4-methyl-5-oxopent-2-enoate 75
Colorless oil, quantitative yield; Rf 0.55 (MeOH/EtOAc 1:99);
1H NMR (300
MHz, CDCl3) δ 10.15 (1H, s), 9.51 (1H, s), 8.11 (1H, s), 7.29 (2H, d, J 8.8
Hz), 6.90 (2H, d, J 8.8 Hz), 6.87 (1H, d, J 15.9 Hz), 6.20 (1H, d, J 15.9 Hz),
4.51-4.45 (4H, m), 4.20 (2H, t, J 6.3 Hz), 3.81 (3H, s), 2.11-2.01 (2H, m),
1.77-1.68 (2H, m), 1.52 (3H, s); 13C NMR (75 MHz, CDCl3) δ 199.7, 185.3,
165.6, 159.6, 148.0, 145.0, 129.6, 129.4 (2C), 125.2, 123.7, 114.1 (2C), 83.3,
66.8, 63.6, 55.4, 50.4, 27.0, 25.7, 19.6.
Representative procedure for the preparation of macrocyclic amin-
es 76, 79, and 81
Amine 81
The dialdehyde 80 (43 mg, 0.10 mmol) was dissolved in anhydrous CH2Cl2
(6.9 mL). The mixture was cooled to 0 ◦C, and a solution of veratrylamine in
anhydrous CH2Cl2 (0.11 M, 1 mL, 0.11 mmol) was added. After stirring at
0 ◦C for 25 minutes, Na(OAc)3BH (65 mg, 0.31 mmol) was added. After stir-
ring at 0 ◦C for further 15 minutes, powdered 3 A˚ molecular sieves (40 mg)
were added. The suspension was then stirred at 0 ◦C for 3 hours, whereafter
it was quenched with Et2O (10 mL) and then water (20 mL). After filtration,
the mixture was transferred to a separatory funnel with Et2O (40 mL) and
CH2Cl2 (20 mL). The organic phase was isolated and washed with a mixture
of sat. aq. NaHCO3 (40 mL) and water (20 mL). The aqueous phase was
extracted with CH2Cl2 (2×30 mL) and Et2O (30 mL). The combined organic
phases were dried (Na2SO4), filtered and concentrated in vacuo. Purification
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by flash column chromatography (EtOAc/heptane 3:1) gave the azalide 81
(34 mg, 60%) as an amorphous solid. Rf 0.30 (MeOH/CH2Cl2 5:95); IR
(neat) ν 3134 (w), 3034 (m), 2996 (m), 2934 (m), 2872 (m), 2834 (m), 1730
(s), 1612 (m), 1589 (m), 1512 (s), 1453 (m), 1418 (m), 1367 (m), 1329 (m),
1301 (m), 1244 (s), 1175 (m), 1108 (s), 1025 (s), 980 (m), 943 (m), 893 (m),
853 (m), 810 (m), 764 (m) cm−1; 1H NMR (300 MHz, CDCl3) δ 7.52 (1H,
s), 7.27 (2H, d, J 8.8 Hz), 6.96 (1H, s), 6.89 (1H, d, J 8.2 Hz), 6.85 (2H,
d, J 8.8 Hz), 6.79 (1H, d, J 8.2 Hz), 5.77 (1H, d, J 15.7 Hz), 5.64 (1H, dt,
J 15.7 Hz, 4.9 Hz), 4.43 (1H, d, J 10.6 Hz), 4.41-4.36 (2H, m), 4.31 (1H,
d, J 10.6 Hz), 4.26-4.11 (2H, m), 3.86 (3H, s), 3.84 (3H, s), 3.81 (2H, s),
3.79 (3H, s), 3.74 (1H, d, J 13.3 Hz), 3.68 (1H, d, J 13.3 Hz), 3.21 (2H, d,
J 4.9 Hz), 2.10-2.01 (2H, m), 1.68-1.62 (2H, m), 1.53 (3H, s); 13C NMR (75
MHz, CDCl3) δ 172.7, 159.2, 149.0, 148.2, 147.4, 131.7, 131.6, 131.0, 130.7,
129.3 (2C), 122.0, 121.1, 113.8 (2C), 112.1, 110.9, 80.3, 66.7, 63.4, 60.6, 56.1,
56.0, 56.0, 55.4, 50.1, 49.4, 26.6, 26.5, 22.4; HRMS (ESI): m/z calcd. for
C30H38N4O6 [M+H]
+ 551.2864, found 551.2859.
Amine (79)
White solid, 46% yield; Rf 0.17 (MeOH/CH2Cl2 5:95); m.p. 141-143
◦C;
IR(neat) ν 3129 (w), 2994 (w), 2966 (w), 2937 (m), 2915 (w), 2875 (w), 2837
(w), 2797 (m), 1718 (s), 1614 (m), 1589 (w), 1516 (s), 1452 (m), 1420 (w),
1389 (w), 1375 (w), 1328 (w), 1252 (s), 1237 (m), 1184 (m), 1160 (m), 1122
(s), 1058 (w), 1024 (m), 966 (w), 929 (w), 879 (w), 856 (w), 826 (m), 805
(m), 761 (w) cm−1; 1H NMR (300 MHz, CDCl3) δ 7.62 (1H, s), 7.32 (2H, d,
J 8.7 Hz), 6.87 (2H, d, J 8.7 Hz), 6.83 (1H, s), 6.76 (2H, s), 5.66 (1H, dt, J
15.7 Hz, 6.0 Hz), 5.49 (1H, d, J 12.1 Hz), 5.44 (1H, d, J 15.7 Hz), 5.31 (1H,
d, J 12.1 Hz), 4.49 (1H, d, J 10.6 Hz), 4.41 (1H, d, J 10.6 Hz), 4.39-4.28
(2H, m), 3.85 (3H, s), 3.84 (3H, s), 3.80 (3H, s), 3.47 (1H, d, J 13.9 Hz),
3.42 (1H, d, J 13.9 Hz), 2.89 (2H, d, J 6.0 Hz), 2.15-2.09 (2H, m), 1.90-1.79
(2H, m), 1.58 (3H, s), 1.27-1.15 (2H, m); 13C NMR (75 MHz, CDCl3) δ 173.0,
159.2, 149.0, 148.1, 142.9, 132.3, 132.3, 131.9, 130.6, 129.3 (2C), 124.7, 120.9,
113.8 (2C), 111.8, 110.8, 80.4, 66.7, 59.3, 58.0, 56.0, 56.0, 55.4, 54.8, 52.7,
50.1, 27.7, 22.7, 20.9; HRMS (ESI): m/z calcd. for C30H38N4O6 [M+H]
+
551.2864, found 551.2862.
Amine (76)
9% yield; Rf 0.30 (MeOH/EtOAc 1:99);
1H NMR (500 MHz, CD3OD) δ 7.57
(1H, s), 7.18 (2H, d, J 8.6 Hz), 7.05 (1H, m), 6.90-6.83 (2H, m), 6.78 (2H, d,
J 8.6 Hz), 6.65 (1H, d, J 16.1 Hz), 5.85 (1H, d, J 16.1 Hz), 4.41 (1H, d, J
11.0 Hz), 4.35 (1H, m), 4.28 (1H, d, J 11.0 Hz), 4.27 (1H, m), 4.23 (1H, m),
4.16 (1H, d, J 13.6 Hz), 4.08 (1H, m), 3.82 (3H, s), 3.74 (6H, s), 3.65 (1H, d,
J 14.3 Hz), 3.57 (1H, d, J 13.6 Hz), 3.43 (1H, d, J 14.3 Hz), 3.05 (1H, d, J
14.2 Hz), 2.85 (1H, d, J 14.2 Hz), 2.10-1.97 (2H, m), 1.84-1.74 (2H, m), 1.35
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(3H, s); HRMS (ESI): m/z calcd. for C30H38N4O6 [M+H]
+ 551.2864, found
551.2845.
Attempt at the synthesis of a macrocyclic amine with ammonium
acetate
The dialdehyde 75 (42 mg, 0.101 mmol) was dissolved in anhydrous CH2Cl2
(7.8 mL). The mixture was cooled to 0 ◦C and a solution of ammonium
acetate in anhydrous CH2Cl2 (0.104 mM, 1 mL, 0.104 mmol) was added.
After stirring at 0 ◦C for 10 minutes, powdered 3 A˚ molecular sieves (39 mg)
were added. After stirring for further 5 minutes at 0 ◦C, Na(OAc)3BH (64
mg, 0.303 mmol) was added. The suspension was then stirred for 22 hours,
whereafter it was quenched with Et2O (10 mL) and then water (20 mL). After
filtration, the mixture was transferred to a separatory funnel with Et2O (40
mL) and CH2Cl2 (20 mL). The organic phase was isolated and washed with a
mixture of sat. aq. NaHCO3 (40 mL) and water (20 mL). The aqueous phase
was extracted with CH2Cl2 (2×30 mL) and Et2O (30 mL). The combined
organic phases were dried (Na2SO4), filtered and concentrated in vacuo. The
residue was purified by flash column chromatography (EtOAc/heptane 1:1
→ MeOH/EtOAc 3:97) to give the hydroxy aldehyde 77 (8 mg, 20%) and
the diol 51 (6 mg, 14%) as colorless oils.
(+/-)-(E)-4-(4-formyl-1H -1,2,3-triazol-1-yl)butyl 5-hydroxy-4-(4-
methoxybenzyloxy)-4-methylpent-2-enoate 77:
1H NMR (300 MHz, CDCl3) δ 10.14 (1H, s), 8.12 (1H, s), 7.25 (2H, d, J 8.7
Hz), 6.98 (1H, d, J 16.1 Hz), 6.88 (2H, d, J 8.7 Hz), 6.05 (1H, d, J 16.1 Hz),
4.49 (2H, t, J 7.1 Hz), 4.39 (1H, d, J 10.7 Hz), 4.33 (1H, d, J 10.7 Hz), 4.21
(2H, t, J 6.3 Hz), 3.81 (3H, s), 3.60 (1H, d, J 11.5 Hz), 3.55 (1H, d, J 11.5
Hz), 2.12-2.02 (2H, m), 1.78-1.68 (2H, m), 1.43 (3H, s).
Representative procedure for the preparation of monodeprotected
macrocyclic amines 82 and 83
Amine 82
The amine 79 (15 mg, 0.027 mmol) was dissolved in CH2Cl2 (0.70 mL) and
water (0.14 mL). DDQ (18 mg, 0.08 mmol) was added, and the reaction
mixture was stirred at 20 ◦C for 21 hours. Subsequently, the mixture was
concentrated in vacuo, and the residue was purified by flash column chro-
matography (EtOAc/toluene 4:1 + 0.5% Et3N) to give the monodeprotected
amine 82 (8 mg, 69%) as a colorless film. Rf 0.07 (MeOH/CH2Cl2 5:95);
1H
NMR (300 MHz, CD3OD) δ 7.94 (1H, s), 6.95 (1H, d, J 1.6 Hz), 6.89 (1H,
d, J 8.2 Hz), 6.83 (1H, dd, J 8.2 Hz, 1.6 Hz), 5.71 (1H, ddd, J 15.4 Hz, 8.5
Hz, 4.4 Hz), 5.60 (1H, d, J 12.3 Hz), 5.44 (1H, d, J 15.4 Hz), 5.11 (1H, d,
J 12.3 Hz), 4.46-4.41 (2H, m), 3.83 (3H, s), 3.81 (3H, s), 3.58 (1H, d, J 13.0
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Hz), 3.51 (1H, d, J 13.0 Hz), 3.07 (1H, ddd, J 14.7 Hz, 4.4 Hz, 1.6 Hz), 2.85
(1H, dd, J 14.7 Hz, 8.5 Hz), 2.15 (2H, t, J 8.1 Hz), 1.90 (1H, m), 1.75 (1H,
m), 1.43 (3H, s), 1.33 (1H, m), 1.07 (1H, m); HRMS (ESI): m/z calcd. for
C22H30N4O5 [M+H]
+ 431.2289, found 431.2289.
Amine 83
33% yield; Rf 0.10 (MeOH/CH2Cl2 5:95);
1H NMR (500 MHz, CD3OD) δ
7.87 (1H, s), 7.07 (1H, s), 6.94 (1H, d, J 8.2 Hz), 6.91 (1H, d, J 8.2 Hz),
5.65 (1H, d, J 15.6 Hz), 5.57 (1H, ddd, J 15.6 Hz, 6.2 Hz, 4.8 Hz), 4.47 (1H,
m), 4.39 (1H, m), 4.27 (1H, m), 4.03 (1H, m), 3.85 (3H, s), 3.82 (3H, s), 3.78
(2H, d, J 6.9 Hz), 3.74 (2H, s), 3.25 (1H, m), 3.18 (1H, dd, J 15.5 Hz, 6.2
Hz), 2.04 (2H, m), 1.66 (1H, m), 1.57 (1H, m), 1.36 (3H, s); HRMS (ESI):
m/z calcd. for C22H30N4O5 [M+H]
+ 431.2289, found 431.2281.
(+/-)-(E)-4-(4-(Iodomethyl)-1H -1,2,3-triazol-1-yl)butyl 5-hydro-
xy-4-(4-methoxybenzyloxy)-4-methylpent-2-enoate 86
Ph3P (110 mg, 0.42 mmol) and imidazole (31 mg, 0.46 mmol) were added
to a stirred solvent mixture of anhydrous CH3CN/Et2O 1:2 (10 mL). The
mixture was cooled to 0 ◦C, and I2 (107 mg, 0.42 mmol) was added in one
portion. After stirring for 35 minutes at 0 ◦C, a solution of the diol 51 in
anhydrous CH3CN/Et2O 1:3 (0.17 M, 1.25 mL, 0.21 mmol) was added drop-
wise to the mixture. The mixture was stirred at 0 ◦C for 5 hours, whereafter
it was diluted with Et2O (30 mL). The white precipitate was filtered off and
washed with Et2O (12 mL). The Et2O phase was washed with a mixture of
sat. aq. Na2S2O3 (7 mL) and water (10 mL), and then with water (10 mL).
The combined aqueous phases were extracted with Et2O (15 mL) and the
combined organic phases were washed with brine (10 mL), dried (Na2SO4),
filtered and concentrated in vacuo. Purification by flash column chromatog-
raphy (EtOAc/heptane 1:1) gave a mixture of the monoiodide 86 and Ph3PO
as a yellowish-white solid (122 mg). NMR yield of 86: 36 mg, 32%. 1H NMR
(300 MHz, CDCl3) δ 7.71-7.63 (Ph3PO), 7.58-7.43 (1H + Ph3PO), 7.25 (2H,
d, J 8.7 Hz), 6.98 (1H, d, J 16.1 Hz), 6.89 (2H, d, J 8.7 Hz), 6.05 (1H, d, J
16.1 Hz), 4.47 (2H, s), 4.39 (1H, d, J 10.7 Hz), 4.38 (2H, t, J 7.1 Hz), 4.33
(1H, d, J 10.7 Hz), 4.19 (2H, t, J 6.3 Hz), 3.81 (3H, s), 3.58 (2H, dd, J 6.7
Hz, 1.9 Hz), 2.07-1.97 (2H, m), 1.76-1.67 (2H, m), 1.66 (3H, s); HRMS (ESI)
m/z calcd. for C21H28IN3O5 [M+H]
+ 530.1146, found 530.1112.
Representative procedure for the preparation of diiodides 87 and
88
(+/-)-(E)-(1-(4-Iodobutyl)-1H -1,2,3-triazol-4-yl)methyl 5-iodo-2-
(4-methoxybenzyloxy)-2-methylpent-3-enoate 87
Ph3P (66 mg, 0.25 mmol) and imidazole (19 mg, 0.27 mmol) were added
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to a stirred solvent mixture of anhydrous CH3CN/Et2O 1:2 (6.0 mL). The
mixture was cooled to 0 ◦C, and I2 (64 mg, 0.25 mmol) was added in one
portion. After stirring for 35 minutes at 0 ◦C, a solution of the diol 55 in
anhydrous CH3CN/Et2O 1:3 (0.12 M, 0.8 mL, 0.097 mmol) was added drop-
wise to the mixture. The mixture was stirred at 0 ◦C for 21
2
hours, and then
it was diluted with Et2O (15 mL). The white precipitate was filtered off and
washed with Et2O (6 mL). The Et2O phase was washed with a mixture of
sat. aq. Na2S2O3 (4 mL) and water (5 mL), and then with water (5 mL).
The combined aqueous phases were extracted with Et2O (8 mL) and the
combined organic phases were washed with brine (5 mL), dried (Na2SO4),
filtered and concentrated in vacuo. Purification by flash column chromatog-
raphy (EtOAc/heptane 1:1) gave the diiodide 87 (27 mg, 43%) as a yellow
oil. 1H NMR (300 MHz, CDCl3) δ 7.59 (1H, s), 7.28 (2H, d, J 8.4 Hz), 6.86
(2H, d, J 8.4 Hz), 6.09 (1H, dt, J 15.7 Hz, 7.9 Hz), 5.92 (1H, d, J 15.7 Hz),
5.33 (2H, s), 4.39-4.35 (4H, m), 3.87 (2H, d, J 7.9 Hz), 3.80 (3H, s), 3.17
(2H, t, J 6.8 Hz), 2.03 (2H, tt, J 7.6 Hz, 7.6 Hz), 1.85-1.76 (2H, m), 1.56
(3H, s).
(+/-)-(E)-4-(4-(Iodomethyl)-1H -1,2,3-triazol-1-yl)butyl 5-iodo-2-
(4-methoxybenzyloxy)-2-methylpent-3-enoate 88
Yellow oil, 77% yield; 1H NMR (300 MHz, CDCl3) δ 7.48 (1H, s), 7.30 (2H,
d, J 8.7 Hz), 6.87 (2H, d, J 8.7 Hz), 6.11 (1H, dt, J 15.5 Hz, 7.9 Hz), 5.92
(1H, d, J 15.5 Hz), 4.44 (2H, s), 4.41 (2H, d, J 3.0 Hz), 4.34 (2H, t, J 7.1
Hz), 4.20 (2H, t, J 6.2 Hz), 3.89 (2H, dd, J 7.9 Hz, 0.7 Hz), 3.80 (3H, s),
2.03-1.93 (2H, m), 1.75-1.65 (2H, m), 1.57 (3H, s).
Part II
Toward Materials from
Silver(I) Acetylides
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Chapter 5
Toward a spacer for carbon
nanotube separation utilizing
silver(I) acetylide chemistry
5.1 Carbon nanotubes - nanoscale electrical
conductivity to be exploited
Carbon nanotubes (CNTs) exist as single walled and multi walled types of
which the former is the most interesting for device construction due to its
well-defined structural and electrical conductivity properties.
5.1.1 Single walled carbon nanotubes
The growth of single walled carbon nanotubes (SWNTs) was first reported
by two independent groups, Iijima and Ichihashi85 and Bethune et al.,86 in
1993. This discovery has had great impact on the scientific community87 and
much progress has been achieved in the investigations of SWNTs since then.
CNTs are microtubules of graphitic carbon.88 The walls have different
chiralities, defined by the angle between the orientation of the hexagonal
lattice and the axis of the CNT. For SWNTs, the extreme cases are the
metallic89 and semiconducting90 forms shown in Figure 5.1. The electrical
properties of SWNTs with a given diameter and chirality can be readily
predicted.91, 92
Despite the promising properties of SWNTs, their use in electronic de-
vices has been limited due to the fact that they have strong interactions
between them, leading to either aggregation85, 93 or flocculation94 in all sol-
vents, thus rendering the development of the ordered arrays necessary for
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Figure 5.1: The metallic (a) and semiconducting (b) forms of SWNTs.
device construction difficult.
5.1.2 Techniques for SWNT separation
Several methods have been attempted to overcome the problem of aggrega-
tion and flocculation of SWNTs. In order to solubulize SWNTs in various
solvents, covalent functionalization has been explored, both as open-end95
and sidewall96 modifications. However, the introduction of defects by chang-
ing the linked carbon atoms from the sp2 to the sp3 hybridized form may
alter the electrical properties of the SWNTs.97, 98
The use of supramolecular interactions between pi-stacking and/or am-
phiphilic molecules and SWNTs is an attractive approach for functionaliza-
tion without introducing defects. Ideally, these molecules will be able to aid
in the assembling of ordered networks of SWNTs whereafter they may be
readily removed.
Polymer wraps
Various polymers have been employed for non-covalent functionalization. For
instance, wrapping of the substituted poly(metaphenylenevinylene) 1 (Figure
5.2) around SWNTs was reported by Stoddart and Heath.99 The polymer
was claimed to have very little consequence on the electrical properties of the
SWNTs.99
Surfactant molecules have been widely utilized for obtaining stable sus-
pensions of SWNTs in aqueous solutions. Recently, Dai and co-workers re-
ported the application of new poly(ethylene glycol) (PEG) branched surfac-
tant polymers, e.g. 2 (Figure 5.2), for functionalization of SWNTs.100 The
polymer-wrapped SWNTs showed excellent stability in aqueous solutions as
well as in serum. Moreover, they exhibited long blood circulation and are
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Figure 5.2: The conjugated polymer 1 and the PEG branced polymer 2.
thus promising materials for in vivo applications.100
Polyaromatic modifiers
Many polyaromatic small molecules have also been used as SWNT surface
modifiers. In particular, pyrene is often used, since it has been found to inter-
act strongly with the sidewalls of SWNTs.101 Dai and co-workers employed
the succinimidyl ester derivative of 1-pyrenebutanoic acid 3 (Figure 5.3a) to
append proteins to SWNTs (Figure 5.3b).101
Figure 5.3: The functionalized pyrene 3 (a) and a schematic illustration of the system
with the appended protein (b).
Despite the fact that bent aromatic molecules provide optimized surface
contact to the cylindrical SWNTs as compared to planar molecules, they have
been less utilized. However, the use of bent molecules as surface modifiers of
SWNTs has been reported by a few groups.102, 103, 104, 105 Recently, the group
of Han used a triptycene moiety which is linked through two di(ethylene
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glycol) spacers to two adamantane units (4, Figure 5.4).102 Prior to addition
of the SWNTs, the adamantane units were complexed to cyclodextrines to
achieve dissolution of the resulting complex in aqueous solvent.102
Figure 5.4: The triptycene surface modifier 4 and the pentacene-based molecular tweezer
5.
Tromp and co-workers reported a pentacene-based molecular tweezer 5
(Figure 5.4), which, apart from circumventing the solubility problems, is
diameter-selective against SWNTs with diameters smaller than ≈1.3 nm.103
5.2 The concept
Inspired by the previous investigations on aromatic SWNT surface modifiers,
a molecular spacer consisting of two modifiers connected through a linker (see
Figure 5.5) is proposed. The aim is to be able to space SWNTs apart on a
surface such that the electrical conductivity properties of the modified surface
might be readily controlled.
Figure 5.5: Schematic topview of the molecular spacer separating two nanotubes.
5.2.1 Design of a molecular spacer
The design of the proposed molecular spacer 6 is shown in Figure 5.6. Trip-
tycene is chosen as the SWNT surface-binding molecule, because it is bent
and has the appropriate size for binding to the SWNTs and still being sus-
ceptible to removal after the SWNTs are connected to a surface. The chosen
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linkers comprise adamantane and acetylene units, as these units form a rigid
system that can hold the two triptycenes at defined positions in space, along
with being electrical insulators. Moreover, the adamantane units are func-
tionalized with PEG units to alter the solubility properties of the spacer
molecule. By using two linkers, the relative geometry of the triptycenes is
under control. However, a molecule with only one linker, in which freedom
of rotation around the adamantyl-acetylene bond would be allowed, might
be more readily accessible as will be described below.
Figure 5.6: The proposed molecular spacer 6.
5.2.2 Synthesis outline
An outline of the proposed synthesis of the molecular spacer is shown in Fig-
ure 5.7. The key step is a coupling between the disilver(I) acetylide 8 (which
is formed from the known diethynyl triptycene 7106) and the previously de-
scribed difluoro diiodoadamantane 9107, 108 to obtain 10. For this purpose,
the silver(I) acetylide chemistry developed by the group of Williams109, 110
(see section below) will be applied. Subsequently, PEG units may be in-
troduced by substitution of the fluorines with bromines followed by reaction
with the appropriate silver carboxylate111 giving the functionalized spacer 6.
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Figure 5.7: Outline of the proposed synthesis of molecular spacer 6.
5.2.3 Alkynylation of adamantyl iodide by use of sil-
ver(I) acetylides
The coupling between 8 and 9 relies on a recently developed method for
alkynylation at the bridgehead of bicyclic cages.109, 110 This involves the re-
action between a silver(I) acetylide (e.g. the phenylacetylide 11, Figure 5.8)
and an iodinated bicyclic cage (e.g. 1-iodoadamantane 12) under reflux in N -
methylmorpholine (NMM), affording an alkynylated product (e.g. 13).109, 110
Figure 5.8: The reaction between silver(I) acetylide 11 and 1-iodoadamantane 12, af-
fording the alkynylated product 13.
Surprisingly, however, the reaction of the disilver(I) acetylide 14112 with
12 only leads to the monoalkynylated product 15 as seen in Figure 5.9. A
deargentation process, giving the monosilver(I) acetylide 16 (Figure 5.10)
is thought to take place before the alkynylation.109 In that case, since the
disilver(I) acetylide 8 is also an arylacetylide, there is a likelihood that it too
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will undergo a deargentation process before the alkynylation, thus yielding a
spacer with only one linker.
Figure 5.9: The reaction between disilver(I) acetylide 14 and 1-iodoadamantane 12,
affording the monoalkynylated product 15.
Figure 5.10: Deargentation process yielding the monosilver(I) acetylide 16.
5.3 Results and discussion
The syntheses of the adamantane and triptycene units are described below,
followed by silver(I) acetylide formation and a subsequent coupling reaction.
5.3.1 Synthesis of the adamantane unit
1,3,5,7-tetrabromoadamantane 17113 was formed in an acceptable yield by
reacting 1-bromoadamantane with bromine and aluminum chloride according
to a literature procedure (however not starting from adamantane).114
Figure 5.11: Synthesis of 1,3,5,7-tetraiodoadamantane 18 in two steps from 1-
bromoadamantane.
Halogen exchange of 17 to obtain 1,3,5,7-tetraiodoadamantane 18115 was
performed by heating of 17 with aluminum and bromine in a diiodomethane
solution as described earlier.115 However, the reaction did not proceed as
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smoothly as previously described, mainly due to purification problems con-
cerning removal of aluminum salts. When using 1.7 equivalents of aluminum
foil, the reaction did not go to completion; accordingly, fragments of 1-bromo-
3,5,7-triiodoadamantane and 1,3-dibromo-5,7-diiodoadamantane were identi-
fied by GCMS analysis of the crude mixture. Subjection of the crude mixture
to the reported conditions115 gave the pure product, albeit in a modest yield
of 15%. Attempts at using longer reaction times did not improve the yield,
and an attempt at using additional equivalents of aluminum and bromine
led to full conversion but a lower isolated yield due to increased purification
problems.
It was then attempted to obtain 1,3-difluoro-5,7-diiodoadamantane 9108
(Figure 5.12) by exchanging two of the iodines of 18 with fluorines as previ-
ously reported.107 However, reaction of 18 with mercuric fluoride in refluxing
chloroform for 3 days did not give 9108 as the only product. 19F NMR∗ and
GCMS† analyses indicated that a mixture of fluorinated products was ob-
tained, including 1,3,5-trifluoro-7-iodoadamantane 19 and 1,3,5,7-tetrafluoro-
adamantane 20 and other fluorine containing compounds. As the reaction
was found to be uncontrollable and the obtained mixture was inseparable by
flash column chromatography, the fluorination was attempted by alternative
reaction conditions.
Figure 5.12: Attempt at the synthesis of 1,3-difluoro-5,7-diiodoadamantane 9 with HgF2.
A literature method for converting bridgehead bromoadamantanes into
the corresponding fluoroadamantanes by reaction with silver(I) fluoride in re-
fluxing cyclohexane117 was attempted. However, treatment of 18 using these
conditions (Figure 5.13) gave only little conversion, resulting in a mixture of
18 and fluorinated compounds. 1H NMR and 19F NMR analyses revealed
the mixture to consist of mainly starting material 18 and some 1-fluoro-
∗The signals in 19F NMR were analyzed according to literature values for 1-
fluoroadamantane (–129.02 to –129.07 (m)116), 1,3-difluoroadamantane (–134.51 (s)116),
1,3,5-trifluoroadamantane (–141.43 (s)116), and 1,3,5,7-tetrafluoroadamantane 20 (–150.87
(s)116). 19F NMR values for fluoro-iodoadamantanes 21, 9, and 19 have not been reported
previously.
†Fragments of 1,3-difluoro-5,7-diiodoadamantane and 1,3,5-trifluoro-7-iodoadamantane
were found in GCMS.
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3,5,7-triiodoadamantane 21. Only traces of the desired product 9 along with
traces of some other fluorine containing compounds were indicated by 19F
NMR.
Figure 5.13: Attempt at the synthesis of 1,3-difluoro-5,7-diiodoadamantane 9 with AgF.
5.3.2 Synthesis of the triptycene unit
2,3-Dibromotriptycene 22118 (Figure 5.14) was obtained according to a lit-
erature procedure;119 that is by slow addition of n-BuLi to a dilute solution
of 1,2,4,5-tetrabromobenzene and anthracene, resulting in a Diels-Alder re-
action120 between the thus formed 4,5-dibromobenzyne and anthracene.
Figure 5.14: Synthesis of 2,3-dibromotriptycene 22 from anthracene and 1,2,4,5-
tetrabromobenzene.
Sonogashira coupling121 of 22 with trimethylsilylacetylene gave the dis-
ilylated 2,3-diethynyltriptycene 23106 (Figure 5.15). Optimization of the
reported reaction conditions (18 hours of reflux106) led to full conversion by
reaction of 22 for 3 hours under microwave heating; however 20 mol% of
the palladium catalyst was needed (as compared to 2 mol%106). Subsequent
desilylation with TBAF gave 2,3-diethynyltriptycene 7 (Figure 5.16) in a
good yield.
5.3.3 Silver(I) acetylide chemistry
Pale and co-workers have demonstrated that 1-hexyne can be transformed
into the silver(I) acetylide 24 (Figure 5.17) by reaction with silver triflate
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Figure 5.15: Sonogashira coupling between 22 and trimethylsilylacetylene yielding 23.
Figure 5.16: Desilylation of 23 furnishing 7.
and base in various solvents.122 Mechanistic studies utilizing 1H, 13C, and
109Ag NMR led to the identification of a pi-alkyne-silver complex intermedi-
ate, which is rapidly deprotonated upon addition of diisopropylethylamine
(DIPEA).122
Figure 5.17: Silver(I) acetylide synthesis through the formation of a pi-alkyne-silver
complex.
Ideally, going toward the spacer 6 with two linkers, the disilver(I) acetylide
8 would be synthesized under the above conditions. However, reaction of 7
with silver triflate (Figure 5.18) in chloroform proceeded with full conver-
sion to the monosilver(I) acetylide 25. Surprisingly, base addition was not
necessary to promote deprotonation. An attempt to use the reverse order of
addition of the reagents was not successful (brown precipitate).
The product, which is insoluble in usual NMR solvents, was verified by
HRMS, which also confirmed that 25 is the only product rather than a mix-
ture of mono and disilver(I) acetylides. This is probably due to 25 precipi-
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tating upon formation, thus preventing further reaction with silver triflate.
Figure 5.18: Formation of silver(I) acetylide 25 from 7.
More recently, the formation of silver(I) acetylides from trimethylsilyl
acetylenes by use of silver nitrate or triflate in protic solvents has also been
reported by Pale and co-workers.123 Mechanistic studies suggested the re-
action to likewise proceed through formation of a pi-alkyne-silver complex
(Figure 5.19).124
Figure 5.19: Silver(I) acetylide synthesis from trimethylsilyl acetylene through the for-
mation of a pi-alkyne-silver complex.
The disilylated compound 23 was subjected to the above reaction condi-
tions (Figure 5.20). Interestingly, this also resulted in high-yielding formation
of the monosilver(I) acetylide 25. Hence, silver(I) acetylide formation takes
place at one of the acetylenes whereas the other is deprotected. The silylated
compound 26 (Figure 5.21) is thus not formed. Since precipitation usually
occurs upon silver(I) acetylide formation, it is surprising that this deprotec-
tion has taken place. Accordingly, there is only little precipitation when the
reaction is performed with only one equivalent of silver triflate, giving 20%
of 25, and confirming that the deprotection has to be done in connection
with the silver(I) acetylide formation. With the two acetylenes of 23 being
in proximity, it is likely that the mechanism goes through an intermediate 27
(Figure 5.21) with a silver ion complexed to both acetylenes simultaneously.
The silver(I) acetylide 25 was coupled with 1-iodoadamantane 12 under
the previously described conditions109, 110 (Figure 5.22). The reaction went
in a modest NMR yield of 21% of the product 28, despite the use of excess
of 12, giving 2,3-diethynyltriptycene 7 as a byproduct formed through dear-
gentation. Due to the Rf values of the triptycene derivatives 7 and 28 being
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Figure 5.20: Direct formation of silver(I) acetylide 25 from 23.
Figure 5.21: Compound 26 which is not formed and a likely intermediate 27.
close, their separation was difficult. Attempts at separation by flash column
chromatography were not successful, but purification by chromatotron led to
11% of isolated product 28.
Figure 5.22: Coupling of silver(I) acetylide 25 with iodoadamantane 12 giving product
28.
5.4 Summary and outlook
Up until this point, a product 28 (Figure 5.23a) which is interesting for in-
vestigation of its interaction with SWNTs on a surface has been synthesized
by use of silver(I) acetylide chemistry. An appropriate linker can be read-
ily attached to the terminal alkyne of 28, e.g. by a Sonogashira coupling,
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whereafter the compound can be attached along with SWNTs to a surface
as illustrated in Figure 5.23b.
Figure 5.23: The obtained product 28 (a) and a possible application (b).
However, the route to the initially proposed spacer for SWNT separation
still needs development. To sum up the results of the project (see Figure
5.24):
• The synthesis of the difluoro-diiodoadamantane unit 9 from 1,3,5,7-
tetraiodoadamantane 18 failed by use of two different reagents, mercuric flu-
oride and silver(I) fluoride, due to an uncontrollable fluorine-iodine exchange
leading to a mixture of fluorinated adamantanes.
• It was shown that the silver(I) acetylide 25 could be obtained in high
yield from two different precursors 7 and 23, one bearing terminal alkynes
and one bearing terminal trimethylsilylacetylenes. Thus, in the latter case
a double-deprotection was found to be necessary in connection with the sil-
ver(I) acetylide formation. Not surprisingly, with previous results in mind,
the triptycene unit 8 was not formed.
• Coupling of silver(I) acetylide 25 and 1-iodoadamantane was possible,
yielding 28, albeit in a modest yield and with semi-isolation due to close
separation between 28 and the byproduct 7.
There is another route by which the synthesis of the adamantane unit 9
can be envisioned (see Figure 5.25). Starting from the commercially available
1,3-dibromoadamantane, difluoroadamantane 29 can be synthesized as pre-
viously described,117 followed by diiodination by a radical iodination reaction
under phase-transfer conditions125 which has been reported to be applicable
to 1-bromo-3-chloro-5-fluoroadamantane.126
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Figure 5.24: An overview of the results of the project.
Figure 5.25: Proposed route for the synthesis of the adamantane unit 9.
With compounds 25 and 9 in hand, it will most likely be possible to
synthesize the functionalized molecular spacer 6 (Figure 5.26) with one linker,
which will be a good starting point for investigating spacer interaction with
SWNTs. From compound 10 with one linker, two successive sequences of
silver(I) acetylide formation and coupling will probably be needed for the
introduction of another linker, followed by functionalization furnishing 6.
The yields of the couplings will probably be low as was the case for the
synthesis of 28.
An alternative approach is to build the spacer by a reverse sequence,
thus starting with the construction of the diethynyladamantane 30 from 9
through reaction with silver(I) triisopropylsilylacetylide followed by depro-
tection. A subsequent Sonogashira coupling with 2,3-dibromotriptycene is
then proposed to yield compound 10, which might then be functionalized
to yield the spacer 6 with two linkers. Coupling of 1-iodoadamantane with
silver(I) triisopropylsilylacetylide has been reported previously, albeit in a
low yield.110
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Figure 5.26: Synthesis of 6 from 25 and 9.
Figure 5.27: Synthesis of 6 by a reverse sequence.
5.5 Concluding remarks
It is demonstrated that a monosilver(I) acetylide of 2,3-diethynyltriptycene
can be formed from both 2,3-diethynyltriptycene and 2,3-di(trimethylsilylethy-
nyl)triptycene by use of the same reagent. The silver(I) acetylide is further
coupled with 1-iodoadamantane. These results open up opportunity for con-
structing new molecules that can interact with SWNTs, potentially leading
to the alignment needed for SWNT-based device construction.
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5.6 Experimental section
Starting materials and reagents were purchased from Sigma-Aldrich Chemical
Co. and used without further purification. Reactions involving air or mois-
ture sensitive reagents were carried out under Ar. Chloroform was washed
with water, dried over Na2SO4 and distilled from P2O5. Cyclohexane was
distilled and stored over 4 A˚ molecular sieves. Toluene and pentane were
dried over 4 A˚ molecular sieves. THF was predistilled from CaH2 and dis-
tilled from Na under Ar. Piperidine and N -methylmorpholine were distilled
from CaH2 under Ar. Flash column chromatography was undertaken on sil-
ica gel (Flash Silica gel 230–400 mesh), with distilled solvents. NMR spectra
were recorded using a Bruker AV300 MHz spectrometer or a Bruker AV400
MHz spectrometer. Chemical shifts were measured in ppm and coupling
constants in Hz, and the field is indicated in each case. The solvent peaks
from CDCl3 (7.24 ppm in
1H NMR and 77.16 ppm in 13C NMR) and TFA
(external reference, 19F NMR) were used as standards. IR analysis was car-
ried out on a Perkin-Elmer (Spectrum 2000) FTIR spectrometer. Melting
points were determined with a Stuart SMP11 Melting Point apparatus and
are uncorrected. High- and low-resolution ESI mass spectroscopic data for
the silver(I) acetylide were recorded on a Thermo Scientific (model LTQ FT)
FTICR mass spectrometer at The University of Melbourne. High- and low-
resolution EI mass spectroscopic data were obtained with a KRATOS MS 25
RFA.
1,3,5,7-Tetrabromoadamantane 17
1-Bromoadamantane (1.048 g, 4.87 mmol) was added portionwise over 30
minutes to a stirred mixture of bromine (8.17 g, 51.13 mmol) and aluminum
chloride (620 mg, 4.65 mmol) at 5-10 ◦C. The mixture was heated to 70 ◦C
over 1 hour. After stirring at that temperature for 24 hours, the mixture
was triturated with sat. aq. sodium sulfite (to remove excess bromine) with
hydrochloric acid added (to dissolve aluminum salts). After cooling on an ice
bath, the red-yellow solids were removed by filtration, washed with water and
air dried. Recrystallization from glacial acetic acid (30 mL) gave the product
17 (1.34 g, 61%) as a tan powder; m.p. 241-242 ◦C (lit.114 245-247 ◦C); 1H
NMR (CDCl3, 300 MHz) δ 2.68 (s, 12H).
1,3,5,7-Tetraiodoadamantane 18
Bromine (98 mg, 0.61 mmol) was added to small pieces of aluminum foil (49
mg, 1.82 mmol) in CH2I2 (5.85 mL). The mixture was heated to 80
◦C and
stirred at that temperature for 35 minutes. Then 1,3,5,7-tetrabromoadaman-
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tane 17 (488 mg, 1.08 mmol) was added in one portion. The mixture was
stirred for 15 minutes at 80 ◦C whereafter it was poured into cold water (10
mL) with stirring. Sodium sulfite was added (to remove excess bromine).
6M HCl (4 mL) was added, and the mixture was stirred for 1 hour (to dis-
solve aluminum salts). The diiodomethane phase was isolated and washed
with water (10 mL). Diiodomethane was removed by distillation in vacuo,
and the residue was washed with chloroform and then acetone. This gave an
off-white product containing some 1-bromo-3,5,7-triiodoadamantane and 1,3-
dibromo-5,7-diiodoadamantane. Treatment of the crude material using the
above reaction conditions gave the product 18 (105 mg, 15%) as a tan pow-
der; m.p. dec (lit.115 370 ◦C dec) 1H NMR (CDCl3, 300 MHz) δ 3.18 (s, 12H).
Attempt at the synthesis of 1,3-difluoro-5,7-diiodoadamantane 9
with HgF2
A solution of 1,3,5,7-tetraiodoadamantane 18 (31 mg, 0.05 mmol) in an-
hydrous chloroform (3.5 mL) was added to mercuric fluoride (32 mg, 0.13
mmol), and the mixture was heated to reflux under Ar. The mixture was
stirred for 3 days at reflux. In this period, sonication was carried out for 1
out of every 12 hours. The reaction mixture was filtered through Celite and
the solvent was removed in vacuo. The residue was redissolved in CH2Cl2
and filtered through a short silica gel column. The filtrate was concentrated
in vacuo giving a mixture of fluorinated compounds. 19F NMR (CDCl3, 376
MHz) δ -138.11 (s), -139.52 (s), -145.88 (s), -147.14 (s), -150.49 (s).
Attempt at the synthesis of 1,3-difluoro-5,7-diiodoadamantane 9
with AgF
1,3,5,7-Tetraiodoadamantane 18 (24 mg, 0.04 mmol) was suspended in an-
hydrous cyclohexane (1 mL). Silver fluoride (10 mg, 0.08 mmol) was added.
The suspension was stirred at reflux under Ar for 4 hours. The solvent was re-
moved in vacuo. The mixture was redissolved in CH2Cl2 and filtered through
Celite. The filtrate was concentrated in vacuo, giving a mixture of 1,3,5,7-
tetraiodoadamantane 18 and fluorinated compounds. 1H NMR (CDCl3, 300
MHz) δ 3.18 (s, 1,3,5,7-tetraiodoadamantane 18), 3.03-2.99 (m, CF-CH2-
CI, 1-fluoro-3,5,7-triiodoadamantane 21), 2.65 (d, J 4.8 Hz, CF-CH2-CF, 1-
fluoro-3,5,7-triiodoadamantane 21); 19F NMR (CDCl3, 376 MHz) δ -128.51
(m), -136.86 (s), -140.31 (s), -147.49 (s), -151.09 (s).
2,3-Dibromotriptycene 22119
1,2,4,5-Tetrabromobenzene (1.005 g, 2.55 mmol) and anthracene (1.005 g,
5.61 mmol) were dissolved in anhydrous toluene (75 mL) and stirred under
Ar. A solution of n-BuLi in anhydrous hexane (1.15 M, 2.22 mL, 2.55 mmol)
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was diluted with anhydrous pentane (47.78 mL). The resulting n-BuLi so-
lution (0.05 M, 50 mL, 2.55 mmol) was added over 3 hours at 20 ◦C. After
stirring for 18 hours, the mixture was quenched with water (50 mL) and
extracted with Et2O (2×75 mL). The organic phase was dried (MgSO4), fil-
tered and concentrated in vacuo. The residue was purified by flash column
chromatography [petroleum spirit (40-60 ◦C)] to give the product 22 (362
mg, 34%) as a yellow solid; m.p. 184-187 ◦C (lit.119 191-192 ◦C); 1H NMR
(CDCl3, 300 MHz) δ 7.60 (s, 2H), 7.37-7.34 (m, 4H), 7.01-6.99 (m, 4H), 5.34
(s, 2H).
2,3-Di(trimethylsilylethynyl)triptycene 23
2,3-Dibromotriptycene 22 (369 mg, 0.89 mmol) was dissolved in anhydrous
piperidine (6.44 mL), and trimethylsilylacetylene (1.24 mL, 8.94 mmol) was
added. The mixture was deoxygenated by bubbling Ar through a sub-
merged needle for 1 hour. Pd(PPh3)4 (207 mg, 0.18 mmol) and CuI (34
mg, 0.18 mmol) were added, and the mixture was flushed with Ar. The
mixture was heated under microwave conditions (115 ◦C, 150 W, 250 PSI,
3 hours). The resulting mixture was suspended in EtOAc (35 mL) and
washed with aqueous 10% NH4OH (3×15 mL). The organic phase was dried
(Na2SO4), filtered and concentrated in vacuo. Flash column chromatography
[2% EtOAc in petroleum spirit (40-60 ◦C)] of the residue gave the product
23 (399 mg, quantitative yield) as an orange solid; m.p. 118-120 ◦C; IR
(neat) ν 3069(w), 2959(m), 2900(w), 2154(m), 1912(w), 1591(w), 1459(m),
1405(w), 1315(w), 1247(s), 1188(w), 1155(m), 1119(w), 1059(w), 1025(w),
834(s), 757(s), 742(s), 694(s), 654(m), 638(m), 629(m), 616(m) cm−1; 1H
NMR (CDCl3, 400 MHz) δ 7.45 (2H, s), 7.33-7.31 (4H, m), 6.98-6.96 (4H,
m), 5.33 (2H, s), 0.20 (18H, s); 13C NMR (CDCl3, 100 MHz) δ 145.3 (2C),
144.3 (4C), 127.3 (2C), 125.4 (4C), 123.7 (4C), 122.7 (2C), 103.5 (2C), 97.5
(2C), 53.6 (2C), 0.0 (6C).
2,3-Diethynyltriptycene 7
2,3-Di(trimethylsilylethynyl)triptycene 23 (397 mg, 0.89 mmol) was dissolved
in anhydrous THF (13.3 mL) and stirred under Ar. TBAF (1 M in THF,
2.67 mL) was added dropwise. After stirring at 20 ◦C for 2 hours, the reac-
tion mixture was concentrated in vacuo, and the crude was combined with
EtOAc (30 mL) and sat. aq. NH4Cl (8 mL). The organic layer was washed
with sat. aq. NH4Cl (2×8 mL), dried (Na2SO4), filtered and concentrated
in vacuo. The residue was purified by flash column chromatography [4%
EtOAc in petroleum spirit (40-60 ◦C)] yielding the product 7 (198 mg, 73%)
as a light orange solid; m.p. 186-188 ◦C dec (lit.106 188-191 ◦C); IR (neat) ν
3286(m), 3021(w), 2962(w), 2104(w), 1458(s), 1402(w), 1250(m), 1192(m),
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1152(m), 1021(m), 938(w), 897(m), 804(w), 746(s), 627(s), 596(s) cm−1; 1H
NMR (CDCl3, 300 MHz) δ 7.50 (s, 2H), 7.38-7.35 (m, 4H), 7.01-6.99 (m,
4H), 5.38 (s, 2H), 3.21 (s, 2H).
2-Ethynyltriptycene-3-silver(I) acetylide 25
Method A: 2,3-diethynyltriptycene 7 (40 mg, 0.13 mmol) was dissolved in
anhydrous chloroform (3 mL) and silver triflate (68 mg, 0.26 mmol) was
added. A yellow precipitate formed shortly after the addition. After stirring
for 10 minutes at 20 ◦C in the dark, the precipitate was filtered off, washed
with cold water and dried, giving the silver(I) acetylide 25 (54 mg, quantita-
tive yield) as a yellow solid. Method B: 2,3-di(trimethylsilylethynyl)tripty-
cene 23 (35 mg, 0.08 mmol) was dissolved in MeOH (2 mL) and silver triflate
(40 mg, 0.16 mmol) was added. After stirring for 10 minutes at 20 ◦C in the
dark, a yellow precipitate was filtered off, washed with cold MeOH and dried,
yielding the product 25 (27 mg, 85%) as a yellow solid; m.p. 182-184 ◦C
dec; IR (neat) ν 3431(m), 3066(m), 2961(m), 2361(m), 1995(m), 1691(m),
1600(m), 1458(s), 1223(s), 1169(s), 1021(s), 940(m), 898(m), 804(m), 758(s),
692(w), 632(s), 606(s), 574(m) cm−1; LRMS (ESI) 450.08 [(M+H)+CH3CN]+;
HRMS (ESI) [(M+H)+CH3CN]
+ C26H17AgN calcd. 450.0406; found 450.0410.
2-(1-Adamantyl)ethynyl-3-ethynyltriptycene 28
2-Ethynyltriptycene-3-silver(I) acetylide 25 (100 mg, 0.25 mmol) was sus-
pended in anhydrous N -methylmorpholine (8.5 mL). 1-Iodoadamantane (257
mg, 0.98 mmol) was added, and the suspension was stirred at reflux under Ar
in the dark. After 3 days, the solvent was evaporated in vacuo. The residue
was diluted with CH2Cl2 (20 mL) and filtered through Celite. The filtrate
was washed with aqueous NaN3 (0.1 M, 20 mL), dried (Na2SO4), filtered
and concentrated in vacuo. The residue was passed through a short silica
gel column (EtOAc) and then purified by chromatotron [petroleum spirit
(40-60 ◦C)] giving the product 28 (12 mg, 11%) as a white solid. Another
fraction containing a mixture of the product 28 and 2,3-diethynyltriptycene
7 (24 mg) was obtained. Total NMR yield of product: 23 mg, 21%; m.p.
213-216 ◦C; 1H NMR (CDCl3, 300 MHz) δ 7.44 (s, 1H), 7.40 (s, 1H), 7.35-
7.31 (m, 4H), 6.99-6.96 (m, 4H), 5.34 (s, 1H), 5.33 (s, 1H), 3.13 (s, 1H),
1.95-1.91 (m, 9H), 1.68 (t, J 2.7 Hz, 6H); 13C NMR (CDCl3, 100 MHz) δ
145.6, 144.4 (2C), 144.3 (2C), 144.2, 127.2, 126.7, 125.4 (2C), 125.4 (2C),
124.3, 123.7 (2C), 123.7 (2C), 121.3, 102.1, 82.7, 79.5, 78.1, 53.6, 53.5, 42.8
(3C), 36.4 (3C), 30.3, 28.0 (3C); LRMS (EI) 436.6 [M]+; HRMS (EI) [M]+
C34H28 calcd. 436.2186; found 436.2195.
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Appendix A
Abbreviations
Ac Acetyl
Alloc Allyloxycarbonyl
anal. Analysis
Arg Arginine
aq. Aqueous
Bn Benzyl
Boc tert-Butoxycarbonyl
br Broad (IR, NMR)
Bu Butyl
Bz Benzoyl
18-C-6 18-Crown-6
calcd. Calculated
CAN Ceric ammonium nitrate
CNT Carbon nanotube
4CR Four-component reaction
d Doublet (NMR)
DAD Diode array detector
Dap 2,3-Diaminopropionic acid
dba Dibenzylideneacetone
DDQ 2,3-Dichloro-5,6-dicyano-1,4-benzoquinone
de Diastereomeric excess
dec Decomposition
δ Chemical shift
DIBAL-H Diisobutylaluminium hydride
DIPEA Diisopropylethylamine
DMAP 4-Dimethylaminopyridine
DMB 3,4-dimethoxybenzyl
DMF Dimethylformamide
DMSO Dimethyl sulfoxide
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DNA Deoxyribonucleic acid
DOS Diversity-oriented synthesis
dr Diastereomeric ratio
EDC 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide
ee Enantiomeric excess
EI Electron ionization
equiv Equivalent(s)
ESI Electrospray ionization
Et Ethyl
FG Functional group
Fmoc 9-Fluorenylmethoxycarbonyl
FT Fourier transform
GC Gas chromatography
Hol Homoleucine
HR High resolution
IBX 2-Iodoxybenzoic acid
ICR Ion cyclotron resonance
IR Infrared
J Coupling constant
L Ligand
LC Liquid Chromatography
lit. Literature
LR Low resolution
m Multiplet (NMR); Medium (IR)
M+ Molecular ion
maj Major
MCR Multicomponent reaction
Me Methyl
MiB Multiple multicomponent macrocyclization including
bifunctional building blocks
min Minor
MMP Matrix metalloproteinase
m.p. Melting point
MS Mass spectrometry
MW Microwave
m/z Mass-to-charge ratio
n normal
NMM N -methylmorpholine
NMR Nuclear magnetic resonance
Ns 2-Nitrobenzenesulfonyl
Nva Norvaline
99
p para
Pbf 2,2,4,6,7-Pentamethyldihydrobenzofuran-5-sulfonyl
PEG Poly(ethylene glycol)
Ph Phenyl
PMB p-Methoxybenzyl
PMBTCA p-Methoxybenzyl trichloroacetimidate
PMP p-Methoxyphenyl
PNP p-Nitrophenyl
PNPCC p-Nitrophenyl chlorocarbonate
ppm parts per million
PPTS Pyridinium p-toluenesulfonate
RCM Ring-closing metathesis
Rf Retention value
s Singlet (NMR); Strong (IR)
SAR Structure-activity relationship
sat. Saturated
SWNT Single walled carbon nanotube
t Triplet (NMR)
t tert
TBAF Tetrabutylammonium fluoride
TBDMS tert-Butyldimethylsilyl
TBDPS tert-Butyldiphenylsilyl
Tf Trifluoromethanesulfonyl
TFA Trifluoroacetic acid
THF Tetrahydrofuran
TIPS Triisopropylsilyl
TLC Thin layer chromatography
TMS Trimethylsilyl
TOS Target-oriented synthesis
TPS Triphenylsilyl
Ts p-Toluenesulfonyl
Tyr Tyrosine
ν Frequency
w Weak (IR)
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The formation of a library of diverse macrocycles with different ring sizes from two easily 
accessible building blocks is presented. Reacting diol precursors with electrophilic reagents lead 
to 17-membered sulfites and 19-membered malonates in 34-79% yield. Double-reductive 
amination of dialdehyde analogs of the diol precursors leads to 15-membered amines in yields 
ranging from 9 to 60%, reflecting large differences in reactivity based on steric environment. 
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1. Introduction  
Macrocyclic compounds are attractive targets within drug 
discovery due to the fact that naturally occurring macrocycles 
often display diverse and interesting biological activities. This 
arises from several structural advantages characteristic for this 
compound class. Macrocycles are conformationally preorganized, 
enabling them to bind selectively to targets with minimal 
entropic loss. However, they have a certain flexibility, which, in 
combination with their functionally independent subregions, 
enables them to bind non-covalently to each other or to mediate 
the assembly of other macromolecules by non-covalent 
interactions. Furthermore, they have the ability of burying away 
polar functionalities, leading to improved membrane 
permeability as compared to their linear analogs. Proteolytic and 
metabolic stability is also improved as a consequence of the 
reduced accessible conformational space.1  
The substructures of naturally occurring macrocycles provide 
valuable inspiration for the design of new synthetic macrocycles, 
because of the above mentioned biological activity of this 
compound class. Substructures frequently present in naturally 
occurring macrocycles are, for example, polyketides, 
heterocycles, peptide, biphenyl and (bi)aryl ether domains.2 A 
drawback of traditional natural product chemistry is the often 
complex structures and the synthetic effort thus required. Hence, 
an approach combining natural product drug discovery and 
combinatorial chemistry has been suggested.3,4 This strategy, 
designing synthetic compounds from easily accessible building 
blocks containing naturally occurring substructural motifs, and 
hence providing rapid access to synthetic libraries, is providing 
an increased chance of finding a potent drug. Despite the 
challenge in forming large ring systems, macrocyclic compounds 
are interesting targets for this strategy and the generation of 
libraries of macrocycles has received significant attention 
recently.5  
Encouraged by our recently reported method on formation of 
macrocyclic rings from diol precursors,6 we were interested in 
generating a library of diverse macrocycles based on this 
strategy. According to the above, we aimed at producing 
macrocycles in a few diversity-generating steps starting from two 
simple building blocks, one containing a heterocycle (triazole) 
and one containing a hydroxy alkene (a fragment inspired by 
polyketides). Four structurally isomeric diol precursors are 
formed through combinations of the two building blocks by 
esterifications. These are then cyclized, either in one step by 
reaction with bis-electrophilic reagents, or in two steps by 
forming the dialdehyde derivatives and then reacting them with a 
nucleophilic reagent.  
2. Results and discussion 
The building blocks for the synthesis of diol precursors were 
readily obtained in good yields from simple, commercially 
available starting materials (Scheme 1 and 2). Substitution of 4-
chlorobutyl benzoate with sodium azide, followed by a copper (I) 
catalyzed alkyne-azide cycloaddition reaction7 of the resulting 
azide with TBDMS protected propargyl alcohol afforded the 
protected triazole building block 1 (Scheme 1). Reductive 
cleavage of the benzoyl group gave one of the desired alcohol 
derivatives 2 (ready for esterification). The other desired alcohol 
derivative 4 was obtained by TBDPS protection of 2 and 
subsequent selective monodeprotection by acidic solvolysis. 
Preliminary attempts to use a triphenylsilyl (TPS) ether as 
protection group instead of TBDPS did not give the desired 
selectivity, as the TPS group was found to be more prone to 
hydrolysis than the TBDMS group. 
 
 
 
 
 
 
 
Scheme 1. Reagents and conditions: (a) i) NaN3, Bu4NI, DMF, 60 ºC, ii) tert-
butyldimethyl(prop-2-ynyloxy)silane, DIPEA, CuI, THF; (b) DIBAL-H, 
CH2Cl2, -78 ºC; (c) TBDPSCl, imidazole, DMF; (d) PPTS, MeOH, 55 ºC. 
Grignard reaction of TBDMS protected hydroxy acetone with 
vinyl magnesium chloride followed by a cross-metathesis 
reaction8 with methyl acrylate gave the (E)-enol building block 6 
(Scheme 2). The Hoveyda-Grubbs second generation catalyst9 
was more efficient in this transformation than the Grubbs second 
generation catalyst.10 Interestingly, despite the reaction being 
somewhat slower with 0.5% catalyst loading as compared to 5%, 
we found the overall conversion to be higher with the lower 
loading.  
PMB protection of 6 with p-methoxybenzyl 
trichloroacetimidate (PMBTCA)11 under mild conditions12 gave 
7, which could be hydrolyzed under basic conditions to yield one 
of the desired carboxylic acid derivatives 8. The alcohol 9 was 
obtained from 7 by reductive cleavage of the methyl ester. 
Deprotection with TBAF went smoothly, giving the diol 10 in an 
excellent yield. Most satisfyingly, the allylic hydroxy group 
could be selectively TBDPS protected at -78 ºC in 
dichloromethane. Swern13 and sodium chlorite14 oxidations 
yielded the other desired carboxylic acid 12. Preliminary attempts 
to selectively cleave the TBDMS group from the TPS protected 
analog of 9 proved unsuccessful for the same reason as specified 
above for the triazole building block.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2. Reagents and conditions: (a) vinyl magnesium chloride, THF, 0 
ºC; (b) Hoveyda-Grubbs’ 2nd gen. cat., methyl acrylate, CH2Cl2, 40 ºC; (c) 
PMBTCA, La(OTf)3, toluene; (d) LiOH, THF/H2O 3:1; (e) DIBAL-H, 
CH2Cl2, -78 ºC; (f) TBAF, THF; (g) TBDPSCl, imidazole, CH2Cl2, -78 ºC; 
(h) i) DMSO, (COCl)2, -78 ºC, Et3N, ii) NaClO2, NaH2PO4, 2-methyl-2-butene, 
t-BuOH, THF. 
The alcohols 2 and 4 were combined with the carboxylic acids 
8 and 12 by carbodiimide promoted esterifications15 (Scheme 3) 
yielding the four esters 13, 15, 17, and 19, which were 
deprotected smoothly with TBAF to give the desired diol 
precursors. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3. Reagents and conditions: (a) EDC·HCl, DMAP, CH2Cl2; (b) 
TBAF, THF. 
 
The diols 14, 16, 18 and 20 were treated with thionyl chloride, 
triethylamine and DMAP under our standard conditions6 to 
obtain the 17-membered macrocyclic sulfites 21, 23, 25 and 27, 
respectively (Scheme 4). The sulfites were obtained in yields 
ranging from 43% to 79% reflecting a difference in the steric 
environment of the cyclization precursors. This is further 
emphasized by the fact that the diastereomeric ratio of 21, formed 
from the most sterically hindered diol precursor, differs from the 
diastereomeric ratios of the other sulfites in being 2:1 as 
compared to 1:1 (or 3:2). Not surprisingly, cyclizations of the 
two least sterically hindered diol precursors 18 and 20 result in 
higher yields than cyclizations of the more hindered substrates 14 
and 16. 
Subsequent deprotection of the PMB ethers with DDQ to 
obtain the sulfites 22a, 24, 26 and 28 resulted in yields ranging 
from 30% to 67%. The low yield for the deprotection of 21 is 
caused by lability of the product to column chromatography. This 
was proven by the isolation of a 5-membered cyclic sulfite by-
product 22b formed upon nucleophilic attack by the tertiary 
hydroxy group on the macrocyclic sulfite. The identification of 
the product 22a and the by-product 22b as single diastereomers 
confirms that only one of the diastereomers of the deprotected 
sulfite is susceptible to the intramolecular transesterification of 
the sulfite.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 4. Reagents and conditions: (a) SOCl2, Et3N, DMAP, CH2Cl2; (b) 
DDQ, CH2Cl2/H2O 18:1. 
Next, we were interested in extending the above cyclization 
method to the formation of malonates. Diol precursors 14 and 16 
were treated with malonyl chloride under the above conditions, 
giving the 19-membered malonates 29 and 31 (Scheme 5) in 37 
and 34% yield, respectively. Thus, the yields for formation of 
malonates are slightly lower than for the formation of sulfites, 
possibly related to the difference in ring sizes formed and/or the 
relative reactivity of the reagents. 
 
 
 
 
 
 
 
Scheme 5. Reagents and conditions: (a) malonyl chloride, Et3N, DMAP, 
CH2Cl2; (b) DDQ, CH2Cl2/H2O 18:1. 
 
The malonates were deprotected analogously to the sulfites, 
giving 30 and 32. The products were obtained in higher yields 
than their sulfite analogs, presumably because the malonates are 
more stable than the sulfites. 
Our next target was the 15-membered macrocyclic amine 34 
(Scheme 6). The dialdehyde cyclization precursor 33 was 
prepared by oxidation of 14 in excellent yield. For this reaction, 
IBX16 was found to be superior to the Dess-Martin periodinane17 
as oxidizing agent. Our choice of amine was 3,4-
dimethoxybenzylamine (DMBNH2) since it has been reported 
that removal of the DMB group from a dialkylated amine can be 
accomplished under mild conditions by the use of DDQ.18 
Unfortunately, double-reductive amination of 33 by use of our 
previously reported method6 resulted in only 9% yield of the 
product 34. The reason for this low yield was likely to be found 
in the steric environment of the aldehyde groups of 33, especially 
in one of them being an α, α, α-trisubstituted carbonyl group. As 
several attempts to optimize the yield by altering the reaction 
conditions (change of reductive agents and amines, addition of 
acid and longer imine formation times) failed, we decided to 
investigate the cyclizations of the two less sterically hindered 
dialdehydes 35 and 39, obtained in excellent yields from 18 and 
20. We were pleased to find that the products 36 and 40 of these 
cyclizations were obtained in highly improved yields, 46% and 
60%, respectively. Thus, these results confirm that 33 is too 
sterically hindered to undergo double-reductive amination in a 
satisfactory yield. 
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Scheme 6. Reagents and conditions: (a) IBX, CH3CN, 55 ºC; (b) DMBNH2, 
Na(OAc)3BH, CH2Cl2; (c) DDQ, CH2Cl2/H2O 5:1; (d) DDQ, CH2Cl2/MeOH 
9:1. 
The deprotection of the amines turned out to be a very slow 
reaction, especially for the removal of the DMB group. Hence, 
the PMB group of the amines 36 and 40 could be selectively 
cleaved by use of 3 equivalents of DDQ, yielding the amines 37 
and 41. Several attempts at the full deprotection of 40 to 42 were 
carried out with DDQ and CAN; use of the former was found to 
give little conversion whereas use of the latter was unsuccessful. 
It has been reported that deprotection of DMB protected amines 
can be inefficient for some substrates.19 Substituting the usual 
biphasic CH2Cl2/H2O solvent to a miscible solvent 
(CH2Cl2/MeOH 9:1) led to the highest conversion, although the 
use of as much as 20 equivalents of DDQ over 7 days gave a 
modest NMR yield of 15%. Attempts at the isolation of 42 
(verified by LCMS) from a mixture of the amines 41 and 42 by 
flash column chromatography were not successful, presumably 
due to the two compounds having the same Rf value.  
Unfortunately, the full deprotection of 36 to 38 was not 
successful by use of the above conditions.  
3. Conclusion 
We have demonstrated that a library of diverse macrocycles 
with different ring sizes and functionalities can be formed in a 
few steps from simple building blocks containing primary 
alcohols. The structural and biological properties of the 
macrocycles are currently under investigation.  
4. Experimental section 
Starting materials, reagents, and solvents were purchased 
from Sigma-Aldrich Chemical Co. and used without further 
purification. Reactions involving air or moisture sensitive 
reagents were carried out under N2. CH2Cl2, DMF, and DMSO 
were dried over 4 Å molecular sieves. THF and toluene were 
distilled from Na under N2. Et3N was distilled from CaH2 under 
N2. TLC was performed on Merck aluminum sheets precoated 
with silica gel 60 F254. Compounds were visualized by charring 
after dipping in a solution of p-anisaldehyde (10 mL of H2SO4 
and 10 mL of p-anisaldehyde in 200 mL of 95% EtOH), or 
cerium sulfate (6.25 g of (NH4)6Mo7O24 and 1.5 g of Ce(SO4)2 in 
250 mL of 10% aqueous H2SO4). Flash column chromatography 
was performed using Merck silica gel 60 (particle size 0.040–
0.063 mm). NMR spectra were recorded using a Varian Mercury 
300 MHz spectrometer or a Varian Unity Inova 500 MHz 
spectrometer. Chemical shifts were measured in ppm and 
coupling constants in Hz, and the field is indicated in each case. 
The solvent peaks from CDCl3 (7.26 ppm in 1H NMR and 77.16 
ppm in 13C NMR) or CD3OD  (3.31 ppm in 1H NMR) were used 
as standards. In case of diastereomeric mixtures, the following 
abbreviations are used; maj: major diastereomer, min: minor 
diastereomer, both: both diastereomers,  one: one diastereomer. 
Elemental analyses were obtained from H. Kolbe, 
Mikroanalytisches Laboratorium, Mülheim/Ruhr, Germany. IR 
analysis was carried out on a Perkin-Elmer 1600 series FTIR 
spectrometer or on a Bruker Alpha FTIR spectrometer. Melting 
points were measured with a Buch & Holm melting point 
apparatus and are uncorrected. High-resolution LC-DAD-MS 
was performed on an Agilent 1100 system equipped with a 
photodiode array detector (DAD) and coupled to an LCT 
orthogonal time-of-flight mass spectrometer (Waters-Micromass) 
with a Z-spray electrospray ionization (ESI) source and a 
LockSpray probe (M + H 556.2771) and controlled by MassLynx 
4.0 software.  
 
4.1. 4-(4-((tert-Butyldimethylsilyloxy)methyl)-1H-1,2,3-triazol-
1-yl)butyl benzoate (1) 
4-Chlorobutyl benzoate (10.02 g, 47.09 mmol) and Bu4NI 
(1.74 g, 4.71 mmol) were dissolved in anhydrous DMF (94 mL). 
NaN3 (3.83 g, 58.86 mmol) was added cautiously. The solution 
was slowly heated to 60 ºC and stirred for 23 hours. The mixture 
was transferred to a separation funnel and diluted with Et2O (600 
mL). After washing with water (3×320 mL), the resulting organic 
phase was concentrated in vacuo to afford a yellow oil, which 
was used without further purification. The crude was dissolved in 
THF (422 mL) and DIPEA (12.09 mL, 70.64 mmol) was added 
followed by CuI (8.97 g, 47.09 mmol) and tert-butyldimethylsilyl 
propargyl ether (9.55 mL, 47.09 mmol). After stirring at 20 ºC 
for 18 hours, the yellow mixture was filtered through a pad of 
Celite, and the filtrate was concentrated in vacuo giving a green 
oil. The residue was dissolved in EtOAc (500 mL) and washed 
with water (2×330 mL) and brine (330 mL). The organic phase 
was dried (MgSO4), filtered and concentrated in vacuo to afford 
an oil which was purified by flash column chromatography 
(MeOH/CH2Cl2 3:97) to give the triazole 1 (18.34 g, quantitative 
yield) as a yellow oil. Rf 0.60 (EtOAc/heptane 1:1); IR (neat, 
AgCl) v 3428 (w), 3138 (m), 3069 (m), 2956 (s), 1719 (s), 1602 
(m), 1585 (m), 1451 (s), 1389 (m), 1361 (m), 1271 (s), 1219 (m), 
1176 (m), 1096 (s) cm-1; 1H NMR (300 MHz, CDCl3) δ 8.04-8.01 
(2H, m), 7.60-7.52 (2H, m), 7.47-7.42 (2H, m), 4.88 (2H, s), 4.46 
(2H, t, J 7.1 Hz), 4.36 (2H, t, J 6.3 Hz), 2.15-2.05 (2H, m), 1.87-
1.77 (2H, m), 0.91 (9H, s), 0.10 (6H, s); 13C NMR (75 MHz, 
CDCl3) δ 166.6, 149.0, 133.2, 130.1, 129.6 (2C), 128.5 (2C), 
121.5, 64.0, 58.1, 49.9, 27.3, 26.0 (3C), 25.9, 18.4, -5.2 (2C). 
4.2. 4-(4-((tert-Butyldimethylsilyloxy)methyl)-1H-1,2,3-triazol-
1-yl)-butan-1-ol (2) 
A solution of the triazole 1 (1.98 g, 5.08 mmol) in anhydrous 
CH2Cl2 (49 mL) was cooled to -78 ºC. DIBAL-H (1.0 M in 
hexane, 11.2 mL, 11.2 mmol) was added, and the mixture was 
stirred at -78 ºC for 3 hours. The reaction was quenched with 
MeOH (2.0 mL) and allowed to reach 20 ºC. A sat. aq. solution 
of Rochelle’s salt (60 mL), water (40 mL) and Et2O (250 mL) 
were added, and the viscous mixture was stirred vigorously for 
15 minutes. The mixture was transferred to a separatory funnel 
and the organic layer was isolated. The aqueous layer was 
extracted with EtOAc (3×80 mL) and the pooled organic phases 
were dried (MgSO4), filtered and concentrated in vacuo to give a 
yellow oil. The product was purified by flash column 
chromatography (EtOAc/heptane 1:1 → EtOAc) to afford the 
alcohol 2 (1.31 g, 90%) as a colorless oil. Rf 0.10 
(EtOAc/heptane 1:1);  IR (neat, AgCl) v 3372 (m), 2929 (s), 1734 
(w), 1636 (w), 1559 (w), 1473 (m), 1257 (m), 1006 (s), 840 (s) 
cm-1; 1H NMR (300 MHz, CDCl3) δ 7.50 (1H, s), 4.85 (2H, s), 
4.41 (2H, t, J 7.1 Hz), 3.69 (2H, t, J 6.2 Hz), 2.07-1.98 (2H, m), 
1.81 (1H, bs, OH), 1.63-1.54 (2H, m), 0.91 (9H, s), 0.10 (6H, s); 
13C NMR (75 MHz, CDCl3) δ 148.8, 121.6, 61.9, 58.0, 50.2, 
29.4, 27.1, 26.0 (3C), 18.5, -5.2 (2C); Anal. calcd. for 
C13H27N3O2Si: C, 54.70; H, 9.53; N, 14.72. Found: C, 54.63; H, 
9.50; N, 14.81. 
4.3. 4-((tert-Butyldimethylsilyloxy)methyl)-1-(4-(tert-
butyldiphenylsilyloxy)butyl)-1H-1,2,3-triazole (3) 
The alcohol 2 (5.95 g, 20.85 mmol) was dissolved in 
anhydrous DMF (41.7 mL). Imidazole (2.84 g, 41.70 mmol) and 
TBDPSCl (8.13 mL, 31.28 mmol) were added. After stirring for 
1 hour at 20 ºC, the mixture was diluted with EtOAc (140 mL) 
and then washed with water (70 mL) and brine (70 mL). The 
organic phase was dried (MgSO4), filtered and concentrated in 
vacuo. The residue was purified by flash column chromatography 
(EtOAc/heptane 1:1) to give 3 (10.92 g, quantitative yield) as a 
colorless oil. Rf 0.85 (EtOAc/heptane 3:1); IR (neat) 3135 (w), 
3071 (w), 3050 (w), 2998 (w), 2953 (m), 2930 (s), 2886 (m), 
2857 (s), 1589 (w), 1471 (m), 1463 (m), 1428 (m), 1389 (m), 
1361 (w), 1334 (w), 1308 (w), 1255 (m), 1218 (w), 1188 (w), 
1134 (m), 1105 (s), 1088 (s), 1045 (m), 1022 (m), 1007 (m), 972 
(w), 938 (w), 910 (w), 836 (m), 777 (m), 736 (m), 687 (s) cm-1; 
1H NMR (300 MHz, CDCl3) δ 7.66-7.63 (4H, m), 7.43-7.35 (7H, 
m), 4.85 (2H, s), 4.34 (2H, t, J 7.2 Hz), 3.68 (2H, t, J 6.0 Hz), 
2.06-1.96 (2H, m), 1.61-1.52 (2H, m), 1.04 (9H, s), 0.91 (9H, s), 
0.10 (6H, s); 13C NMR (75 MHz, CDCl3) δ 147.0, 135.7 (4C), 
133.8 (2C), 129.8 (2C), 127.8 (4C), 121.4, 63.1, 58.1, 50.2, 29.4, 
27.2, 27.0 (3C), 26.0 (3C), 19.3, 18.5, -5.1 (2C).  
4.4. (1-(4-(tert-Butyldiphenylsilyloxy)butyl)-1H-1,2,3-triazol-4-
yl)methanol (4) 
The disilylprotected compound 3 (10.92 g, 20.85 mmol) was 
dissolved in MeOH (350 mL). PPTS (262 mg, 1.04 mmol) was 
added, and the solution was heated to 55 ºC. After stirring for 23 
hours, the solvent was removed in vacuo. The residue was 
redissolved in EtOAc (420 mL) and washed with brine (420 mL) 
and water (420 mL). The organic phase was dried (MgSO4), 
filtered and concentrated in vacuo. The residue was purified by 
flash column chromatography (EtOAc/heptane 3:7 → EtOAc) to 
give the alcohol 4 (6.54 g, 77%) as white crystals. Rf 0.39 
(EtOAc/heptane 3:1); m.p. 111-112 ºC; IR (neat) v 3232 (s), 3126 
(m), 2927 (s), 2854 (m), 1472 (w), 1427 (m), 1359 (w), 1225 (w), 
1145 (w), 1109 (s), 1081 (s), 1020 (m), 980 (m), 817 (w), 708 (s) 
cm-1; 1H NMR (300 MHz, CDCl3) δ 7.65-7.62 (4H, m), 7.47 (1H, 
s), 7.43-7.35 (6H, m), 4.79 (2H, d, J 6.1 Hz), 4.35 (2H, t, J 7.2 
Hz), 3.68 (2H, t, J 6.0 Hz), 2.23 (1H, t, J 6.1 Hz, OH), 2.07-1.97 
(2H, m), 1.63-1.52 (2H, m), 1.04 (9H, s); 13C NMR (75 MHz, 
CDCl3) δ 147.8, 135.6 (4C), 133.7 (2C), 129.8 (2C), 127.8 (4C), 
121.7, 63.0, 56.3, 50.3, 29.4, 27.0, 27.0 (3C), 19.3; anal. calcd. 
for C23H31N3O2Si: C, 67.44; H, 7.63; N, 10.26. Found: C, 67.52; 
H, 7.59; N, 10.22. 
4.5. (±)-1-(tert-Butyldimethylsilyloxy)-2-methylbut-3-en-2-ol 
(5) 
1-(tert-Butyldimethylsilyloxy)propan-2-one (12 mL, 62.18 
mmol) was dissolved in anhydrous THF (114 mL). The mixture 
was stirred at 0 ºC, and vinyl magnesium chloride (1.6 M in THF, 
47 mL, 74.62 mmol) was added dropwise over 20 minutes. The 
cooling bath was removed and after two hours, the reaction 
mixture was diluted with Et2O (480 mL) and washed with sat. aq. 
NH4Cl (290 mL) and water (290 mL). The combined aqueous 
phases were extracted with Et2O (200 mL). The combined 
organic phases were dried (MgSO4), filtered and concentrated in 
vacuo to give 5 as a colorless oil (10.43 g, 78%), which was used 
without further purification. Rf 0.63 (EtOAc/heptane 1:1); IR 
(neat, AgCl) v 3447 (br), 3088 (w), 2931 (s), 1718 (w), 1653 (w), 
1472 (m), 1362 (m), 1257 (m), 1100 (s), 1006 (m), 922 (m), 838 
(s), 778 (m) cm-1;  1H NMR (300 MHz, CDCl3) δ 5.87 (1H, dd, J 
17.4 Hz, 10.8 Hz), 5.29 (1H, dd, J 17.4 Hz, 1.4 Hz), 5.11 (1H, 
dd, J 10.8 Hz, 1.4 Hz), 3.47 (1H, d, J 9.5 Hz), 3.42 (1H, d, J 9.5 
Hz), 1.23 (3H, s), 0.90 (9H, s), 0.06 (3H, s), 0.06 (3H, s); 13C 
NMR (75 MHz, CDCl3) δ 142.4, 113.6, 73.1, 70.4, 26.0 (3C), 
23.9, 18.5, -5.2, -5.3. 
4.6. (±)-(E)-Methyl 5-(tert-butyldimethylsilyloxy)-4-hydroxy-4-
methylpent-2-enoate (6) 
Alcohol 5 (8.40 g, 38.82 mmol) was dissolved in anhydrous 
CH2Cl2 (400 mL) and methyl acrylate (69.45 mL, 776.4 mmol) 
was added. Hoveyda-Grubbs’ 2nd generation catalyst (0.122 g, 
0.195 mmol) was added, and the mixture was heated to reflux. 
After stirring for 48 hours, the mixture was concentrated in vacuo 
to give a green semisolid, which was recrystallized from 
EtOAc/heptane, and a crystalline byproduct was filtered off. The 
filtrate was concentrated in vacuo to give a green oil. The crude 
product was purified by flash column chromatography 
(EtOAc/heptane 1:7) to afford the methyl ester 6 (9.31 g, 88 %) 
as a pale yellow oil. Rf 0.30 (EtOAc/heptane 1:4); IR (neat, 
AgCl) v 3482 (br), 2954 (s), 2858 (s), 1728 (s), 1662 (m), 1472 
(m), 1437 (m), 1363 (m), 1259 (s), 1100 (s), 981 (m), 838 (s), 
778 (m) cm-1; 1H NMR (300 MHz, CDCl3) δ 6.91 (1H, d, J 15.7 
Hz), 6.10 (1H, d, J 15.7 Hz), 3.74 (3H, s), 3.53 (1H, d, J 9.6 Hz), 
3.48 (1H, d, J 9.6 Hz), 1.26 (3H, s), 0.88 (9H, s), 0.06 (3H, s), 
0.04 (3H, s); 13C NMR (75 MHz, CDCl3) δ 167.2, 152.1, 119.9, 
73.1, 69.8, 51.7, 25.9 (3C), 23.6, 18.4, -5.3, -5.4.    
4.7.  (±)-(E)-Methyl 5-(tert-butyldimethylsilyloxy)-4-(4-
methoxybenzyloxy)-4-methylpent-2-enoate (7) 
The methyl ester 6 (4.16 g, 15.16 mmol) and PMBTCA20 
(8.14 g, 30.32 mmol) were dissolved in anhydrous toluene (125 
mL), and La(OTf)3 (622 mg, 1.06 mmol) was added. After 
stirring at 20 ºC for 16 hours, the mixture was filtered through a 
pad of Celite. The filtrate was concentrated in vacuo to give a 
yellowish oil which was purified by flash column 
chromatography (EtOAc/toluene/heptane 1:50:50) to give the 
PMB-protected methyl ester 7 (5.07 g, 85%) as a colorless oil. Rf 
0.73 (toluene/heptane 1:4); IR (neat, AgCl) v 2952 (s), 2856 (s), 
2061 (w), 1883 (w), 1726 (s), 1658 (m), 1613 (m), 1587 (m), 
1515 (s), 1465 (m), 1382 (m), 1250 (s), 1113 (s), 939 (m), 840 (s) 
cm-1; 1H NMR (300 MHz, CDCl3) δ 7.26 (2H, d, J 8.6 Hz), 6.99 
(1H, d, J 16.0 Hz), 6.88 (2H, d, J 8.6 Hz), 6.06 (1H, d, J 16.0 
Hz), 4.44 (1H, d, J 10.7 Hz), 4.38 (1H, d, J 10.7 Hz), 3.81 (3H, 
s), 3.77 (3H, s), 3.63 (2H, s), 1.41 (3H, s), 0.89 (9H, s), 0.05 (3H, 
s), 0.04 (3H, s); 13C NMR (75 MHz, CDCl3) δ 167.0, 159.1, 
151.2, 131.1, 129.1 (2C), 121.6, 113.9 (2C), 78.3, 69.0, 65.3, 
55.4, 51.8, 25.9 (3C), 20.3, 18.3, -5.3 (2C).      
4.8. (±)-(E)-5-(tert-Butyldimethylsilyloxy)-4-(4-
methoxybenzyloxy)-4-methylpent-2-enoic acid (8) 
The methyl ester 7 (3.47 g, 8.79 mmol) was dissolved in THF 
(132 mL) and cooled to 0 ºC. A solution of LiOH (631 mg, 26.37 
mmol) in H2O (44 mL) was added, and the resulting mixture was 
stirred at 20 ºC. After 46 hours, the reaction was quenched with 
sat. aq. NaH2PO4 (100 mL), and EtOAc (100 mL) was added. 
The organic phase was isolated, and the aqueous phase was 
extracted with EtOAc (3×100 mL). The pooled organic phases 
were washed with water (200 mL) and brine (200 mL). 
Subsequently, they were dried (MgSO4), filtered and 
concentrated in vacuo. The residue was purified by flash column 
chromatography (EtOAc/heptane/AcOH 9:90:1) to afford the 
carboxylic acid 8 (2.97 g, 89%) as a white solid. Rf 0.60 
(EtOAc/heptane/AcOH 70:30:1); m.p. 68-71 ºC; IR (neat) v 2927 
(br), 1880 (w), 1698 (s), 1652 (m), 1614 (m), 1587 (m), 1515 (s), 
1463 (m), 1373 (m), 1254 (s), 939 (m), 845 (s) cm-1; 1H NMR 
(300 MHz, CDCl3) δ 7.26 (2H, d, J 8.6 Hz), 7.09 (1H, d, J 16.0 
Hz), 6.87 (2H, d, J 8.6 Hz), 6.06 (1H, d, J 16.0 Hz), 4.44 (1H, d, 
J 10.7 Hz), 4.38 (1H, d, J 10.7 Hz), 3.80 (3H, s), 3.63 (2H, s), 
1.42 (3H, s), 0.88 (9H, s), 0.04 (3H, s), 0.03 (3H, s); 13C NMR 
(75 MHz, CDCl3) δ 171.9, 159.1, 153.8, 131.0, 129.1 (2C), 
121.4, 113.9 (2C), 78.3, 68.9, 65.4, 55.4, 25.9 (3C), 20.3, 18.3, 
-5.3 (2C); anal. calcd. for C20H32O5Si: C, 63.12; H, 8.48. Found: 
C, 63.20; H, 8.36.  
4.9. (±)-(E)-5-(tert-Butyldimethylsilyloxy)-4-(4-
methoxybenzyloxy)-4-methylpent-2-en-1-ol (9) 
The methyl ester 7 (703 mg, 1.78 mmol) was dissolved in 
anhydrous CH2Cl2 (16 mL) and cooled to –78 ºC. DIBAL-H (1.0 
M in hexanes, 3.92 mL, 3.92 mmol) was added, and the mixture 
was stirred at –78 ºC for 3 hours. The reaction was quenched 
with MeOH (1.0 mL) and the cold bath was removed. At 20 ºC, a 
sat. aq. solution of Rochelle’s salt (20 mL), water (10 mL) and 
Et2O (100 mL) was added, and the viscous mixture was stirred 
vigorously for 15 minutes. The organic phase was isolated, and 
the aqueous phase was extracted with EtOAc (3×50 mL). The 
pooled organic phases were dried (MgSO4), filtered and 
concentrated in vacuo to give a yellow oil. The oil was purified 
by flash column chromatography (EtOAc/heptane 1:2) to  afford 
the alcohol 9 (0.583 g, 89%) as a colorless oil. Rf 0.87 
(MeOH/EtOAc 1:99); IR (neat, AgCl) v 3418 (br), 2930 (s), 1740 
(m), 1613 (m), 1587 (m), 1514 (s), 1464 (m), 1379 (m), 1250 (s), 
1172 (m), 1110 (s) cm-1: 1H NMR (300 MHz, CDCl3) δ 7.25 (2H, 
d, J 8.5 Hz), 6.86 (2H, d, J 8.5 Hz), 5.88 (1H, dt, J 16.2 Hz, 5.3 
Hz), 5.74 (1H, d, J 16.2 Hz), 4.39 (2H, s), 4.19 (2H, dd, J 5.3 Hz, 
1.0 Hz), 3.79 (3H, s), 3.59 (1H, d, J 9.9 Hz), 3.55 (1H, d, J 9.9 
Hz), 1.36 (3H, s), 0.89 (9H, s), 0.04 (3H, s), 0.03 (3H, s); 13C 
NMR (75 MHz, CDCl3) δ 158.9, 134.5, 131.8, 130.7, 129.0 (2C), 
113.8 (2C), 78.0, 69.6, 64.7, 63.6, 55.4, 26.0 (3C), 20.3, 18.4, 
-5.2, -5.2; anal. calcd for C20H34O4Si: C, 65.53; H, 9.35. Found: 
C, 65.45; H, 9.31. 
4.10. (±)-(E)-4-(4-Methoxybenzyloxy)-4-methylpent-2-en-1,5-
diol (10) 
The alcohol 9 (8.80 g, 24.01 mmol) was dissolved in 
anhydrous THF (59 mL) and TBAF (1.0 M in THF, 36.01 mL, 
36.01 mmol) was added dropwise. After stirring for 19 hours, the 
mixture was diluted with EtOAc (150 mL) and washed with sat. 
aq. NH4Cl (120 mL) and water (2×120 mL). The combined 
aqueous phases were extracted with EtOAc (2×120 mL). The 
combined organic phases were dried (MgSO4), filtered and 
concentrated in vacuo. The residue was purified by flash column 
chromatography (EtOAc/heptane 1:1 → MeOH/EtOAc 1:99) 
giving the diol 10 (6.06 g, quantitative yield) as a colorless oil, 
which crystallizes upon storage at 5 ºC to give a white solid. Rf 
0.54 (MeOH/EtOAc 1:99); m.p. 44-45 ºC; IR (neat, AgCl) v 
3379 (br), 2935 (s), 1613 (m), 1586 (m), 1514 (s), 1465 (m), 
1381 (m), 1302 (m), 1248 (s), 1173 (m), 1112 (m), 1036 (s), 981 
(m), 913 (w), 891 (w), 822 (m), 733 (m) cm-1: 1H NMR (300 
MHz, CDCl3) δ 7.25 (2H, d, J 8.6 Hz), 6.87 (2H, d, J 8.6 Hz), 
5.91 (1H, dt, 16.1 Hz, 5.2 Hz), 5.78 (1H, d, J 16.1 Hz), 4.33 (2H, 
s), 4.19 (2H, d, J 5.2 Hz), 3.80 (3H, s), 3.50 (2H, s), 2.08 (2H, br 
s), 1.38 (3H, s); 13C NMR (75 MHz, CDCl3) δ 159.1, 132.9, 
131.8, 131.1, 129.2 (2C), 113.9 (2C), 77.9, 69.7, 64.6, 63.0, 55.4, 
19.3.    
4.11. (±)-(E)-5-(tert-Butyldiphenylsilyloxy)-2-(4-
methoxybenzyloxy)-2-methylpent-3-en-1-ol (11) 
The diol 10 (1.41 g, 5.60 mmol) was dissolved in anhydrous 
CH2Cl2 (65 mL) and imidazole (539 mg, 8.41 mmol) was added. 
The mixture was cooled to –78 ºC, and a solution of TBDPSCl 
(1.46 mL, 5.60 mmol) in anhydrous CH2Cl2 (10 mL) was added 
over 5 minutes. After 3 hours, the mixture was diluted with 
CH2Cl2 (60 mL) and washed with brine (40 mL) and water (40 
mL). The combined organic phases were dried (MgSO4), filtered 
and concentrated in vacuo. The crude product was purified by 
flash column chromatography (EtOAc/heptane 1:2) affording the 
TBDPS-protected alcohol 11 (2.75 g, quantitative yield) as a 
colorless oil. Rf 0.30 (EtOAc/heptane 1:2); IR (neat, AgCl) v 
3457 (br), 2932 (s), 1613 (m), 1588 (m), 1514 (s), 1473 (m), 
1428 (m), 1380 (m), 1302 (m), 1249 (s), 1173 (m), 1112 (s), 978 
(m), 823 (m), 741 (m), 702 (m) cm-1: 1H NMR (300 MHz, 
CDCl3) δ 7.70-7.66 (4H, m), 7.45-7.33 (6H, m), 7.23 (2H, d, J 
8.5 Hz), 6.86 (2H, d, J 8.5 Hz), 5.81-5.80 (2H, m), 4.29-4.28 
(4H, m), 3.80 (3H, s), 3.52 (1H, d, J 10.9 Hz), 3.41 (1H, d, J 10.9 
Hz), 1.98 (1H, br s), 1.36 (3H, s), 1.07 (9H, s); 13C NMR (75 
MHz, CDCl3) δ 159.1, 135.6 (4C), 133.7, 133.7, 131.9, 131.5, 
131.2, 129.8 (2C), 129.3 (2C), 127.8 (4C), 113.9 (2C), 77.9, 69.8, 
64.7, 64.1, 55.4, 27.0 (3C), 19.4, 19.3; anal. calcd. for 
C30H38O4Si: C, 73.43; H, 7.81. Found: C, 73.27; H, 7.75. 
4.12. (±)-(E)-5-(tert-Butyldiphenylsilyloxy)-2-(4-
methoxybenzyloxy)-2-methylpent-3-enoic acid (12) 
Anhydrous CH2Cl2 (220 mL) and DMSO (5.79 mL, 81.66 
mmol) were mixed and cooled to –78 ºC. Oxalyl chloride (3.45 
mL, 40.83 mmol) was added dropwise, followed by dropwise 
addition of  a solution of the alcohol 11 (10.02 g, 20.42 mmol) in 
anhydrous CH2Cl2 (110 mL). After 30 minutes, anhydrous Et3N 
(28.50 mL, 204.15 mmol) was added. After further 15 minutes, 
the mixture was allowed to reach 20 ºC and then diluted with 
CH2Cl2 (600 mL) and washed with sat. aq. NH4Cl (400 mL) and 
water (400 mL) The organic phase was dried (MgSO4), filtered 
and concentrated in vacuo to give the crude aldehyde, which was 
used without further purification. The crude aldehyde was 
dissolved in THF (120 mL). t-BuOH (240 mL) and 2-methyl-2-
butene (86 mL, 811.23 mmol) were added followed by a solution 
of NaClO2 (23.26 g, 257.14 mmol) and NaH2PO4 (30.85 g, 
257.14 mmol) in water (160 mL). After 1½ hours, the mixture 
was diluted with sat. aq. NaH2PO4 (500 mL) and stirred for 15 
minutes. Subsequently, the mixture was extracted with EtOAc 
(3×500 mL) and the combined organic phases were dried 
(MgSO4), filtered and concentrated in vacuo. The residue was 
purified by flash column chromatography (EtOAc/heptane/AcOH 
66:33:1) to afford the carboxylic acid 12 (9.89 g, 96%) as a 
colorless oil. Rf 0.25 (MeOH/toluene 5:95); IR (neat) v 3071 (m), 
3049 (m), 2997 (m), 2956 (m), 2931 (m), 2893 (m), 2857 (m), 
1712 (m), 1613 (m), 1588 (w), 1513 (m), 1462 (m), 1428 (m), 
1380 (m), 1302 (m), 1247 (s), 1202 (m), 1174 (m), 1107 (s), 
1028 (m), 998 (m), 971 (m), 939 (m), 909 (m), 821 (m), 735 (m), 
700 (s) cm-1: 1H NMR (300 MHz, CDCl3) δ 7.68-7.65 (4H, m), 
7.42-7.34 (6H, m), 7.25 (2H, d, J 8.7 Hz), 6.89 (2H, d, J 8.7 Hz), 
6.01 (1H, dt, J 15.7 Hz, 3.4 Hz), 5.92 (1H, m), 4.43 (1H, d, J 
10.5 Hz), 4.38 (1H, d, J 10.5 Hz), 4.29 (2H, dd, J 3.4 Hz, 1.1 
Hz), 3.82 (3H, s), 1.65 (3H, s), 1.07 (9H, s); 13C NMR (75 MHz, 
CDCl3) δ 175.4, 159.5, 135.6 (4C), 133.5, 133.2 (2C), 129.9 
(2C), 129.8, 129.6 (2C), 128.1, 127.9 (4C), 114.0 (2C), 80.2, 
66.5, 63.6, 55.4, 26.9 (3C), 22.1, 19.4; anal. calcd. for 
C30H36O5Si: C, 71.39; H, 7.19. Found: C, 70.67; H, 7.17. 
4.13. Representative procedure for the preparation of esters 
(13, 15, 17, 19) 
(±)-(E)-4-(4-((tert-Butyldimethylsilyloxy)methyl)-1H-1,2,3-
triazol-1-yl)butyl 5-(tert-butyldimethylsilyloxy)-4-(4-
methoxybenzyloxy)-4-methylpent-2-enoate (13) 
The carboxylic acid 8 (0.624 g, 1.640 mmol) and the alcohol 2 
(0.515 g, 1.804 mmol) were dissolved in anhydrous CH2Cl2 (25 
mL) and  DMAP (0.040 g, 0.328 mmol) and EDC·HCl (0.472 g, 
2.460 mmol) were added. The reaction was stirred for 18 hours at 
20 ºC and then concentrated in vacuo. The residue was purified 
by flash column chromatography (EtOAc/heptane 1:2) to afford 
the ester 13 (0.930 g, 87%) as a colorless oil. Rf 0.31 
(MeOH/toluene 5:95); IR (neat, AgCl) v 2927 (s), 1734 (s), 1653 
(m), 1613 (m), 1516 (m), 1472 (m), 1374 (m), 1249 (s), 1104 (s), 
939 (w), 839 (m), 779 (m) cm-1; 1H NMR (300 MHz, CDCl3) δ 
7.46 (1H, s), 7.25 (2H, d, J 8.4 Hz), 6.97 (1H, d, J 16.0 Hz), 6.86 
(2H, d, J 8.4 Hz), 6.02 (1H, d, J 16.0 Hz), 4.84 (2H, s), 4.42 (1H, 
d, J 11.1 Hz), 4.38 (2H, t, J 7.4 Hz), 4.37 (1H, d, J 11.1 Hz), 4.18 
(2H, t, J 6.3 Hz), 3.79 (3H, s), 3.61 (2H, s), 2.05-1.95 (2H, m), 
1.76-1.65 (2H, m), 1.40 (3H, s), 0.91 (9H, s), 0.87 (9H, s), 0.09 
(6H, s), 0.02 (3H, s), 0.01 (3H, s); 13C NMR (75 MHz, CDCl3) δ 
166.4, 159.1, 151.5, 148.9, 131.1, 129.0 (2C), 121.6, 121.5, 113.9 
(2C), 78.3, 68.9, 65.3, 63.5, 58.1, 55.4, 49.9, 27.2, 26.0 (3C), 
25.9 (3C), 25.9, 20.2, 18.5, 18.3, -5.1 (2C), -5.3 (2C).  
(±)-(E)-(1-(4-(tert-Butyldiphenylsilyloxy)butyl)-1H-1,2,3-triazol-
4-yl)methyl 5-(tert-butyldimethylsilyloxy)-4-(4-
methoxybenzyloxy)-4-methylpent-2-enoate (15) 
Colorless oil, 87% yield. Rf 0.40 (MeOH/toluene 5:95); IR 
(neat) v 3139 (w), 3071 (w), 3048 (w), 2998 (w), 2954 (s), 2930 
(s), 2894 (m), 2857 (s), 1720 (s), 1656 (w), 1613 (w), 1588 (w), 
1514 (m), 1463 (m), 1442 (m), 1428 (m), 1387 (m), 1361 (w), 
1301 (m), 1249 (s), 1169 (m), 1105 (s), 1033 (m), 1007 (m), 938 
(w), 910 (w), 836 (s), 823 (m), 777 (m), 731 (m), 701 (s) cm-1; 1H 
NMR (300 MHz, CDCl3) δ 7.65-7.62 (4H, m), 7.56 (1H, s), 7.45-
7.36 (6H, m), 7.23 (2H, d, J 8.5 Hz), 7.00 (1H, d, J 16.1 Hz), 
6.85 (2H, d, J 8.5 Hz), 6.05 (1H, d, J 16.1 Hz), 5.30 (2H, s), 
4.46-4.32 (4H, m), 3.79 (3H, s), 3.68 (2H, t, J 6.0 Hz), 3.60 (2H, 
s), 2.07-1.97 (2H, m), 1.61-1.52 (2H, m), 1.38 (3H, s), 1.04 (9H, 
s), 0.86 (9H, s), 0.01 (3H, s), 0.00 (3H, s); 13C NMR (75 MHz, 
CDCl3) δ 171.6, 164.4, 157.3, 148.2, 141.0 (4C), 139.0 (2C), 
136.4, 135.2 (2C), 134.4 (2C), 133.2 (4C), 129.1, 126.7, 119.2 
(2C), 83.6, 74.3, 70.6, 68.4, 63.2, 60.7, 55.7, 34.7, 32.4, 32.3 
(3C), 31.3 (3C), 25.6, 24.7, 23.7, 0.0, 0.0. 
(±)-(E)-(1-(4-(tert-Butyldiphenylsilyloxy)butyl)-1H-1,2,3-triazol-
4-yl)methyl 5-(tert-butyldiphenylsilyloxy)-2-(4-
methoxybenzyloxy)-2-methylpent-3-enoate (17)  
Colorless oil, 58% yield. Rf 0.40 (MeOH/toluene 5:95); IR 
(neat) v 3136 (w), 3071 (w), 3048 (w), 3013 (w), 2998 (w), 2955 
(m), 2931 (m), 2892 (m), 2857 (m), 1736 (m), 1613 (w), 1588 
(w), 1514 (m), 1471 (m), 1462 (m), 1427 (m), 1387 (m), 1362 
(w), 1302 (w), 1248 (m), 1174 (m), 1105 (s), 1047 (m), 1032 
(m), 998 (m), 968 (m), 939 (w), 910 (w), 822 (m), 735 (m), 700 
(s) cm-1; 1H NMR (300 MHz, CDCl3) δ 7.67-7.62 (8H, m), 7.48 
(1H, s), 7.44-7.32 (12H, m), 7.26 (2H, d, J 8.7 Hz), 6.84 (2H, d, J 
8.7 Hz), 6.03 (1H, dt, J 15.7 Hz, 1.6 Hz), 5.91 (1H, dt, J 15.7 Hz, 
4.0 Hz), 5.31 (2H, s), 4.42 (1H, d, J 10.6 Hz), 4.36 (1H, d, J 10.6 
Hz), 4.28 (2H, t, J 7.3 Hz), 4.24 (2H, dd, J 4.0 Hz, 1.6 Hz), 3.78 
(3H, s), 3.66 (2H, t, J 6.0 Hz), 2.01-1.91 (2H, m), 1.56 (3H, s), 
1.55-1.48 (2H, m), 1.05 (9H, s), 1.04 (9H, s); 13C NMR (75 MHz, 
CDCl3) δ 173.2, 159.2, 142.7, 135.6 (4C), 135.6 (4C), 133.7 
(2C), 133.6 (2C), 131.6, 130.7, 129.8 (4C), 129.4, 129.4 (2C), 
127.8 (4C), 127.8 (4C), 123.7, 113.8 (2C), 80.1, 66.9, 63.8, 63.0, 
58.6, 55.4, 50.3, 29.4, 27.0, 27.0 (3C), 26.9 (3C), 24.2, 19.4, 
19.3. 
(±)-(E)-4-(4-((tert-Butyldimethylsilyloxy)methyl)-1H-1,2,3-
triazol-1-yl)butyl 5-(tert-butyldiphenylsilyloxy)-2-(4-
methoxybenzyloxy)-2-methylpent-3-enoate (19)  
Colorless oil, 71% yield. Rf 0.31 (MeOH/toluene 5:95); IR 
(neat) v 3136 (w), 3071 (w), 3048 (w), 2997 (w), 2954 (m), 2931 
(s), 2893 (m), 2856 (m), 1734 (m), 1613 (m), 1588 (w), 1514 
(m), 1462 (m), 1428 (m), 1381 (m), 1362 (m), 1301 (m), 1247 
(s), 1174 (m), 1105 (s), 1043 (m), 970 (m), 939 (w), 836 (m), 777 
(m), 740 (m), 701 (m) cm-1; 1H NMR (300 MHz, CDCl3) δ 7.68-
7.64 (4H, m), 7.42-7.33 (7H, m), 7.28 (2H, d, J 8.6 Hz), 6.85 
(2H, d, J 8.6 Hz), 6.04 (1H, dt, J 15.7 Hz, 1.5 Hz), 5.92 (1H, dt, J 
15.7 Hz, 3.8 Hz), 4.83 (2H, s), 4.44 (1H, d, J 10.8 Hz), 4.38 (1H, 
d, J 10.8 Hz), 4.31 (2H, t, J 7.0 Hz), 4.26 (2H, dd, J 3.9 Hz, 1.5 
Hz), 4.18 (2H, t, J 6.4 Hz), 3.79 (3H, s), 2.01-1.90 (2H, m), 1.73-
1.60 (2H, m), 1.58 (3H, s), 1.06 (9H, s), 0.91 (9H, s), 0.09 (6H, 
s); 13C NMR (75 MHz, CDCl3) δ 173.2, 159.2, 148.8, 135.6 (4C), 
133.6 (2C), 131.5, 130.8, 129.9 (2C), 129.6, 129.2 (2C), 127.8 
(4C), 121.5, 113.8 (2C), 80.2, 66.8, 64.3, 63.8, 58.1, 55.4, 49.7, 
27.1, 26.9 (3C), 26.0 (3C), 25.7, 24.0, 19.4, 18.5, -5.1 (2C).  
4.14. Representative procedure for the preparation of diols (14, 
16, 18, 20) 
(±)-(E)-4-(4-(Hydroxymethyl)-1H-1,2,3-triazol-1-yl)butyl 5-
hydroxy-4-(4-methoxybenzyloxy)-4-methylpent-2-enoate (14) 
The ester 13 (2.034 g, 3.14 mmol) was dissolved in anhydrous 
THF (27.7 mL) and TBAF (1.0 M in THF, 9.42 mL, 9.42 mmol) 
was added dropwise. The mixture was stirred for 4½ hours and 
then diluted with EtOAc (140 mL), washed with sat. aq. NH4Cl 
(80 mL) and water (2×80 mL). The combined aqueous phases 
were extracted with EtOAc (2×80 mL) and the combined organic 
phases were dried (MgSO4), filtered and concentrated in vacuo. 
The residue was purified by flash column chromatography 
(MeOH/EtOAc 1:99 → 5:95) to afford the diol 14 (1.133 g, 86%) 
as a colorless oil. Rf 0.10 (MeOH/EtOAc 1:99); IR (neat) v 3374 
(br), 3142 (m), 2938 (m), 2873 (m), 2839 (m), 1712 (s), 1654 
(m), 1612 (m), 1513 (m), 1462 (m), 1443 (m), 1383 (m), 1301 
(m), 1247 (s), 1171 (m), 1110 (m), 1031 (s), 895 (w), 821 (m), 
778 (w), 754 (w), 726 (w) cm-1; 1H NMR (300 MHz, CDCl3) δ 
7.54 (1H, s), 7.25 (2H, d, J 8.8 Hz), 6.97 (1H, d, J 16.1 Hz), 6.88 
(2H, d, J 8.8 Hz), 6.04 (1H, d, J 16.1 Hz), 4.77 (2H, s), 4.40 (2H, 
t, J 7.1 Hz), 4.39 (1H, d, J 10.6 Hz), 4.32 (1H, d, J 10.6 Hz), 4.17 
(2H, t, J 6.3 Hz), 3.80 (3H, s), 3.60 (1H, d, J 11.5 Hz), 3.55 (1H, 
d, J 11.5 Hz), 2.07-1.97 (2H, m), 1.75-1.66 (2H, m), 1.42 (3H, s); 
13C NMR (75 MHz, CDCl3) δ 166.1, 159.3, 150.0, 147.9, 130.4, 
129.3 (2C), 122.5, 121.8, 114.0 (2C), 78.1, 68.9, 65.3, 63.7, 56.7, 
55.4, 49.9, 27.1, 25.7, 19.3; anal. calcd. for C21H29N3O6: C, 
60.13; H, 6.97; N, 10.02. Found: C, 60.02; H, 7.06; N, 9.88. 
(±)-(E)-(1-(4-Hydroxybutyl)-1H-1,2,3-triazol-4-yl)methyl 5-
hydroxy-4-(4-methoxybenzyloxy)-4-methylpent-2-enoate (16)  
White solid, 78% yield. Rf 0.15 (MeOH/EtOAc 1:99); m.p. 
70-71 ºC; IR (neat) v 3332 (br), 3120 (m), 3072 (w), 3034 (w), 
2935 (m), 2870 (m), 2838 (m), 1716 (s), 1655 (m), 1612 (m), 
1586 (w), 1513 (m), 1462 (m), 1442 (m), 1381 (m), 1316 (m), 
1301 (m), 1249 (m), 1218 (m), 1171 (s), 1108 (m), 1046 (s), 
1007 (m), 973 (m), 942 (w), 900 (w), 871 (m), 827 (m), 815 (m), 
781 (m) cm-1;   1H NMR (300 MHz, CDCl3) δ 7.65 (1H, s), 7.24 
(2H, d, J 8.7 Hz), 7.00 (1H, d, J 16.1 Hz), 6.87 (2H, d, J 8.7 Hz), 
6.07 (1H, d, J 16.1 Hz), 5.30 (2H, s), 4.41 (2H, t, J 7.1 Hz), 4.37 
(1H, d, J 10.4 Hz), 4.31 (1H, d, J 10.4 Hz), 3.80 (3H, s), 3.67 
(2H, t, J 6.2 Hz), 3.57 (1H, d, J 11.5 Hz), 3.52 (1H, d, J 11.5 Hz), 
2.07-1.97 (2H, m), 1.62-1.53 (2H, m), 1.41 (3H, s); 13C NMR (75 
MHz, CDCl3) δ 166.0, 159.3, 150.4, 142.7, 130.4, 129.2 (2C), 
124.1, 122.2, 114.0 (2C), 78.1, 68.8, 65.2, 61.9, 57.8, 55.4, 50.3, 
29.3, 27.0, 19.3; anal. calcd. for C21H29N3O6: C, 60.13; H, 6.97; 
N, 10.02. Found: C, 60.04; H, 7.08; N, 9.94. 
(±)­(E)-(1-(4-Hydroxybutyl)-1H-1,2,3-triazol-4-yl)methyl 5-
hydroxy-2-(4-methoxybenzyloxy)-2-methylpent-3-enoate (18) 
Colorless oil, 76% yield. Rf 0.15 (MeOH/EtOAc 1:99); IR 
(neat) v 3362 (br), 3143 (m), 3042 (w), 2937 (m), 2870 (m), 2839 
(m), 1732 (s), 1612 (m), 1586 (w), 1513 (s), 1456 (m), 1443 (m), 
1381 (m), 1302 (m), 1245 (s), 1175 (m), 1107 (s), 1084 (m), 
1051 (m), 1027 (s), 968 (m), 821 (m), 784 (w), 755 (w) cm-1; 1H 
NMR (300 MHz, CDCl3) δ 7.60 (1H, s), 7.27 (2H, d, J 8.8 Hz), 
6.85 (2H, d, J 8.8 Hz), 5.96 (1H, dt, J 15.8 Hz, 4.4 Hz), 5.87 (1H, 
d, J 15.8 Hz), 5.35 (1H, d, J 12.7 Hz), 5.29 (1H, d, J 12.7 Hz), 
4.44 (1H, d, J 10.4 Hz), 4.39 (2H, t, J 7.0 Hz), 4.37 (1H, d, J 10.4 
Hz), 4.15 (2H, dd, J 4.4 Hz, 0.9 Hz), 3.79 (3H, s), 3.63 (2H, t, J 
6.2 Hz), 2.08-1.93 (2H, m), 1.60 (3H, s), 1.57-1.48 (2H, m); 13C 
NMR (75 MHz, CDCl3) δ 173.0, 159.2, 142.5, 131.9, 130.6, 
130.5, 129.4 (2C), 123.9, 113.8 (2C), 80.0, 66.8, 62.5, 61.7, 58.4, 
55.4, 50.3, 29.3, 26.9, 23.1; anal. calcd. for C21H29N3O6: C, 
60.13; H, 6.97; N, 10.02. Found: C, 60.45; H, 7.06; N, 10.08. 
(±)­(E)-4-(4-(Hydroxymethyl)-1H-1,2,3-triazol-1-yl)butyl 5-
hydroxy-2-(4-methoxybenzyloxy)-2-methylpent-3-enoate (20) 
Colorless oil, 93% yield. Rf 0.10 (MeOH/EtOAc 1:99); 
IR(neat) v 3360 (br), 3144 (m), 2961 (m), 2936 (m), 2872 (m), 
2839 (m), 1730 (s), 1668 (w), 1613 (m), 1586 (w), 1553 (w), 
1513 (s), 1457 (m), 1382 (m), 1301 (m), 1246 (s), 1175 (m), 
1112 (m), 1084 (m), 1031 (s), 979 (m), 880 (w), 821 (m), 778 
(m), 756 (m) cm-1; 1H NMR (300 MHz, CDCl3) δ 7.52 (1H, s), 
7.28 (2H, d, J 8.7 Hz), 6.85 (2H, d, J 8.7 Hz), 6.00 (1H, dt, J 15.8 
Hz, 4.5 Hz), 5.90 (1H, d, J 15.8 Hz), 4.73 (2H, s), 4.45 (1H, d, J 
10.6 Hz), 4.38 (1H, d, J 10.6 Hz), 4.34 (2H, t, J 7.0 Hz), 4.20-
4.16 (4H, m), 3.78 (3H, s), 3.30 (2H, br s), 1.98 (2H, tt, J 7.3 Hz, 
7.3 Hz), 1.71-1.62 (2H, m), 1.59 (3H, s); 13C NMR (75 MHz, 
CDCl3) δ 173.0, 159.1, 147.9, 131.9, 130.5, 130.5, 129.2 (2C), 
122.2, 113.8 (2C), 80.0, 66.6, 64.3, 62.3, 56.1, 55.4, 49.8, 27.0, 
25.5, 22.9; anal. calcd. for C21H29N3O6: C, 60.13; H, 6.97; N, 
10.02. Found: C, 59.71; H, 7.19; N, 9.94. 
4.15. Representative procedure for the preparation of 
macrocyclic sulfites (21, 23, 25, 27) 
Sulfite (21) 
The diol 14 (107 mg, 0.26 mmol) was dissolved in anhydrous 
CH2Cl2 (21 mL). Anhydrous Et3N (0.11 mL, 0.77 mmol) and 
DMAP (6 mg, 0.05 mmol) were added. A solution of SOCl2 in 
anhydrous CH2Cl2 (0.36 M, 1 mL, 0.36 mmol) was added over 
10 min at 20 ºC, under vigorous stirring. After stirring for 1 hour, 
the reaction mixture was concentrated in vacuo. The residue was 
redissolved in EtOAc, filtered through Celite and concentrated in 
vacuo. Purification by flash column chromatography 
(MeOH/CH2Cl2 1:99) gave the sulfite 21 (60 mg, 51%) as white 
crystals. Rf 0.60 (MeOH/EtOAc 1:99); m.p. 91-93 ºC; dr: 2:1, de: 
33% (NMR); IR (neat) v 3133 (w), 2963 (m), 2933 (m), 2879 
(m), 2841 (m), 1716 (s), 1657 (m), 1613 (m), 1587 (w), 1515 
(m), 1457 (m), 1390 (m), 1361 (w), 1317 (m), 1304 (m), 1286 
(m), 1247 (m), 1194 (m), 1168 (s), 1111 (m), 1028 (s), 1001 (m), 
939 (m), 899 (m), 828 (m), 777 (m), 729 (m), 706 (m), 690 (m), 
669 (m) cm-1; 1H NMR (500 MHz, CDCl3) δ 7.57 (maj, s), 7.56 
(min, s), 7.24 (min, d, J 8.6 Hz), 7.21 (maj, d, J 8.6 Hz), 6.87 
(min, d, J 8.7 Hz), 6.86 (maj, d, J 8.7 Hz), 6.82 (both, d, J 16.1 
Hz), 6.05 (min, d, J 16.1 Hz), 6.03 (maj, d, J 16.1 Hz), 5.55 (maj, 
d, J 13.3 Hz), 5.49 (min, d, J 13.0 Hz), 4.96 (min, d, J 13.0 Hz), 
4.95 (maj, d, J 13.3 Hz), 4.48-4.33 (m), 4.30-4.24 (m), 4.19-4.11 
(m), 4.14 (min, d, J 10.1 Hz), 4.13 (maj, J 11.0 Hz), 3.92 (maj, d, 
J 11.0 Hz), 3.87 (min, d, J 10.1 Hz), 3.79 (both, s), 2.09-2.02 
(m), 1.76-1.66 (m), 1.45 (min, s), 1.43 (maj, s); 13C NMR (75 
MHz, CDCl3) δ 165.6 (min), 165.5 (maj), 159.3 (min), 159.2 
(maj), 149.2 (min), 148.6 (maj), 143.8 (maj), 143.4 (min), 130.2 
(maj), 130.2 (min), 129.1 (2C, min), 128.9 (2C, maj), 123.0 
(min), 122.9 (maj), 122.8 (maj), 122.5 (min), 114.0 (2C, min), 
113.9 (2C, maj), 76.3 (maj), 76.2 (min), 69.3 (maj), 67.7 (min), 
65.3 (maj), 65.2 (min), 63.5 (both), 56.6 (min), 56.0 (maj), 55.4 
(both), 49.5 (both), 26.8 (both), 25.0 (min), 24.9 (maj), 20.2 
(min), 19.6 (maj); HRMS (ESI): m/z calcd. for C21H27N3O6S 
[M+H]+ 466.1643, found 466.1637. 
Sulfite (23) 
White crystals, 43% yield; Rf 0.60 (MeOH/EtOAc 1:99); m.p. 
130-131 ºC; dr: 3:2 (NMR); IR(neat) v 3133 (w), 3075 (w), 3034 
(w), 2963 (m), 2875 (m), 2841 (w), 1714 (s), 1643 (w), 1612 (m), 
1585 (w), 1514 (m), 1462 (m), 1446 (m), 1384 (m), 1304 (m), 
1250 (s), 1225 (m), 1203 (m), 1174 (m), 1141 (m), 1115 (m), 
1056 (m), 1031 (m), 1001 (m), 977 (m), 897 (m), 884 (m), 854 
(m), 824, 806, 773, 733, 711 cm-1; 1H NMR (300 MHz, CDCl3) δ 
7.63 (both, s), 7.22 (both, d, J 8.6 Hz), 6.87 (both, d, J 8.6 Hz), 
6.85 (both, d, J 16.1 Hz), 6.04 (min, d, J 16.1 Hz), 6.03 (maj, d, J 
16.1 Hz), 5.39-5.38 (m), 4.53-4.37 (m), 4.40 (both, d, J 10.6 Hz), 
4.34 (both, d, J 10.6 Hz), 3.94 (min, d, J 10.3 Hz), 3.91 (maj, d, J 
9.6 Hz), 3.79 (both, s), 3.78 (min, d, J 10.3 Hz), 3.74 (maj, d, J 
9.6 Hz), 3.65-3.48 (m), 1.97-1.86 (m), 1.54-1.46 (m), 1.44 (both, 
s); 13C NMR (75 MHz, CDCl3) δ 166.0 (maj), 165.9 (min), 159.3 
(maj), 159.3 (min), 150.3 (maj), 150.0 (min), 144.2 (both),  130.2 
(min), 130.2 (maj), 129.1 (2C, maj), 129.0 (2C, min), 123.9 
(maj), 123.8 (min), 122.8 (maj), 122.7 (min), 114.0 (2C, maj), 
114.0 (2C, min), 76.4 (min), 76.3 (maj), 68.3 (min), 67.4 (maj), 
65.3 (maj), 65.2 (min), 62.7 (maj), 62.1 (min), 57.7 (both), 55.4 
(both), 50.1 (both), 27.1 (min), 27.0 (maj), 26.3 (min), 26.3 
(maj), 19.6 (maj), 19.4 (min).   
Sulfite (25) 
White crystals, 79% yield; Rf 0.60 (MeOH/EtOAc 1:99); m.p. 
130-131 ºC; dr: 1:1 (NMR); IR (neat) v 3127 (w), 3071 (w), 3044 
(w), 3001 (w), 2954 (m), 2930 (m), 2877 (w), 2858 (w), 2836 
(w), 1730 (s), 1680 (w), 1613 (m), 1586 (w), 1512 (m), 1454 (m), 
1390 (m), 1331 (w), 1303 (m), 1274 (w), 1246 (m), 1233 (m), 
1199 (m), 1172 (m), 1133 (m), 1106 (m), 1053 (m), 1036 (m), 
1011 (m), 994 (m), 971 (m), 951 (m), 919 (m), 898 (m), 820 (m), 
780 (m), 754 (m), 732 (m) cm-1; 1H NMR (300 MHz, CDCl3) δ 
7.61 (both, s), 7.33 (both, d, J 8.7 Hz), 6.88 (both, d, J 8.7 Hz), 
5.76-5.73 (m), 5.49 (one, d, J 12.5 Hz), 5.46 (one, d, J 12.5 Hz), 
5.32 (one, d, J 12.5 Hz), 5.30 (one, d, J 12.5 Hz), 4.54-4.31 (m), 
4.28-4.26 (m), 4.12-4.02 (m), 3.80 (both, s), 3.77-3.67 (m), 2.04-
1.92 (m), 1.63 (one, s), 1.63 (one, s), 1.59-1.47 (m); 13C NMR 
(75 MHz, CDCl3) δ 172.4 (both), 159.3 (both), 143.0 (both), 
134.9 (one), 134.4 (one), 130.3 (one), 130.3 (one), 129.4 (2C, 
both), 125.8 (one), 125.6 (one), 124.3 (one), 124.2 (one), 113.9 
(2C, both), 80.0 (one), 79.9 (one), 67.0 (both), 62.3 (one), 62.1 
(one), 62.0 (one), 61.7 (one), 58.2 (both), 55.4 (both), 50.0 
(both), 27.0 (one), 27.0 (one), 26.4 (one), 26.4 (one), 22.2 (one), 
22.1 (one); anal. calcd. for C21H27N3O7S: C, 54.18; H, 5.85; N, 
9.03. Found: C, 54.28; H, 5.77; N, 8.95.     
Sulfite (27) 
White crystals, 74% yield; Rf 0.60 (MeOH/EtOAc 1:99); m.p. 
92 ºC; dr: 1:1 (NMR); IR(neat) v 3145 (w), 3046 (w), 2994 (m), 
2960 (m), 2941 (m), 2922 (m), 2877 (m), 2837 (m), 1735 (s), 
1614 (m), 1587 (w), 1512 (m), 1458 (m), 1440 (m), 1387 (m), 
1303 (m), 1243 (m), 1201 (m), 1189 (m), 1172 (m), 1145 (m), 
1107 (s), 1038 (m), 1006 (m), 981 (m), 941 (m), 924 (m), 904 (s), 
839 (m), 813 (m), 804 (m), 786 (m), 757 (m), 739 (m), 717 (m) 
cm-1; 1H NMR (300 MHz, CDCl3) δ 7.65 (one, s), 7.64 (one, s), 
7.28 (one, d, J 8.6 Hz), 7.27 (one, d, J 8.6 Hz), 6.86 (both, d, J 
8.6 Hz), 5.86-5.84 (m), 5.60 (one, d, J 13.4 Hz), 5.55 (one, d, J 
13.4 Hz), 4.96 (one, d, J 13.4 Hz), 4.93 (one, d, J 13.4 Hz), 4.51-
4.22 (m), 3.79 (both, s), 1.99-1.84 (m), 1.76-1.64 (m), 1.59 (one, 
s), 1.58 (one, s); 13C NMR (75 MHz, CDCl3) δ 172.3 (both), 
159.3 (both), 143.4 (one), 143.3 (one), 134.7 (one), 134.7 (one), 
130.2 (one), 130.2 (one), 129.3 (2C, both), 125.4 (one), 125.3 
(one), 124.1 (one), 124.1 (one), 113.9 (2C, both), 79.9 (one), 79.9 
(one), 66.8 (both), 64.1 (one), 64.1 (one), 62.7 (one), 62.6 (one), 
55.4 (both), 55.3 (one), 55.1 (one), 49.5 (both), 27.5 (one), 27.5 
(one), 25.5 (both), 22.3 (both).  
4.16. Representative procedure for the preparation of 
deprotected sulfites (22a, 22b, 24, 26, 28) 
Sulfite (22a)  
The sulfite 21 (259 mg, 0.56 mmol) was dissolved in CH2Cl2 
(52.8 mL) and water (2.9 mL). DDQ (152 mg, 0.67 mmol) was 
added, and the mixture was stirred at 20 ºC for 6 hours. Then the 
mixture was diluted with EtOAc (260 mL) and washed with 40% 
aqueous NaHSO3 (260 mL) and water (2×260 mL). The aqueous 
phase was extracted with EtOAc (260 mL) and the combined 
organic phases were dried (MgSO4), filtered and concentrated in 
vacuo. The residue was purified twice by flash column 
chromatography (EtOAc/toluene 1:1) to give the deprotected 
sulfite 22a (58 mg, 30%, one diastereomer) as white crystals and 
the sulfite 22b (one diastereomer). 22a: Rf 0.42 (MeOH/EtOAc 
1:99); m.p. 121-123 ºC; IR(neat) v 3362 (m), 3134 (m), 2961 
(m), 2929 (m), 2876 (m), 1716 (s), 1658 (m), 1467 (m), 1455 
(m), 1408 (w), 1392 (w), 1378 (w), 1362 (w), 1304 (m), 1284 
(m), 1248 (m), 1194 (m), 1177 (m), 1133 (m), 1105 (m), 1059 
(m), 1049 (m), 1033 (m), 1004 (m), 989 (m), 947 (m), 886 (m), 
815 (m), 766 (m), 731 (m) cm-1; 1H NMR (300 MHz, CDCl3) δ 
7.64 (1H, s), 6.78 (1H, d, J 15.8 Hz), 6.05 (1H, d, J 15.8 Hz), 
5.66 (1H, d, J 13.2 Hz), 4.87 (1H, d, J 13.2 Hz), 4.50 (1H, ddd, J 
13.9 Hz, 7.0 Hz, 5.1 Hz), 4.38 (1H, ddd, J 13.9 Hz, 7.0 Hz, 5.1 
Hz), 4.22 (2H, t, J 5.5 Hz), 4.03 (1H, d, J 10.3 Hz), 3.86 (1H, d, J 
10.3 Hz), 2.99 (1H, br s), 2.17-2.01 (2H, m), 1.77-1.65 (2H, m), 
1.33 (3H, s); 13C NMR (75 MHz, CDCl3) δ 165.7, 150.8, 143.1, 
123.8, 120.9, 71.9, 71.3, 63.3, 55.3, 49.7, 26.6, 25.2, 23.7; 
HRMS (ESI): m/z calcd. for C13H19N3O6S [M+H]+ 346.1067, 
found 346.1048; anal. calcd. for C13H19N3O6S: C, 45.21; H, 5.55; 
N, 12.17. Found: C, 45.30; H, 5.51; N, 12.08. 22b: Rf 0.12 
(MeOH/EtOAc 1:99); 1H NMR (300 MHz, CDCl3) δ 7.56 (1H, 
s), 6.81 (1H, d, J 15.5 Hz), 6.04 (1H, d, J 15.5 Hz), 4.81 (2H, s), 
4.56 (1H, d, J 8.9 Hz), 4.42 (1H, d, J 8.9 Hz), 4.43-4.39 (2H, m), 
4.18 (2H, t, J 6.3 Hz), 2.05-1.97 (2H, m), 1.78 (3H, s), 1.74-1.67 
(2H, m); HRMS (ESI): m/z calcd. for C13H19N3O6S [M+H]+ 
346.1067, found 346.1094. 
Sulfite (24)  
White crystals, 47% yield; Rf 0.42 (MeOH/EtOAc 1:99); m.p. 
115-118 ºC; dr: 3:2 (NMR); IR(neat) v 3152 (w), 3065 (w), 2965 
(m), 2944 (m), 2917 (w), 2872 (w), 2842 (w), 1747 (m), 1725 
(m), 1711 (s), 1657 (m), 1611 (w), 1514 (m), 1466 (w), 1449 
(m), 1413 (w), 1382 (m), 1324 (m), 1300 (m), 1283 (m), 1264 
(m), 1249 (m), 1220 (m), 1179 (m), 1149 (m), 1134 (m), 1027 
(m), 1003 (m), 975 (m), 928 (m), 892 (m), 846 (w), 821 (m), 802 
(w), 787 (m), 757 (m), 741 (m), 700 (m) cm-1;   1H NMR (300 
MHz, CDCl3) δ 7.64 (maj, s), 7.63 (min, s), 6.84 (maj, d, J 15.6 
Hz), 6.82 (min, d, J 15.6 Hz), 6.07 (both, d, J 15.6 Hz), 5.46 
(maj, d, J 12.2 Hz), 5.41 (min, d, J 12.3 Hz), 5.32 (min, d, J 12.3 
Hz), 5.27 (maj, d, J 12.2 Hz), 4.52-4.37 (m), 3.91 (min, d, J 10.1 
Hz), 3.87 (maj, d, J 10.0 Hz), 3.77 (maj, d, J 10.0 Hz), 3.72 (min, 
d, J 10.1 Hz), 3.68 (min, dt, J 7.2 Hz, 7.2 Hz), 3.64 (maj, dt, J 7.1 
Hz, 7.1 Hz), 3.51 (maj, dt, J 7.6 Hz, 7.6 Hz), 3.47 (min, dt, J 7.6 
Hz, 7.6 Hz), 2.69 (both, br s), 2.02-1.78 (m), 1.52-1.41 (m), 1.33 
(min, s), 1.32 (maj, s); 13C NMR (75 MHz, CDCl3) δ 166.2 (maj), 
166.2 (min), 151.8 (maj), 151.8 (min), 144.3 (maj), 144.2 (min), 
123.9 (min), 123.8 (maj), 120.8 (both), 72.2 (min), 72.1 (maj), 
70.7 (maj), 69.0 (min), 62.6 (min), 62.0 (maj), 57.5 (min), 57.5 
(maj), 50.1 (maj), 50.1 (minor), 27.1 (both), 26.2 (both), 23.6 
(both); HRMS (ESI): m/z calcd. for C13H19N3O6S [M+H]+ 
346.1067, found 346,1068; anal. calcd. for C13H19N3O6S: C, 
45.21; H, 5.55; N, 12.17. Found: C, 45.06; H, 5.48; N, 12.07. 
 
Sulfite (26)  
White crystals, 65% yield; Rf 0.36 (MeOH/EtOAc 1:99); m.p. 
129-130 ºC; dr: 1:1 (NMR); IR (neat) v 3503 (br), 3142 (w), 
2970 (m), 2941 (m), 2889 (w), 2871 (w), 1713 (s), 1470 (w), 
1447 (m), 1364 (m), 1342 (w), 1264 (m), 1228 (m), 1197 (s) 
1150 (m), 1135 (m), 1069 (m), 1053 (m), 983 (m), 970 (m), 946 
(m), 920 (m), 871 (m), 839 (w), 821 (w), 805 (w), 777 (m), 731 
(m), 678 (m) cm-1; 1H NMR (500 MHz, CDCl3) δ 7.55 (both, s), 
5.88-5.82 (one, m), 5.81 (one, d, J 15.4 Hz), 5.75 (one, d, J 15.4 
Hz), 5.70 (both, d, J 12.5 Hz), 5.16 (one, d, J 12.5 Hz), 5.15 (one, 
d, J 12.5 Hz), 4.58-4.42 (m), 4.39-4.23 (m), 4.07-4.01 (m), 3.74-
3.65 (m), 3.28 (both, br s), 2.07-1.97 (m), 1.96-1.85 (m), 1.66-
1.54 (m), 1.53 (both, s); 13C NMR (75 MHz, CDCl3) δ 174.9 
(one), 174.8 (one), 142.7 (one), 142.7 (one), 136.3 (one), 135.2 
(one), 124.1 (both), 124.1 (one), 123.9 (one), 74.3 (both), 62.2 
(one), 62.0 (one), 61.9 (one), 61.8 (one), 58.9 (one), 58.8 (one), 
50.0 (one), 50.0 (one), 26.9 (one), 26.9 (one), 26.4 (one), 26.3 
(one), 25.2 (both); HRMS (ESI): m/z calcd. for C13H19N3O6S 
[M+H]+ 346.1067, found 346.1073; anal. calcd. for C13H19N3O6S: 
C, 45.21; H, 5.55; N, 12.17. Found: C, 44.59; H, 5.78; N, 12.07. 
 
Sulfite (28)  
White crystals, 67% yield; Rf 0.36 (MeOH/EtOAc 1:99); m.p. 
93-95 ºC; dr: 1:1 (NMR); IR (neat) v 3500 (m), 3151 (w), 2966 
(m), 2872 (w), 1719 (s), 1676 (w), 1454 (m), 1443 (m), 1373 (m) 
1278 (m), 1198 (m), 1171 (s), 1134 (m), 1075 (w), 1049 (m), 
1027 (m), 978 (m), 940 (m), 925 (m), 889 (m), 854 (m), 835 (m), 
788 (m), 767 (m), 736 (m), 710 (m), 670 (m) cm-1; 1H NMR (300 
MHz, CDCl3) δ 7.63 (one, s), 7.61 (one, s), 5.94-5.74 (m), 5.63 
(one, dd, J 13.6 Hz, 0.4 Hz), 5.54 (one, dd, J 13.6 Hz, 0.4 Hz), 
4.97 (one, dd, J 13.6 Hz, 0.4 Hz), 4.91 (one, dd, J 13.6 Hz, 0.4 
Hz), 4.61-4.18 (m), 4.05-3.98 (m), 3.36 (both, br s), 1.99-1.62 
(m), 1.46 (one, s), 1.45 (one, s); 13C NMR (75 MHz, CDCl3) δ 
175.1 (one), 175.0 (one), 143.7 (one), 143.7 (one), 135.4 (one), 
135.3 (one), 124.1 (one), 124.0 (one), 123.8 (one), 123.6 (one), 
74.1 (one), 74.1 (one), 64.6 (one), 64.6 (one), 63.0 (one), 62.2 
(one), 55.7 (one), 54.6 (one), 49.5 (one), 49.5 (one), 27.4 (one), 
27.3 (one), 26.0 (one), 25.9 (one), 25.8 (one), 25.8 (one); HRMS 
(ESI): m/z calcd. for C13H19N3O6S [M+H]+ 346.1067, found  
346,1063; anal. calcd. for C13H19N3O6S: C, 45.21; H, 5.55; N, 
12.17. Found: C, 45.56; H, 5.76; N, 11.85. 
 
4.17. Representative procedure for the preparation of 
macrocyclic malonates (29, 31) 
Malonate (29) 
The diol 14 (55 mg, 0.13 mmol) was dissolved in anhydrous 
CH2Cl2 (9.74 mL) and anhydrous Et3N (0.05 mL, 0.36 mmol) 
and DMAP (3 mg, 0.03 mmol) were added. A solution of 
malonyl chloride in anhydrous CH2Cl2 (0.18 M, 1 mL, 0.18 
mmol) was added over 10 min at 20 ºC, under vigorous stirring. 
After stirring for 1½ hours, the reaction mixture was concentrated 
in vacuo. The residue was redissolved in EtOAc, filtered through 
Celite and concentrated in vacuo. Purification by flash column 
chromatography (MeOH/CH2Cl2 1:99) gave the malonate 29 (23 
mg, 37%) as a colorless oil. Rf 0.54 (MeOH/EtOAc 1:99); IR 
(neat) v 3146 (w), 2956 (m), 2872 (w), 2838 (w), 1751 (s), 1733 
(s), 1715 (s), 1656 (w), 1613 (m), 1586 (w), 1514 (m), 1463 (m), 
1443 (m), 1409 (w), 1385 (m), 1364 (m), 1300 (m), 1247 (s), 
1172 (m), 1146 (m), 1130 (m), 1030 (m), 993 (m), 911 (m), 822 
(m), 727 (m) cm-1;   1H NMR (300 MHz, CDCl3) δ 7.68 (1H, s), 
7.24 (2H, d, J 8.7 Hz), 6.91 (1H, d, J 16.0 Hz), 6.87 (2H, d, J 8.7 
Hz), 6.04 (1H, d, J 16.0 Hz), 5.36 (1H, d, J 12.7 Hz), 5.21 (1H, d, 
J 12.7 Hz), 4.46 (2H, t, J 6.4 Hz), 4.42 (1H, d, J 10.5 Hz), 4.36 
(1H, d, J 10.5 Hz), 4.29 (1H, d, J 11.1 Hz), 4.22 (1H, d, J 11.1 
Hz), 4.28-4.13 (2H, m), 3.80 (3H, s), 3.48 (1H, d, J 16.3 Hz), 
3.42 (1H, d, J 16.3 Hz), 2.05-1.89 (2H, m), 1.67-1.59 (2H, m), 
1.45 (3H, s); 13C NMR (75 MHz, CDCl3) δ 166.7, 165.9, 165.9, 
159.3, 149.3, 143.0, 130.3, 129.0 (2C), 124.0, 122.4, 114.0 (2C), 
76.1, 69.5, 65.2, 63.0, 59.1, 55.4, 49.5, 41.2, 27.0, 25.5, 20.6.  
Malonate (31) 
White crystals, 34% yield; m.p. 113-115 ºC; Rf 0.54 
(MeOH/EtOAc 1:99); IR(neat) v 3153 (w), 3064 (w), 3039 (w), 
2998 (w), 2944 (m), 2916 (w), 2872 (m), 2842 (w), 1747 (s), 
1726 (s), 1712 (s), 1657 (m), 1611 (m), 1587 (w), 1514 (m), 1465 
(w), 1449 (m), 1413 (w), 1383 (m), 1324 (m), 1300 (m), 1283 
(m), 1265 (m), 1249 (m), 1220 (m), 1179 (s), 1149 (m), 1135 
(m), 1122 (m), 1059 (m), 1027 (s) 976 (m), 928 (m), 847 (m), 
821 (m), 803 (m), 788 (m), 757 (m), 742 (w) cm-1;   1H NMR (500 
MHz, CDCl3) δ 7.70 (1H, s), 7.24 (2H, d, J 8.5 Hz), 6.94 (1H, d, 
J 16.0 Hz), 6.87 (2H, d, J 8.5 Hz), 6.08 (1H, d, J 16.0 Hz), 5.38 
(1H, d, J 12.8 Hz), 5.35 (1H, d, J 12.8 Hz), 4.48-4.43 (2H, m), 
4.42 (1H, d, J 10.7 Hz), 4.37 (1H, d, J 10.7 Hz), 4.27 (1H, d, J 
11.2 Hz), 4.15 (1H, d, J 11.2 Hz), 4.00-3.90 (2H, m), 3.80 (3H, 
s), 3.34 (1H, d, J 15.9 Hz), 3.30 (1H, d, J 15.9 Hz), 1.96-1.91 
(2H, m), 1.54-1.47 (2H, m), 1.44 (3H, s); 13C NMR (75 MHz, 
CDCl3) δ 166.2, 166.1, 165.7, 159.3, 149.4, 148.6, 130.3, 129.0 
(2C), 124.2, 122.5, 113.9 (2C), 76.3, 69.5, 65.2, 64.2, 58.1, 55.4, 
49.6, 41.3, 26.1, 25.3, 20.2. 
4.18. Representative procedure for the preparation of 
deprotected macrocyclic malonates (30, 32) 
Malonate (30) 
The malonate 29 (100 mg, 0.21 mmol) was dissolved in 
CH2Cl2 (19.5 mL) and water (1.1 mL). DDQ (56 mg, 0.25 mmol) 
was added, and the mixture was stirred at 20 ºC for 5½ hours. 
Then the mixture was diluted with EtOAc (100 mL) and washed 
with 40% aqueous NaHSO3 (120 mL) and water (2×80 mL). The 
aqueous phase was extracted with EtOAc (120 mL) and the 
combined organic phases were dried (MgSO4), filtered and 
concentrated in vacuo. The residue was purified twice by flash 
column chromatography (EtOAc/toluene 1:1) to give the 
deprotected malonate 30 (59 mg, 78%) as a colorless oil. Rf 0.38 
(MeOH/EtOAc 1:99); IR (neat) v 3468 (br), 3148 (w), 2958 (m), 
1713 (s), 1658 (m), 1444 (m), 1373 (m), 1328 (m), 1264 (s), 
1182 (m), 1136 (s), 1046 (m), 1024 (m), 979 (m) cm-1;   1H NMR 
(500 MHz, CDCl3) δ 7.70 (1H, s), 6.92 (1H, d, J 15.7 Hz), 6.04 
(1H, d, J 15.7 Hz), 5.44 (1H, d, J 12.6 Hz), 5.17 (1H, d, J 12.6 
Hz), 4.48 (1H, d, J 10.9 Hz), 4.46 (2H, t, J 6.4 Hz), 4.42 (1H, m), 
4.03 (1H, d, J 10.9 Hz), 4.02 (1H, m), 3.48 (1H, d, J 17.5 Hz), 
3.45 (1H, d, J 17.5 Hz), 2.13 (1H, m), 2.04 (1H, m), 1.73 (1H, 
m), 1.57 (1H, m), 1.36 (3H, s); 13C NMR (75 MHz, CDCl3) δ 
168.1, 166.1, 165.7, 151.5, 142.5, 124.6, 120.2, 72.2, 71.1, 63.2, 
59.1, 49.5, 41.1, 26.9, 25.1, 23.6; HRMS (ESI): m/z calcd. for 
C16H21N3O7 [M+H]+ 368.1452, found 368.1449; anal. calcd. for 
C16H21N3O7: C, 52.31; H, 5.76; N, 11.44. Found: C, 52.23; H, 
5.71; N, 11.40. 
 
Malonate (32) 
White crystals, 69% yield; m.p. 105-106 ºC; Rf 0.38 
(MeOH/EtOAc 1:99); IR (neat) v 3308 (br), 3156 (w), 2986 (w), 
2968 (m), 2941 (w), 2873 (w), 1727 (s), 1711 (s), 1650 (w), 1462 
(w), 1447 (w), 1422 (w), 1376 (w), 1351 (m), 1324 (m), 1295 
(m), 1259 (m), 1239 (m), 1224 (m), 1169 (m), 1075 (m), 1065 
(m), 1030 (m), 1007 (m), 981 (m), 841 (m), 782 (m) cm-1; 1H 
NMR (500 MHz, CDCl3) δ 7.69 (1H, s), 6.96 (1H, d, J 15.7 Hz), 
6.10 (1H, d, J 15.7 Hz), 5.39 (1H, d, J 12.6 Hz), 5.33 (1H, d, J 
12.6 Hz), 4.49-4.40 (2H, m), 4.24 (1H, d, J 11.2 Hz), 4.17 (1H, d, 
J 11.2 Hz), 3.92 (2H, t, J 7.3 Hz), 3.35 (1H, d, J 16.4 Hz), 3.32 
(1H, d, J 16.4 Hz), 1.96-1.90 (2H, m), 1.52-1.45 (2H, m), 1.35 
(3H, s); 13C NMR (75 MHz, CDCl3) δ 166.5, 166.1, 165.9, 151.4, 
143.8, 124.2, 120.4, 72.3, 71.4, 64.3, 57.8, 49.7, 41.2, 25.9, 25.4, 
24.1; HRMS (ESI): m/z calcd. for C16H21N3O7 [M+H]+ 368.1452, 
found 368,1450; anal. calcd. for C16H21N3O7: C, 52.31; H, 5.76; 
N, 11.44. Found: C, 52.18; H, 5.74; N, 11.29. 
 
4.19. Representative procedure for the preparation of 
dialdehydes (33, 35, 39) 
(±)‐(E)-4-(4-Formyl-1H-1,2,3-triazol-1-yl)butyl 2-(4-
methoxybenzyloxy)-2-methyl-5-oxopent-3-enoate (39) 
The diol 20 (51 mg, 0.12 mmol) was dissolved in CH3CN (2.1 
mL). IBX21 (202 mg, 0.72 mmol) was added, and the suspension 
was heated to 55 ºC. After stirring at 55 ºC for 3½ hours, the 
suspension was concentrated in vacuo. The residue was 
redissolved in ether, filtered and concentrated in vacuo giving the 
dialdehyde 39 (50 mg, quantitative yield) as a colorless oil. Rf 
0.46 (MeOH/CH2Cl2 5:95); IR (neat) v 3133 (w), 2960 (m), 2937 
(m), 2872 (m), 2837 (m), 1733 (s), 1688 (s), 1612 (m), 1531 (m), 
1513 (s), 1463 (m), 1443 (m), 1384 (m), 1301 (m), 1245 (s), 
1174 (m), 1110 (s), 1092 (s), 1028 (s), 979 (m), 822 (m), 782 (m) 
cm-1;   1H NMR (300 MHz, CDCl3) δ 10.13 (1H, s), 9.62 (1H, d, J 
7.7 Hz), 8.02 (1H, s), 7.27 (2H, d, J 8.5 Hz), 6.99 (1H, d, J 15.9 
Hz), 6.87 (2H, d, J 8.5 Hz), 6.43 (1H, dd, J 15.9 Hz, 7.7 Hz), 
4.44 (2H, s), 4.43 (2H, t, J 7.1 Hz), 4.23 (2H, t, J 6.3 Hz), 3.80 
(3H, s), 2.07-1.97 (2H, m), 1.77-1.70 (2H, m), 1.67 (3H, s); 13C 
NMR (75 MHz, CDCl3) δ 193.2, 185.1, 171.3, 159.4, 155.1, 
147.9, 132.3, 129.6, 129.1 (2C), 125.3, 113.9 (2C), 80.3, 67.4, 
64.9, 55.4, 50.2, 26.9, 25.5, 23.6. 
(±)-(E)-(1-(4-Oxobutyl)-1H-1,2,3-triazol-4-yl)methyl 2-(4-
methoxybenzyloxy)-2-methyl-5-oxopent-3-enoate (35)  
Colorless oil, 98% yield; Rf 0.35 (MeOH/CH2Cl2 5:95); IR 
(neat) v 3143 (w), 2957 (m), 2938 (m), 2837 (m), 2733 (w), 1723 
(s), 1688 (s), 1613 (m), 1514 (s), 1461 (m), 1443 (m), 1386 (m), 
1302 (m), 1247 (s), 1175 (m), 1106 (s), 1048 (m), 1028 (m), 979 
(m), 913 (m), 821 (m), 729 (m) cm-1; 1H NMR (300 MHz, 
CDCl3) δ 9.72 (1H, s), 9.58 (1H, d, J 7.8 Hz), 7.58 (1H, s), 7.25 
(2H, d, J 8.6 Hz), 6.99 (1H, d, J 15.9 Hz), 6.86 (2H, d, J 8.6 Hz), 
6.38 (1H, dd, J 15.9 Hz, 7.8 Hz), 5.37 (1H, d, J 13.2 Hz), 5.32 
(1H, d, J 13.2 Hz), 4.44-4.37 (4H, m), 3.80 (3H, s), 2.52 (2H, t, J 
6.8 Hz), 2.24-2.15 (2H, m), 1.66 (3H, s); 13C NMR (75 MHz, 
CDCl3) δ 200.3, 193.2, 171.3, 159.4, 155.1, 142.3, 132.2, 129.6, 
129.4 (2C), 124.1, 113.9 (2C), 80.2, 67.5, 58.9, 55.4, 49.4, 40.2, 
23.8, 22.7. 
(±)-(E)-4-(4-Formyl-1H-1,2,3-triazol-1-yl)butyl 4-(4-
methoxybenzyloxy)-4-methyl-5-oxopent-2-enoate (33) 
Colorless oil, quantitative yield; Rf 0.55 (MeOH/EtOAc 1:99); 
1H NMR (300 MHz, CDCl3) δ 10.15 (1H, s), 9.51 (1H, s), 8.11 
(1H, s), 7.29 (2H, d, J 8.8 Hz), 6.90 (2H, d, J 8.8 Hz), 6.87 (1H, 
d, J 15.9 Hz), 6.20 (1H, d, J 15.9 Hz), 4.51-4.45 (4H, m), 4.20 
(2H, t, J 6.3 Hz), 3.81 (3H, s), 2.11-2.01 (2H, m), 1.77-1.68 (2H, 
m), 1.52 (3H, s); 13C NMR (75 MHz, CDCl3) δ 199.7, 185.3, 
165.6, 159.6, 148.0, 145.0, 129.6, 129.4 (2C), 125.2, 123.7, 114.1 
(2C), 83.3, 66.8, 63.6, 55.4, 50.4, 27.0, 25.7, 19.6. 
4.20. Representative procedure for the preparation of 
macrocyclic amines (34, 36, 40) 
Amine (40) 
The dialdehyde 39 (43 mg, 0.10 mmol) was dissolved in 
anhydrous CH2Cl2 (6.9 mL). The mixture was cooled to 0 ºC, and 
a solution of veratrylamine in anhydrous CH2Cl2 (0.11 M, 1 mL, 
0.11 mmol) was added. After stirring at 0 ºC for 25 min, 
Na(OAc)3BH (65 mg, 0.31 mmol) was added. After stirring at 0 
ºC for further 15 minutes, powdered 3 Å molecular sieves (40 
mg) were added. The suspension was then stirred at 0 ºC for 3 h, 
whereafter it was quenched with ether (10 mL) and then water 
(20 mL). After filtration, the mixture was transferred to a 
separatory funnel with ether (40 mL) and CH2Cl2 (20 mL). The 
organic phase was isolated and washed with a mixture of sat. aq. 
NaHCO3 (40 mL) and water (20 mL). The aqueous phase was 
extracted with CH2Cl2 (2×30 mL) and ether (30 mL). The 
combined organic phases were dried (Na2SO4), filtered and 
concentrated in vacuo. Purification by flash column 
chromatography (EtOAc/heptane 3:1) gave the azalide 40 (34 
mg, 60%) as an amorphous solid. Rf 0.30 (MeOH/CH2Cl2 5:95); 
IR (neat) v 3134 (w), 3034 (m), 2996 (m), 2934 (m), 2872 (m), 
2834 (m), 1730 (s), 1612 (m), 1589 (m), 1512 (s), 1453 (m), 
1418 (m), 1367 (m), 1329 (m), 1301 (m), 1244 (s), 1175 (m), 
1108 (s), 1025 (s), 980 (m), 943 (m), 893 (m), 853 (m), 810 (m), 
764 (m) cm-1;   1H NMR (300 MHz, CDCl3) δ 7.52 (1H, s), 7.27 
(2H, d, J 8.8 Hz), 6.96 (1H, s), 6.89 (1H, d, J 8.2 Hz), 6.85 (2H, 
d, J 8.8 Hz), 6.79 (1H, d, J 8.2 Hz), 5.77 (1H, d, J 15.7 Hz), 5.64 
(1H, dt, J 15.7 Hz, 4.9 Hz), 4.43 (1H, d, J 10.6 Hz), 4.41-4.36 
(2H, m), 4.31 (1H, d, J 10.6 Hz), 4.26-4.11 (2H, m), 3.86 (3H, s), 
3.84 (3H, s), 3.81 (2H, s), 3.79 (3H, s), 3.74 (1H, d, J 13.3 Hz), 
3.68 (1H, d, J 13.3 Hz), 3.21 (2H, d, J 4.9 Hz), 2.10-2.01 (2H, 
m), 1.68-1.62 (2H, m), 1.53 (3H, s); 13C NMR (75 MHz, CDCl3) δ 172.7, 159.2, 149.0, 148.2, 147.4, 131.7, 131.6, 131.0, 130.7, 
129.3 (2C), 122.0, 121.1, 113.8 (2C), 112.1, 110.9, 80.3, 66.7, 
63.4, 60.6, 56.1, 56.0, 56.0, 55.4, 50.1, 49.4, 26.6, 26.5, 22.4; 
HRMS (ESI): m/z calcd. for C30H38N4O6 [M+H]+ 551.2864, 
found 551.2859. 
 
Amine (36) 
White solid, 46% yield; Rf 0.17 (MeOH/CH2Cl2 5:95); m.p. 
141-143 ºC; IR(neat) v 3129 (w), 2994 (w), 2966 (w), 2937 (m), 
2915 (w), 2875 (w), 2837 (w), 2797 (m), 1718 (s), 1614 (m), 
1589 (w), 1516 (s), 1452 (m), 1420 (w), 1389 (w), 1375 (w), 
1328 (w), 1252 (s), 1237 (m), 1184 (m), 1160 (m), 1122 (s), 1058 
(w), 1024 (m), 966 (w), 929 (w), 879 (w), 856 (w), 826 (m), 805 
(m), 761 (w) cm-1; 1H NMR (300 MHz, CDCl3) δ 7.62 (1H, s), 
7.32 (2H, d, J 8.7 Hz), 6.87 (2H, d, J 8.7 Hz), 6.83 (1H, s), 6.76 
(2H, s), 5.66 (1H, dt, J 15.7 Hz, 6.0 Hz), 5.49 (1H, d, J 12.1 Hz), 
5.44 (1H, d, J 15.7 Hz), 5.31 (1H, d, J 12.1 Hz), 4.49 (1H, d, J 
10.6 Hz), 4.41 (1H, d, J 10.6 Hz), 4.39-4.28 (2H, m), 3.85 (3H, 
s), 3.84 (3H, s), 3.80 (3H, s), 3.47 (1H, d, J 13.9 Hz), 3.42 (1H, d, 
J 13.9 Hz), 2.89 (2H, d, J 6.0 Hz), 2.15-2.09 (2H, m), 1.90-1.79 
(2H, m), 1.58 (3H, s), 1.27-1.15 (2H, m); 13C NMR (75 MHz, 
CDCl3) δ 173.0, 159.2, 149.0, 148.1, 142.9, 132.3, 132.3, 131.9, 
130.6, 129.3 (2C), 124.7, 120.9, 113.8 (2C), 111.8, 110.8, 80.4, 
66.7, 59.3, 58.0, 56.0, 56.0, 55.4, 54.8, 52.7, 50.1, 27.7, 22.7, 
20.9; HRMS (ESI): m/z calcd. for C30H38N4O6 [M+H]+ 551.2864, 
found 551.2862. 
 
Amine (34) 
9% yield; Rf 0.30 (MeOH/EtOAc 1:99); 1H NMR (500 MHz, 
CD3OD) δ 7.57 (1H, s), 7.18 (2H, d, J 8.6 Hz), 7.05 (1H, m), 
6.90-6.83 (2H, m), 6.78 (2H, d, J 8.6 Hz), 6.65 (1H, d, J 16.1 
Hz), 5.85 (1H, d, J 16.1 Hz), 4.41 (1H, d, J 11.0 Hz), 4.35 (1H, 
m), 4.28 (1H, d, J 11.0 Hz), 4.27 (1H, m), 4.23 (1H, m), 4.16 
(1H, d, J 13.6 Hz), 4.08 (1H, m), 3.82 (3H, s), 3.74 (6H, s), 3.65 
(1H, d, J 14.3 Hz), 3.57 (1H, d, J 13.6 Hz), 3.43 (1H, d, J 14.3 
Hz), 3.05 (1H, d, J 14.2 Hz), 2.85 (1H, d, J 14.2 Hz), 2.10-1.97 
(2H, m), 1.84-1.74 (2H, m), 1.35 (3H, s); HRMS (ESI): m/z 
calcd. for C30H38N4O6 [M+H]+ 551.2864, found 551.2845. 
 
4.21. Representative procedure for the preparation of 
monodeprotected macrocyclic amines (37, 41) 
Amine (37) 
The amine 36 (15 mg, 0.027 mmol) was dissolved in CH2Cl2 
(0.70 mL) and water (0.14 mL). DDQ (18 mg, 0.08 mmol) was 
added, and the reaction mixture was stirred at 20 ºC for 21 hours. 
Subsequently, the mixture was concentrated in vacuo, and the 
residue was purified by flash column chromatography 
(EtOAc/toluene 4:1 + 0.5% Et3N) to give the monodeprotected 
amine 37 (8 mg, 69%) as a colorless film. Rf 0.07 
(MeOH/CH2Cl2 5:95); 1H NMR (300 MHz, CD3OD) δ 7.94 (1H, 
s), 6.95 (1H, d, J 1.6 Hz), 6.89 (1H, d, J 8.2 Hz), 6.83 (1H, dd, J 
8.2 Hz, 1.6 Hz), 5.71 (1H, ddd, J 15.4 Hz, 8.5 Hz, 4.4 Hz), 5.60 
(1H, d, J 12.3 Hz), 5.44 (1H, d, J 15.4 Hz), 5.11 (1H, d, J 12.3 
Hz), 4.46-4.41 (2H, m), 3.83 (3H, s), 3.81 (3H, s), 3.58 (1H, d, J 
13.0 Hz), 3.51 (1H, d, J 13.0 Hz), 3.07 (1H, ddd, J 14.7 Hz, 4.4 
Hz, 1.6 Hz), 2.85 (1H, dd, J 14.7 Hz, 8.5 Hz), 2.15 (2H, t, J 8.1 
Hz), 1.90 (1H, m), 1.75 (1H, m), 1.43 (3H, s), 1.33 (1H, m), 1.07 
(1H, m); HRMS (ESI): m/z calcd. for C22H30N4O5 [M+H]+ 
431.2289, found 431.2289. 
Amine (41) 
33% yield; Rf 0.10 (MeOH/CH2Cl2 5:95); 1H NMR (500 
MHz, CD3OD) δ 7.87 (1H, s), 7.07 (1H, s), 6.94 (1H, d, J 8.2 
Hz), 6.91 (1H, d, J 8.2 Hz), 5.65 (1H, d, J 15.6 Hz), 5.57 (1H, 
ddd, J 15.6 Hz, 6.2 Hz, 4.8 Hz), 4.47 (1H, m), 4.39 (1H, m), 4.27 
(1H, m), 4.03 (1H, m), 3.85 (3H, s), 3.82 (3H, s), 3.78 (2H, d, J 
6.9 Hz), 3.74 (2H, s), 3.25 (1H, m), 3.18 (1H, dd, J 15.5 Hz, 6.2 
Hz), 2.04 (2H, m), 1.66 (1H, m), 1.57 (1H, m), 1.36 (3H, s); 
HRMS (ESI): m/z calcd. for C22H30N4O5 [M+H]+ 431.2289, 
found 431.2281. 
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a b s t r a c t
A method for the formation of synthetic macrocycles with different ring sizes from diols is presented.
Reacting a simple diol precursor with electrophilic reagents leads to a cyclic carbonate, sulﬁte, or phos-
phate in a single step in 25–60% yield. Converting the cyclization precursor to a bis-electrophilic iodide or
aldehyde enables preparation of a cyclic sulﬁde and amine, respectively, the latter using a double-reduc-
tive amination to induce ring closure.
 2008 Elsevier Ltd. All rights reserved.
In connection with an ongoing program to produce libraries of
macrocyclic compounds from simple building blocks, we were
interested in the possibility of forming large rings from bifunc-
tional precursors.
An important challenge in forming large ring molecules is the
fact that it is often necessary to tailor reaction conditions to indi-
vidual substrates,1 which can render the generation of libraries
impractical. With this in mind, we decided to investigate the cycli-
zation in one to two synthetic steps with the added potential for
diversity in the ring-forming step. Our initial efforts, reported here,
have been focused on using a diol and its electrophilic derivatives
as cyclization precursors, and reacting them with bifunctional re-
agents in a single cyclization step.
In order to test different cyclization methods, we synthesized
the simple precursor 7 (Scheme 1). Addition of lithium 3-(tert-
butyldimethylsilyloxy)propynide to c-butyrolactone followed by
TBDPS protection of the resulting alcohol afforded the acetylenic
ketone 2. Reduction of the alkynone2 followed by neutral methyl-
ation3 gave 3, which could be selectively monodeprotected by
acidic solvolysis. Esteriﬁcation with the known4 acid 5 and depro-
tection with TBAF yielded the desired diol 7.
Our ﬁrst macrocyclic target was the carbonate 8 (Scheme 2 and
Table 1). Treatment of the precursor 7 with carbonyl diimidazole
(entry 1) or phosgene,5 either as a solution (entry 2) or prepared
in situ from triphosgene (entries 3 and 4), all resulted in no or
low conversion. Using p-nitrophenyl chlorocarbonate (PNPCC)
with DMAP as the base led to a 19% yield of 8 by NMR (entry 6),
and enabled isolation of the desired product. Optimized conditions
called for slow addition of separate solutions of DMAP and the car-
0040-4039/$ - see front matter  2008 Elsevier Ltd. All rights reserved.
doi:10.1016/j.tetlet.2008.11.100
* Corresponding author. Tel.: +45 45252131; fax: +45 45933968.
E-mail address: mhc@kemi.dtu.dk (M.H. Clausen).
O
O TBDMSO
MeLi
THF
62%
CH2Cl2
62%
TBDPSCl
Imidazole
O
TBDMSO
93%
1) NaBH4, CeCl3, MeOH
2) MeI, Ag2O, Et2O
OMe
TBDMSO
PPTS
EtOH
88% OMe
HO
EDC, DMAP
CH2Cl2
95%
OMe
O
OR2
O
OR1
TBDPSO TBDPSO
TBDPSO
6 : R1 = TBDPS, R2 = TBDMS
7: R1 = R2 = H
COOH
OTBDMS
2 3
4
5
TBAF, THF
70%
O
TBDMSO
OH
1
Scheme 1. Synthesis of the cyclization precursor.
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bonate to a methylene chloride solution of the diol over 24 h with a
ﬁnal concentration of 25 mM (entry 7). This protocol gave the de-
sired product in 45% yield. By-products were of an oligomeric nat-
ure; we did not isolate any larger cyclic structures in any of the
experiments.
Encouraged by the results of the one-pot approach to the car-
bonate, we next prepared a cyclic sulﬁte.6 Dropwise addition of
thionyl chloride to a 10 mM solution of 7, triethylamine and DMAP
in methylene chloride led to the isolation of cyclic sulﬁte 9 in 55%
yield as a 1:1 mixture of inseparable diastereoisomers. Similarly,
we were able to prepare the macrocyclic phosphate 10 by reaction
with p-nitrophenyl phosphorodichloridate (PNPOPOCl2) in 50%
yield.
Due to the large inﬂuence of the conformations of the precur-
sors on macrocyclizations,7 it was important to test other sub-
strates under the standard conditions for cyclization. To elucidate
whether the approach was general, we studied the formation of
cyclic sulﬁtes from other diols (Scheme 3).8 Gratifyingly, partial
(substrate 11) or full (precursor 12) reduction of the triple bond
did not negatively affect the yield of the cyclization under our stan-
dard conditions in a signiﬁcant manner. On the other hand, com-
bining 4 with a sorbic acid derivative to form precursor 13 did
result in a decreased yield for the cyclization—perhaps not surpris-
ing, considering that the resulting 17-membered macrocycle 16
contains 5 sp2 and 2 sp-hybridized carbon atoms. Substrates that
cyclize reluctantly under these conditions generally led to oligo-
mers or eventually conversion of the alcohols into chlorides, which
was also the case for the reaction of 13. Overall, we were pleased
that identical conditions led to a reasonable isolated yield for all
the cyclizations without the need for optimization of the individual
reactions.
To investigate the potential of macrocyclizations involving
reactions with nucleophiles, we prepared two bis-electrophilic
derivatives of 7, the diiodide 17 and the dialdehyde 18 (Scheme
4). Reaction of 17 with sodium or lithium sulﬁde in a range of
solvents did not afford the desired product. However, using the
organic sulﬁde equivalent bis(tributyltin)sulﬁde in the presence
of CsF and 18-crown-69 led to the isolation of the 15-membered
cyclic sulﬁde 19 in 56% yield. To the best of our knowledge, the
use of double-reductive amination of dialdehydes with a mono-
amine to prepare macrocyclic compounds has never been re-
ported.10 It was therefore with great pleasure we noted that
benzylamine reacted with 18 in the presence of sodium triacet-
oxyborohydride to give the product 20, proving that cyclization
is also feasible when nucleophilic reagents are reacted with
bis-electrophiles.
In conclusion, we have demonstrated that a simple diol and its
electrophilic derivatives can serve as precursors for cyclic mole-
cules formed in a single step under standard conditions. We be-
lieve that this method will help gain easy access to large ring
Table 1
Conditions for the formation of cyclic carbonate 8 from diol 7
Entry CDIa (equiv) COCl2 (equiv) Triphosgene (equiv) PNPCCb (equiv) Pyridine (equiv) Et3N (equiv) DMAP (equiv) Concn of 7 (mM) Yield of 8c (%)
1 1 — — — — — 0.1 10 No conv.
2d — 1.2 — — — 1.4 0.2 10 <5
3d — — 0.5e — 3 3 0.05 20 <5
4d — — 0.6f — 5 — 0.05 10 <5
5 — — — 1.2 — — 2.4 25 <10
6 — — — 1.35 — — 2.4 12.5 19
7g — — — 1 — — 1.3 25 45
a Carbonyl diimidazole.
b p-Nitrophenyl chlorocarbonate.
c Determined by 1H NMR of the crude after aqueous work-up.
d Reagents added at 78 C.
e 0.05 equiv of LiCl added.
f 0.02 equiv of Aliquot 336 added.
g Separate CH2Cl2 solutions of DMAP and PNPCC added over 24 h.
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Scheme 2. Formation of macrocycles from diol precursors.
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molecules, and we are currently pursuing libraries of macrocycles
based on this strategy.
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